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ABSTRACT
The erbB1 receptor regulates cellular programs including proliferation, migration,
and differentiation and is the prototypical receptor tyrosine kinase (RTK). The erbB
family consists of four homologous transmembrane receptors (erbB1/HER1/EGFR,
erbB2/HER2, erbB3/HER3, erbB4). Canonically, ligand binding leads to an extracellular
conformational change that promotes the formation of a receptor-mediated back-to-back
dimer, asymmetric orientation of the catalytic kinase domains, and downstream
transphosphorylation of cytoplasmic tyrosine residues. Exceptions to this paradigm are
the orphan erbB2 and the kinase defective erbB3. The erbB receptors are implicated in
mechanisms of carcinogenesis and are, thus, important therapeutic targets. Antibodies
and small molecule inhibitors have been used to target cancer cells expressing erbB1
and erbB2, however, tumors often become resistant to treatment. Recent evidence
implicates erbB3 in escape from erbB1- and erbB2-targeted pharmacological agents.
Therefore, understanding the function of these receptors and their interactions with
each other is important for designing better therapeutics.
Here, we investigated erbB dimer formation and lifetime using live cell imaging
and an analytical three-state Hidden Markov Model (HMM). First, multi-color quantum
dot (QD) based probes that label resting or activated receptors were used to directly
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observe dimerization and quantify diffusion and correlated motion. Second, pairwise
analyses of single particle trajectories in our HMM are used to characterize transition
rates between free, confined, and dimerized states. We examined preformed,
unliganded erbB1 homodimers and demonstrate that these do not display correlated
motion and that observed dimers are short lived. Interestingly, liganded erbB1 dimers
have the same off rate regardless of the activation status of the kinase domain. We
further describe features of membrane organization, in particular demonstrating
differential partitioning of activated receptors that alters mobility and permits repeated
interactions within domains.
Important mechanistic insight comes from our novel observations of short lived
erbB2-erbB3 heterodimers and long lived erbB3 homodimers. Prior biochemical studies
suggested that the erbB2-erbB3 heterodimer was the functional signaling unit. Our
single particle tracking results are consistent with a new model for an active erbB3
kinase domain that is dependent on interactions with erbB2. Furthermore, our data
indicate that erbB3 dimers and, ultimately, oligomers may be the principal signaling
complex. This work demonstrates the importance of membrane architecture and
reorganization in signal transduction and sheds new light on mechanisms of erbB
activation with unprecedented spatial and temporal resolution.
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CHAPTER 1: INTRODUCTION
1.1 Overview
Cells must finely tune their responses to environmental cues in order to survive,
promote differentiation and proliferation, and modulate other essential mechanisms.
This is accomplished through transduction of extracellular signals through the plasma
membrane into the cytoplasm and nucleus, controlling enzymatic activity and genetic
programs. Although stringent regulation of cell signaling is necessary to maintain
homeostasis, the details of the spatiotemporal control of these pathways are still poorly
understood. The dynamics of cell surface receptors, including diffusive characteristics,
spatial distribution, and interactions with binding partners must be better characterized
to understand how these parameters impact signal integration. In particular, studying
these properties in the context of the cell membrane is essential to understand how
membrane composition and fluidity affects protein-protein interactions and clustering
(Singer and Nicolson, 1972; Metzger, 1992).
The work presented here addresses some of these important issues with a focus on
the erbB family of receptors. The following sections of this introduction describe erbB
signaling, with a focus on mechanisms of receptor dimerization and the role of
membrane reorganization on signaling. Next, the specific biophysical and analytical
techniques that are applied to studying receptor dynamics at the single molecule level
are described. Finally, this section closes with an overview of results presented within
this dissertation, including the central hypothesis and the significance of this body of
work.
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1.2 Quantitative approaches to erbB1 receptor activation, signaling, and
regulation
1.2.1 Key Words
EGFR/erbB1, receptor tyrosine kinase, receptor-mediated dimerization, tetramer, single
molecule fluorescence, FRET
1.2.2 Abstract
Due to its complexity, the spatiotemporal control of erbB receptor dynamics has
been of longstanding interest and the subject of extensive investigation, innovation, and
debate. As canonical models for signal transduction, these transmembrane proteins
have provided the prototype for many other cellular pathways and mechanisms.
Biophysical studies to investigate erbB activation, signaling, and regulation have used a
variety of approaches from biochemical to microscopy techniques. Mechanisms of erbB
receptor dynamics have largely relied on structural studies that suggest the sequential
formation of a dimer with extracellular symmetry and intracellular asymmetry. Recent
investigations into the structure of the domain-bridging juxtamembrane sequence
reconcile some outstanding questions about erbB activation and highlight a role for this
region to stabilize the kinase dimer. In addition, approaches based on fluorescence
imaging have permitted live cell monitoring of erbB dynamics. Data from these new
methods refine the model for erbB receptor activity and the reactions that occur
proximal to the plasma membrane, from ligand binding to downstream phosphorylation
and adaptor protein recruitment. In this chapter, we highlight the molecular mechanisms
of erbB receptor activation that have emerged from biophysical approaches, with an
emphasis on fluorescence-based techniques.
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1.2.3 Introduction
The identification of oncogenic mutations in proteins has led to ongoing efforts to
better characterize the subtleties of protein-protein interactions that lead to the aberrant
phenotype (Zhang et al., 2007). Under physiological conditions, receptor tyrosine kinase
(RTK) receptors are implicated in normal growth, differentiation, adhesion, and cellular
migration events. These transmembrane receptors are found in a variety of cell lineages
and coordinate normal development. In the disease state, aberrant signaling by RTKs is
often associated with poor outcomes. Despite decades of investigation into RTK
function, many fundamental questions about the spatiotemporal regulation of receptor
signaling dynamics remain unanswered.
The erbB family of RTKs is comprised of four homologous plasma membrane
spanning receptors whose archetype member, the Epidermal Growth Factor Receptor
(EGFR or erbB1 or HER1) is the main subject of this chapter. These ~170-180 kDa
receptors share an architecture based on three principal domains: a ligand binding
ectodomain, a transmembrane domain, and a cytoplasmic region associated with
tyrosine kinase activity (Figure 1.1). The intracellular and extracellular domains are
further subdivided into functional units that have been implicated in receptor activation
and downstream signaling. Upon binding of the epidermal growth factor (EGF) ligand,
the extracellular domain of erbB1 undergoes a conformational change from a tethered
configuration to an extended one. In this conformation, the ectodomain of the receptor is
poised to form the characteristic back-to-back dimer that serves as the activated and
signaling competent complex (Mattoon et al., 2004). A family of structurally similar
ligands potentiates the signaling of erbB receptors, leading to combinatorial complexity
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in the formation of homo- and heterodimers, and, ultimately, clusters of receptors. The
erbB2 and erbB3 members are exceptions to the general architecture and activity of
these RTKs; the former has no cognate ligand and the latter was formerly believed to
have limited, if not absent, intrinsic kinase activity (Yarden and Sliwkowski, 2001).
Dimerization of erbB receptors is classically considered as the initiating event in
signal transduction by these RTKs and involves substantial domain rearrangements in
the extracellular domain upon ligand activation. Domains I and III contain the ligand
recognition motifs, whereas domains II and IV contain critical cysteine residues involved
in the formation of disulfide bonds that stabilize the dimer. Domain II, in particular,
contains a dimer arm motif that is occluded during normal tethering. Upon activation and
release of the intermolecular tether, domain II is exposed and can interact with other
receptors. Dynamic untethering permits the exposure of the dimer arm in absence of
ligand, due to a small energy barrier that has been calculated for the reorientation of
domains I and III that is associated with ligand binding (Ferguson et al., 2003; Mattoon
et al., 2004) (Figure 1.1).
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Figure 1.1 – Major domain rearrangements take place upon activation of erbB
receptors. A. Binding of epidermal growth factor (EGF; yellow) to erbB1 brings domains
I and III into close apposition (red, green, respectively) and permits intermolecular
interactions of cysteine residues in domains II and IV of the extracellular domain (blue,
purple, respectively). The dimer arm of domain II contributes the majority of the stability
to the dimer. The transmembrane domains of receptors (orange) are thought to interact
through the GXXXG motifs during dimerization (Lemmon et al., 1994). The cytoplasmic
domain has three components: the juxtamembrane domain (black) which forms coiled
coils upon dimerization, the catalytic kinase domain (pink; shown oriented with the Nlobe pointing toward the inner leafleft of the plasma membrane and the C-lobe toward
the cytoplasm) involved in the asymmetric dimer, and the cytoplasmic tail (brown). Each
of these three components contains tyrosine residues that may become phosphorylated
upon receptor activation. B. Domain reorientation and rotation in response to ligand
binding (Ferguson et al., 2003).
Ferguson provides a very thorough review of the insights that high resolution
crystal structures have provided in understanding erbB signaling mechanisms
(Ferguson, 2008). In that article, structural changes that occur upon receptor activation
are extensively discussed. In the absence of a structure of the intact receptor, a
comprehensive model of the domain rearrangements associated with signaling is
difficult to assemble. Most importantly, erbB1 has been shown to differ from other RTKs
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in the formation of a 2:2 EGF:erbB1 dimer, rather than the 1:2 ligand:receptor dimers
that had been shown for closely related RTKs such as the insulin receptor (Burgess et
al., 2003; De Meyts, 2008). For the latter, divalent ligands may crosslink receptors and
activate downstream signaling, including autophosphorylation of tyrosine residues in the
cytoplasmic tail and recruitment of adaptor proteins. The phosphorylated tyrosine
residues serve as docking sites for adaptor proteins containing the Src homology
domain 2 (SH2) (Pawson, 2004).
Upon the formation of an extracellular dimer, the erbB1 cytoplasmic tails reorient to
form an asymmetric intracellular dimer. The N- and C- lobes of the kinase domain
associate in an antiparallel fashion that is favorable for transphosphorylation (Figure
1.1). This configuration leads to an activation mechanism analogous to that seen in the
interactions of cyclins (Zhang et al., 2006b) and their activators, leading to the use of
the terms, “activator” and “receiver” to specify the enzyme and substrate components of
the complex.
Structural studies of RTK activation form the basis of our understanding of
mechanisms of activation and signaling initiation. However, newer methods have been
developed to further detail erbB receptor regulation. Here, we highlight efforts to
observe the intact receptor within the cellular membrane as a means of understanding
real time receptor dynamics. This chapter focuses on biophysical characterization of
membrane-proximal events in erbB1 activation and signaling including:
i. Ligand-induced conformational changes and receptor dimerization
ii. Membrane environment rearrangements
iii. Tetramerization, oligomerization, and clustering
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iv. Structural dimerization conferred by juxtamembrane domain interactions
v. Phosphorylation of cytoplasmic erbB1 residues
vi. Interactions with adaptor proteins
vii. Endocytosis
The concepts presented here, while focused on erbB1 may be applicable to other
members of the erbB family and, more generally, to other transmembrane receptors
whose signaling is driven by dimerization and clustering.
1.2.4 Structural insights into juxtamembrane domain activation
A substantial recent advance in our understanding of erbB signaling is the
characterization of the juxtamembrane (JM) domain by two independent groups (Jura et
al., 2009a; Red Brewer et al., 2009). This domain is divided into part A, that contains a
helical motif, and part B that interacts directly with the kinase domain (Figure 1.1).
Phosphorylation of a threonine residue (Thr654) within the A sequence leads to reduced
internalization of erbB1 (Lund et al., 1990). This finding is consistent with a model for
inhibition of catalytic activity of the cytoplasmic domain that precludes adaptor protein
and endocytic machinery recruitment.
The juxtamembrane domains are autoinhibitory in other members of the RTK
family (Hubbard, 2004). Jura, et al. analyzed the cytoplasmic domain of erbB4, including
its JM, and Brewer, et al. crystallized a construct of erbB1 containing the entire JM
domain (Jura et al., 2009a; Red Brewer et al., 2009). Mutations analysis was used by
both groups. In the case of the erbB4 cytoplasmic tail, the JM-A segments could form a
coiled-coil as shown using nuclear magnetic resonance. Furthermore, deletion of the
JM-A led to diminished kinase activity, suggesting its role in stabilizing the activated
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dimer. Unexpectedly, the erbB1 crystal by Brewer, et al. does not demonstrate the JM-A
dimer expected from the Jura model, which may be explained by the different construct
lengths used in these studies. One important caveat is that measurements in the
absence of the intact receptor are difficult to equivocate.
Results of Jura, et al. suggest that the formation of a symmetric kinase domain
dimer may represent a non-signaling complex. The C-terminal tail may block the C-lobe,
preventing the activating phosphorylation event. This could explain the lack of signaling
in preformed dimers that have been reported (Jura et al., 2009a; Hofman et al., 2010).
The transition that takes place to transform an autoinhibitory, symmetric dimer to a
signaling competent, asymmetric one remains unclear. The role of the JM segment in
the activation mechanism of erbB1 remains incompletely elucidated but the potential for
this bridging sequence to control events in erbB1 signaling seems considerable.
1.2.5 Negative cooperativity
Just as the soluble extracellular domain of erbB1 (sEGFR) was important to early
crystallographic studies of receptor homodimerization, this recombinant construct has
also been invaluable in the early investigations of EGF ligand binding affinity and the
kinetics of dimerization (Lemmon et al., 1997; Dawson et al., 2005). Furthermore, these
kinds of studies have been invoked to understand the concave up Scatchard plots that
are characteristic for EGF binding to sEGFR (Lemmon et al., 1997). Such plots derived
from biochemical measurements suggest bimodal ligand binding affinity states (high
and low). Based on structure alone, an increased ligand binding affinity is expected
upon dimer formation due to accessibility of domains I and III in the membrane proud
conformation. Importantly, the curvature of Scatchard plots implies negative
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cooperativity in ligand binding to erbB1 and suggests that the transition from 1:2
ligand:receptor hetero-complex to a 2:2 homodimer should be entropically unfavorable
(Wofsy et al., 1992; Lemmon et al., 1997; Klein et al., 2004).
The formation of the asymmetric tail dimer may be interpreted to correlate
structure, mechanism and the Scatchard plot characteristics. In this case, inside-out
regulation of signaling could take the form of altered conformation that promotes or
impairs ligand binding. Negative cooperativity has been argued in models for receptor
dissociation that lead to signal amplification (Macdonald and Pike, 2008). The loss of
affinity in a 1:2 ligand:receptor dimer could alter downstream interactions with adaptor
proteins and molecules within the membrane.
Evidence for positive cooperativity has been suggested by an amplified
phosphorylation response that exceeds a 1:1 stoichiometric ratio with ligand added
(Ichinose et al., 2004). However, it is unclear if a second ligand binding event occurs in
the immediate vicinity of the first. Furthermore, this phenomenon may relate to the
monomer-dimer equilibrium, rather than simply accounting for receptor affinity for
ligand. The argument for positive cooperativity is based on the energetic contribution
that the kinase dimer may make to extracellular conformational stability.
1.2.6 ErbB1 dimers, tetramers, and higher-order oligomers
The formation of erbB1 complexes through homoassociation has been
characterized

using

biochemical

approaches

including

chemical

crosslinking,

immunoprecipitation, small angle x-ray scattering, and sucrose gradient centrifugation
(Boni-Schnetzler and Pilch, 1987; Sherrill and Kyte, 1996; Lemmon et al., 1997; Moriki
et al., 2001). From these studies, the formation of erbB1 homodimers suggests that
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these species constitute the minimal signaling unit (Lemmon et al., 1997; Ferguson et
al., 2003). However, direct mechanistic evidence of dimer formation and function using
the full-length protein and the live cell context remained elusive until the development of
sophisticated imaging approaches.
Fluorescence imaging has revolutionized cell biology by providing a toolbox to
observe cellular phenomena in situ (Lidke and Wilson, 2009). In particular, single
molecule approaches have pushed the resolution of imaging well beyond the Rayleigh
limit and permitted observation of individual proteins with nanometer accuracy. These
high precision imaging approaches have bridged the atomic level information of crystal
structures with molecular level details of receptor behaviors and spatial distributions.
Several fluorescent probes can be employed in single molecule measurements. Organic
dyes and genetically expressed protein tags are useful in monitoring the entire
population of erbB receptors simultaneously. Paired dyes that have overlapping spectral
properties are useful in approaches that demonstrate the spatial relationship between
closely apposed species and will be explained in greater detail in a subsequent section.
Complementation assays using fluorescent markers have also been used to provide a
high throughput method for screening erbB1 interaction partners (Blakely et al., 2000).
Quantum dots (QDs) are particularly important probes due to their bright signal and
optical characteristics, which permit long-term observation of individually labeled
macromolecules. The combination of ensemble and single molecule approaches has
provided both insight and controversy in understanding erbB signal activation and
transduction.
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Lidke, et al. demonstrated successful derivitization of biotinylated EGF ligand
with QDs to create a novel probe to detect and monitor the behavior of activated erbB1.
In addition to using EGF-QDs to monitor the diffusion of receptors, Lidke, et al. were the
first to describe a mechanism for retrograde transport of erbB1 receptors along
filopodial projections toward the cell body using a mechanism that is coupled to actin
dynamics (Figure 1.2). Using a potent inhibitor of erbB1 kinase activity, PD153035, this
work further demonstrated that the signaling competent 2:2 dimer is the fundamental
signaling unit (Lidke et al., 2004; Lidke et al., 2005a). Diffusion measurements based on
mean squared displacement (MSD) on the filopodia are consistent with other
coefficients reported for erbB1 (Appendix A) (Lidke et al., 2005a).

Figure 1.2. Binding of QD-EGF to cell surface erbB1 leads to activation. A. QD-EGF
ligand binds to erbB1 receptors and colocalizes with GFP-erbB1. B. Activated receptors

11

are internalized. C. erbB1 receptors are visualized on cell projections called filopodia
using QD-EGF (Arndt-Jovin et al., 2006).

An intriguing feature of erbB1 diffusion is the effect of dimerization and signaling
on its magnitude. Some reports indicate that a two-fold slowing in receptor mobility
reflects successful dimerization, however this parameter was not directly measured
(Xiao et al., 2008; Chung et al., 2010). Single-color QD tracking of erbB1 using a
cumulative squared displacement approach (CSD) to monitor the K721M mutant that
lacks catalytic activity highlighted kinetic stability conferred to dimers by the domain II
dimer arm (Chung et al., 2010). Work in our group implementing a multi-color QD
tracking method demonstrates that a two-fold decrease in diffusion is observed for
liganded receptors that enter a membrane microdomain and that an ultimate 6-fold
decrease in mobility marks the formation of a signaling competent dimer. Furthermore,
this diffusional slowing is dependent on kinase domain function. In the presence of
PD153035, ligand-bound receptors form dimers whose mobility decreases by only a
factor of two compared to the monomeric form of the occupied, inhibited erbB1.
Importantly, these observations were based on direct visualization of erbB1
homodimerization and diffusion characterized on state-dependent analysis of single
molecule trajectories resulting from fitting using a 3-state Hidden Markov Model (HMM).
This approach has also permitted extrapolation of receptor interaction kinetics and
direct measurement of resting receptor behavior.
Dimers have been detected in the absence of ligand binding and a role for socalled preformed dimers, or predimers, is the subject of some debate (Gadella and
Jovin, 1995; Moriki et al., 2001). In particular, the existence of predimers at steady state
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(Burgess et al., 2003), or as a function of receptor overexpression, has been queried to
understand basal activation and signaling as well as a source of hyperactivity and a
sensitized calcium response (Uyemura et al., 2005). ErbB1 receptors observed by total
internal reflection fluorescence (TIRF) microscopy showed almost instantaneous twofold increases in intensity at sites of soluble, fluorescent ligand binding, suggesting
activation was promoted by the initial presence of 0:2 or 1:2 dimers. This would also
provide some support for the positive cooperativity model since the binding of the first
ligand in the dimer permitted rapid binding of a second ligand and, thus, the increased
collected emission. These ligand bound dimers demonstrated downstream activity
based on the binding of a fluorescently labeled antibody recognizing a phosphotyrosine
residue on the cytoplasmic tail of erbB1 (Sako et al., 2000). Preformed resting
complexes were also suggested to be enriched in the periphery of cells observed under
TIRF illumination with the potential to sensitize the cellular response to ligand activation
in an erbB1 density-dependent manner (Chung et al., 2010). The effect of receptor
number on the formation of preformed dimers was also argued using the number and
brightness (NB) approach that uses fluorescence signals within a region to quantify the
total receptors within the focal area (Nagy et al., 2010). On the contrary, preformed
dimer complexes have also been argued to represent non-signaling receptor units
whose distribution and behavior changes upon activation (Hofman et al., 2010). These
studies have taken advantage of another spectroscopic tool, Förster resonance energy
transfer (FRET).
FRET is a potent technique to demonstrate distances between molecules (Lidke
and Wilson, 2009). The non-radiative exchange of energy between two fluorophores
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from a donor of shorter wavelength to an acceptor of longer wavelength requires that a
small separation distance, r, of less than 10 nanometers (Energy ∝ 1/r6). Measurements
of energy transfer between erbB1 receptors using fluorescent ligand suggest both
dimerization and larger order clustering. Comparisons of homo-FRET between
endogenous proteins on live cells with those on vesicle preparations indicate energy
transfer that is dependent on oligomerization, rather than dimerization (Whitson et al.,
2005). This contrasts with two-color FRET detection that suggests dimers, despite the
anticipated separation of two ligands in the dimer having a separation exceeding 10 nm
(Sako et al., 2000). In addition to FRET approaches, image correlation studies
suggested that resting complexes comprised of at least two receptors per cluster
increase in number to approximately four proteins per cluster following stimulation
(Clayton et al., 2005). The efficiency of energy transfer suggests an equilibrium between
activated dimers and tetramers that may represent a transition between the monomerdimer steady state for resting receptors. Another study found that two FRET distances
can be detected between fluorescent ligand molecules (of approximately 8 and 5.5 nm).
This is consistent with a model using the crystal structures of back-to-back dimers
uniting with two other receptors, possibly interacting as another dimer, to form a
tetramer (Webb et al., 2008). These orientations may relate to the affinity status of the
receptor and could provide an activation cascade that depends on correct interactions
between the quaternary elements of the complex. While these kinds of studies provide
interesting mechanistic insight, ligand-bound receptors are observed in the presence of
unlabeled ones, making the findings difficult to interpret.
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In addition to forming dimeric and tetrameric complexes, erbB1 and its homologues
combine to form larger order oligomeric clusters. Mapping of receptors and adaptor
proteins by transmission electron microscopy (TEM) highlighted the role of clustering
and membrane patches in signal transduction (Wilson et al., 2004; Yang et al., 2007).
The rotational mobility of receptors has been shown to slow as cluster size increases
(Zidovetzki et al., 1986). This may relate to ligand binding affinity, which is suggested to
be higher in oligomeric complexes (Uyemura et al., 2005) and could result from
stimulation of resting clusters (Saffarian et al., 2007; Yang et al., 2007). The roles of
membrane components in clustering, endocytosis and microdomain organization have
been extensively studied and are the subject of section 1.1.8. Increases in receptor
cluster size are correlated with signaling, as demonstrated by studies showing tyrosine
kinase dependent clustering of erbB1 (Ariotti et al., 2010; Hofman et al., 2010). The
large-scale reorganization that takes places upon ligand stimulation has led to a model
for signal propagation that does not require all receptors within an oligomer to be
occupied with ligand.
1.2.7 Lateral signaling propagation
A model for the spreading of erbB signaling has been proposed that relies on
lateral propagation of phosphorylation along the membrane in a manner that cannot be
explained by diffusion of receptors alone. This spread is observed as early as 60
seconds following activation and persists for up to 15 minutes. The phosphorylation
status of receptors was monitored using a FRET-based technique that shows the
degree of phosphorylation exceeds the concentration of the stimulus in both whole cells
and semi-intact cellular membranes (Verveer et al., 2000; Ichinose et al., 2004).
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Furthermore, the phosphorylated sites are spatially separated from the locations of
stimuli as the EGF ligands in these assays are immobilized on beads (Verveer et al.,
2000). This supports a role for transient dimers in perpetuating activation signals but it
remains unclear if the interactions and signaling of singly liganded dimers differs from
that of preformed, unoccupied dimers (Figure 1.3).
The conclusion that erbB receptors alone spread the phosphorylation signal is
supported by studies using the Src family kinase inhibitor PP2 (Ichinose et al., 2004).
Large scale recruitment of cytoplasmic Grb2 may require as few as 20% of erbB1
receptors to be ligand bound (Reynolds et al., 2003). Normal erbB signaling is regulated
by

the

balance

of

phosphorylation

and

dephosphorylation

by

kinases

and

phosphatases, respectively. The production of hydrogen peroxide may be the normal
result of erbB1 activation, leading to inhibition of phosphatase activity and promote the
signaling cascade. This is supported by evidence that inhibition of hydrogen peroxide
activity abolishes the lateral signaling mechanism (Reynolds et al., 2003). Mathematical
models also demonstrate that equilibrium favors a high degree of receptor
phosphorylation (Reynolds et al., 2003).
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Figure 1.3. Lateral signaling propagation provides a mechanism to explain widespread
erbB phosphorylation after minimal stimulation by ligand. A. At rest, erbB1 is present on
the plasma membrane in the tether or extended conformation and preformed dimers
can occur in the absence of ligand. B. Following addition of EGF, signaling dimers form
and transphosphorylate tyrosine residues (shown as red circles). C. In lateral signaling
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propagation, activated receptors can phosphorylate nearby receptors, even without
ligand stimulation of those neighbors. D. After minutes, and as a consequence of
diffusion, the phosphorylated receptors may outnumber the ligand bound and dimerized
receptors.
The dynamics of clustering and signal propagation could have a more pronounced
importance in the disease state. In the case of aberrant signaling, conformational
stability of the extracellular domain could promote dimerization or altered kinase activity.
Another feature of lateral propagation could include a role for negative cooperativity in
dissociating activated receptors to diffuse to adjacent erbBs and relay the stimulatory
signal. Understanding the kinetics of dimerization can offer some insight into this
mechanism. The lifetime of singly liganded dimers is less than that of the 2:2 dimer,
suggesting that this erbB1 complex would require very rapid phosphorylation in order to
signal (Low-Nam, et al., Chapter 3). The kinetics of phosphatase and kinase activities
need to be better understood in order to fully comprehend the role for lateral signaling in
erbB activation.
1.2.8 ErbB1 endocytosis and membrane organization
The localization of resting erbB1 and the redistribution of the receptor upon
activation have been of broad interest and highlight the significance of the local
environment in modifying receptor behavior. Studies involving inhibition or depletion of
membrane components have demonstrated the complexity of erbB receptor partitioning.
Receptor clusters may be detected in so-called membrane rafts (Keating et al., 2008)
and erbB1 mobility is affected by cholesterol depletion, possibly through an actinmediated mechanism (Orr et al., 2005; Ariotti et al., 2010). The role of actin in
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modulating receptor behavior has been previously demonstrated (Andrews et al., 2008)
and may link activation to endocytosis.
A principal mechanism for the downregulation of signaling involves the
internalization of receptors and degradation or recycling to the surface. The route of
receptor endocytosis is unclear. Evidence suggests both clathrin- and caveolinmediated internalization that may be dependent on the extent of activation (Keating et
al., 2008; Xiao et al., 2008). Internalization may also play a role in signaling based on
evidence of erbB1 activity from endosomes (Wang et al., 2002). Direct evidence to
corroborate receptor activation state with recruitment of endocytic machinery and the
route of internalization remains elusive.
1.2.9 Outstanding questions and future directions
Extensive investigations into erbB receptor dynamics have detailed mechanisms
for receptor activation, diffusion, interaction, and signaling. Microscopy, in particular,
has informed our understanding of receptors on live cells and has reconciled some of
the questions that biochemistry and structure alone cannot address. However, a
number of issues remain in order to assemble a comprehensive model of erbB
signaling. Some of these questions are listed below:
• Are dimers that interact for a few seconds actively signaling?
• What other downstream molecules can be observed to monitor signaling in real
time?
• What is the relationship between the affinity states of the receptor and the
conformation, density of erbBs?

19

• Can activator and receiver kinases in a single dimer exchange roles in order to
allow phosphorylation to occur in all combinations of cis- and trans-?
As tools to investigate receptor dynamics continue to be developed and increase
our molecular level understanding of cellular signaling, we hope to reconcile some of
these questions. Importantly, many of these mechanisms are not mutually exclusive and
may contribute to cellular homeostasis and control of erbB behaviors. The advent of
fluorescence techniques to more directly observe these phenomena has provided great
progress and provides avenues for further discovery.

1.3 Single Particle Tracking and Hidden Markov Models
1.3.1 Single Particle Tracking Background
High spatial resolution is required to fully investigate and appreciate the dynamics
of erbB diffusion and protein-protein interactions. While ensemble measurements
provide valuable information about average properties of proteins, single molecule data
provide information on the full range of heterogeneous behaviors exhibited by cellular
macromolecules. A variety of single molecule techniques have been established in
order to monitor cellular behaviors in the sub-diffraction limited regime imposed by
conventional light microscopy approaches (Saxton and Jacobson, 1997).

Single

particle tracking (SPT), in particular, provides both the spatial and temporal resolution
necessary (Anderson et al., 1992) to study the diffusion and dimerization of erbB
receptors on live cells. Single molecule methods take advantage of individual labeling of
a target with a polystyrene bead, gold particle, or fluorescent dye or protein. We take
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advantage of fluorescence approaches, based on the simple mechanism shown in
Figure 1.4.

Figure 1.4. Jablonski diagram of the mechanism of fluorescence. The promotion of an
electron to an excited state (S1’) occurs through the absorption of a high energy photon.
From this excited state, the electron undergoes relaxation which dissipates some
energy (to energy state S1) before the electron, ultimately, returns to the ground state
(S0). This final step results in the emission of a photon of longer wavelength.

Specific conjugation schemes are used to control the stoichiometry of fluorescent
labeling of proteins and are explained in greater detail in Chapter 2. Visualization of
labeled targets is achieved using a variety of microscopy approaches. For SPT, target
proteins are labeled at a low density in order to resolve each probe with very high
precision (Saxton and Jacobson, 1997) and permit the tracking of particles over time.
Importantly, a high degree of sampling is required in order to capture the heterogeneity
characteristic of biological systems.
Live cell SPT is accomplished by imaging probes over time using either transmitted
light or fluorescent illumination. The advent of high-speed cameras has permitted rapid
acquisition of data at rates up to thousands of frames per second (Murase et al., 2004).
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Despite this capability, most data is collected at slower speeds to allow for sufficient
signal collection from probes at each frame in order to optimize fitting and tracking
during post-processing. This trade off between acquisition rate and signal-to-noise is a
delicate balance that must be optimized for each system of probes and cells. The signal
from polystyrene beads and gold is very high and does not diminish as a function of
time. However, these nanoparticles are very large and carry the disadvantage of
perturbing the normal dynamics of the labeled target (Saxton and Jacobson, 1997). On
the other hand, the smaller size of fluorescence-based probes is advantageous in
preserving normal molecular behaviors, but the photophysical properties of these
probes vary widely. Fluorescent dyes, proteins, and nanoparticles are imaged at slower
rates (equivalent to long integration times) in order to collect more signal and improve
localization accuracy, with theoretical precision of less than 1 nm (Jonas et al., 2006).
Lower intensity of illumination is also ideal in order to prevent loss of signal from
photobleaching. Another confounding feature of fluorescent probe emission is
intermittency (“blinking”) due to trapping of an electron in the so-called dark state
(Nirmal et al., 1995). Ongoing efforts are aimed at improving fluorescent tags to
optimize signal-to-noise and overcome the negative effects on probes associated with
prolonged imaging.
As explained in greater detail in Chapter 2, inorganic quantum dots (QDs) have
come to the forefront as superior single molecule probes. Conventional QDs are
nanometer-scale semiconductor crystals composed of a cadmium selenide core and
zinc sulfide coating (Michalet et al., 2005). Compared to typical organic dyes, QDs
provide a high signal-to-noise ratio, even under widefield illumination. These
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nanoparticles display an array of useful photophysical properties, including high
photostability, a high absorption cross-section, high quantum yield, and tunable
emission. They can be imaged at a rapid rate for long periods. All of these
characteristics are ideal for single particle tracking and provide the molecular scale
resolution needed for understanding erbB biology.
Analysis of single-particle tracking data requires fitting each QD to the pointspread-function of the optical system followed by subsequent estimation of particle
coordinates at each time step (Anderson et al., 1992; Schutz et al., 1997; Cheezum et
al., 2001). Trajectories are assembled from high precision short tracks that are
determined to have a high probability of forming spatially and temporally independent
sequences of coordinates. Long trajectories are required to detect changes in diffusivity
within tracks, to sample different regions of the membrane, and to increase precision in
determining relative behaviors of pairwise tracks. The approaches that we employ to
analyze point emitters are detailed in Chapters 2 and 3 (Smith et al., 2010).
Analysis of SPT data within single trajectories or across data sets is used to extract
results that describe underlying biochemical and cellular processes. Of particular
interest is detection of space- or time-dependent behaviors that can manifest as shifts in
mobility or reflect changes in local environment or protein-protein interactions. Typical
parameters derived from single particle trajectories include diffusion coefficient and
estimation of confinement zone sizes (Kusumi et al., 1993). Vectorial displacement of
trajectories of different colors can be implemented to assess correlated motion on
interacting species (Andrews et al., 2008). Unfortunately, the aforementioned analyses
are insufficient to acquire kinetic on and off rates for individual dimerization events. As
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previously discussed, these parameters have been of great interest to erbB biologists
and modelers as a measure of receptor dynamics. We extend SPT data processing in
order to extrapolate characteristics of erbB dimerization directly from our live cell
measurements.
1.3.2 Hidden Markov Model Background
Hidden Markov Modeling (HMM) is a form of statistical analysis in which
parameters for the behaviors of “hidden” states are extracted from a set of observables.
It is based on a Markov process, which models the evolution of a memoryless system.
An HMM is defined by a number of model and observable states and the parameter set
that describes the probabilities of state transitions (Rabiner, 1989). It is not necessary to
identify the state at each time step; instead, an overall kinetic model is assumed for the
underlying process and its transitions. Previous applications of HMM approaches to
single particle datasets include analysis of DNA looping and actin cytoskeletal
dynamics. Monitoring DNA looping by excursion of a tethered polystyrene bead required
filtering of data due to diffusion of the bead that was independent of the nucleic acid
dynamics (Beausang et al., 2007). Our data sets do not necessitate this pre-processing
because movement of the QDs is small compared to the protein diffusion.
In this work, an HMM is developed and implemented to interrogate erbB receptor
dimerization and dimer lifetime, as measured by two spectrally distinct QDs overlapping
for varied time periods. Long observation times are also important in permitting
discrimination of mechanisms with slow kinetics. For dimerization of erbB receptors
under physiological and oncogenic conditions, we anticipated a range of interaction
rates. The distance between particles at each time step serves as the essential
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parameter in the model, with the ability to resolve the molecular-scale formation of a
dimer complex. The probability of protein-protein interactions is further modulated by
protein mobility and membrane microenvironment. The implementation of a three-state
HMM (free, domain-confined, and dimer states) is explained in Chapter 3.

1.4 Hypothesis
1.4.1 Hypothesis
This dissertation focuses on members of the erbB receptor tyrosine kinase (RTK)
family and investigates protein diffusion, dimer lifetimes and interactions within the cell
membrane using novel biophysical and computational approaches. This work
addresses the prior lack of mechanistic information about dimer formation, as well as a
paucity of quantitative parameter values for dimerization kinetics on live cells.
At the beginning of this project, I proposed the hypothesis that diffusional and
conformational dynamics of erbB receptors regulate homo- and hetero- dimerization,
initiating signal transduction. I further hypothesized that these important parameters are
perturbed by both mutation and inhibitory drugs.
To test this hypothesis, I set about to study erbB dynamics in both wild type and
mutant cells. Carefully planned experiments included pretreatments with erbB-targeted
therapeutic agents (laptinib, therapeutic antibodies). HMM analysis of single particle
tracking data suggested three interaction states for erbB receptors: free, confined, and
dimerized. As a result, I propose the following refinements to my central hypothesis: 1)
that differential levels of ligand occupancy affect erbB dimer off rates, influencing signal
initiation and duration; 2) that the local membrane environment impacts receptor
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encounter frequency; and 3) state-dependent changes in diffusional dynamics reflect a
modest contribution from the increase in size of dimers and a larger contribution due to
recruitment of cytoplasmic signaling partners. The molecular-level understanding that
results from these studies has addressed erbB signaling in ways that previous
approaches have not accomplished. Taken together, these experiments are expected to
demonstrate the complexity of erbB signal initiation and provide a means of
investigating these dynamics with high spatial and temporal resolution.
The structure of this work is shown in Figure 1.5. Chapter 2 provides details of
experimental approaches that have been developed in the laboratory and further refined
in order to address the problems of erbB dynamics and dimerization. The first section
explains the development and characterization of probes used in fluorescence
microscopy and single particle tracking. The second provides the approaches used in
acquiring SPT data and, in particular, the image processing methods used to quantify
receptor behaviors. Chapter 3 details the studies that have been performed to
characterize erbB1 homodimerization on A431. Chapter 4 applies the approaches
developed for erbB1 dimerization studies to erbB2 and erbB3. In this section, our
approaches provide particular insight into erbB3 biology and argue that this receptor is
an active kinase that is sequentially controlled by erbB2-erbB3 heterodimerization and
erbB3 homodimerization. Finally, Chapter 5 provides a discussion of all the studies
presented and focuses on the impact of our approaches to the field of membrane
biology.
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Figure 1.5. Overview of chapters in dissertation. Chapter 2 focuses on tools that are
developed and improved in this work. Dissection of erbB1 homodimerization follows in
Chapter 3. Extensions of these approaches to address questions related to erbB2 and
erbB3 dimerization are the subject of Chapter 4. Finally, discussion in Chapter 5
summarizes findings and highlights the insights into membrane biology, in particular.
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CHAPTER 2: PROBE DEVELOPMENT AND METHODOLOGY
2.1 Specific contributions
The following chapter details the methods that have been implemented, refined,
and developed during the course of this dissertation project. The first section on probe
development was written by the author. I made Fab fragments with help from Dr. Walter
Kisiel and the NHS ester labeling section was developed with contributions from Dr.
Amanda Carroll-Portillo and Samantha Schwartz. The biotin quantitation section is
excerpted from a chapter in Methods in Molecular Biology written by Diane Lidke,
myself, Patrick Cutler, and Keith Lidke. All of the other protocols in this section were
generated from my own notes and experiments.
The section on single particle tracking and data analysis using the Hidden
Markov Model includes parts of the Methods in Molecular Biology chapter, but I have
modified it for specific labeling and observation of erbB receptors. Furthermore, I
composed the HMM section at the end of the chapter, including generating example
data sets shown in the figures. The MatLab code provided in Appendix D was compiled
by me, but includes contributions from Keith Lidke and Patrick Cutler. The Notes
sections in each part of this chapter were mainly contributed by myself, but also include
information from the Methods in Molecular Biology chapter.

2.2 Antibody fragmentation and probe conjugation chemistries
2.2.1 Summary
Antibody labeling through covalent chemical crosslinking is a common strategy
used to specifically tag and monitor proteins of interest. There are several
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bioconjugation chemistries that permit antibodies and antibody fragments to be linked to
fluorophores for use in fluorescence microscopy. Here, protocols are described to: 1)
cleave antibodies to produce Fab fragments, 2) label using an NHS-ester linkage, 3)
reduce and label using thioether chemistry, and 4) characterize probes.
Keywords: antibody, VHH, NHS-ester, maleimide thioether, biotin, streptavidin
2.2.2 Introduction
Epitope-specific antibodies are commonly used to label proteins of interest and
provide a useful tool that is used to observe subcellular localization and behavior with a
high degree of specificity. Canonical immunoglobulins (IgG) are produced by immune
cells and are raised against many foreign molecules. A typical IgG molecule forms an
antigen-recognition cleft through the combination of heavy (VH) and light (VL) chain
variable regions (Figure 2.1). Variation in the genes encoding the VH and VL regions
confers a high degree of diversity to the IgG repertoire.
The generation of monovalent antibodies and antibody fragments is essential to
measurements requiring a 1:1 stoichiometry of labeling. In particular, studies involving
the dimerization of two individual proteins can be confounded by artificial crosslinking
induced by bivalent antibodies. The structure of an IgG is shown in Figure 2.1, with its
essential interchain disulfide bonds at the hinge region. These bonds can be cleaved
using enzymes and the use of the cysteine protease, papain, to produce Fab fragments
is described below. In addition to monovalent labeling using Fab fragments, the arm of a
heavy chain only Camelid antibody (VHH) can be used to singly label proteins and has
increased stability in the absence of paired heavy and light chains. Nanobody (VHH)
molecules have been shown to have high thermal stability and dissociation constants
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comparable to intact antibodies (Muyldermans et al., 2001; Dumoulin et al., 2002;
Holliger and Hudson, 2005; Harmsen and De Haard, 2007; Roovers et al., 2007).
Another strategy for labeling cell surface receptors is to conjugate ligands to probes; the
example of specifically tagging the erbB1ligand, epidermal growth factor (EGF) is
explained here.
Reactive groups are required to conjugate dyes and other macromolecules to erbB
probes. Despite the diversity of the amino acid building blocks that proteins are
comprised of, only a few have the tunable characteristics that are useful for conjugation
schemes. The reactive primary amine groups that are found on Lysine (K) residues are
attractive candidates for linking protocols because side chain reactivity is pHdependent. These positively charged groups are usually outward-facing in the globular
structure of proteins and, thus, easy to access. The typical crosslinking involving K
residues uses reactive NHS esters to form peptide bonds (Figure 2). However, since
many proteins contain multiple K residues, control of labeling stoichiometry using this
approach can be very difficult. An attractive alternative modification approach takes
advantage of the reactivity of sulfhydryl groups found exclusively on cysteine (C)
residues. In higher-order protein conformations, cysteine residues are typically involved
in bridging polypeptide sequences through the formation of disulfide bonds, making
these groups inaccessible. However, these bridges are made available through
reduction procedures, making the use of this reactive group problematic in the case of
excess reduction that leads to protein denaturation (see Note 2.1). In this case, linkages
through sulfhydryls use reactive maleimides to create thioether crosslinks (Figure 2.2).
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A useful strategy to link to probes is through the high affinity interaction between
biotin and avidin proteins. Biotin is a naturally occurring, small molecule, vitamin H and
is 244 Daltons (Da) in size. Its affinity for tetravalent avidin glycoproteins (67 kDa) is on
the order of 1015 M-1, conferring a very high degree of stability to probes crosslinked
using this chemistry (Chapman-Smith and Cronan, 1999). Due to its high avidity,
conjugations based on biotin-streptavidin linkages require carefully regulated protocols
in order to achieve the desired 1:1 stoichiometry. The flexibility permitted by biotinylating
probes and introducing streptavidin Quantum Dots (QDs) on demand increases the
shelf life of these labels. Biotinylation can be achieved using either of the chemistries
described above and will be detailed in the subsequent protocols.
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Figure 2.1. Antibodies and antibody fragments used in fluorescent labeling. A.
Canonical IgGs are comprised of paired heavy and light chains. B. Upon fragmentation
at the hing region by papain, fragments retaining epitope recognition clefts are produced
(Fabs). C. A protein engineering approach to the production of monovalent antibody
fragments involves the linking of the variable domains of the heavy and light chains to
produce single chain antibodies (scFvs). D-E. An alternative form of antibody found in
llamas is the heavy-chain only, camelid antibody, whose monovalent fragment is a
nanobody (VHH).
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A.

B.

Figure 2.2. Conjugation chemistries. A. NHS ester conjugation using reactive primary
amines. B. Maleimide thioether crosslinking using reactive thiols that are exposed by
protein reduction.
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2.2.3 Materials
1. Microcon Centrifugal Filter Devices (Millipore, Ultracel YM-10 (10,000 MWCO))
2. PD Spin Trap G-25 Columns (GE 28-9180-04)
3. Pierce Slide-A-Lyzer MINI Dialysis Units (2000 MWCO; #69580)
4. Antibody ([1 mg/mL]; antibody = IgG, reduced antibody = rIgG)
5. 6-((6-((biotinoyl)amino)hexanoyl)amino)hexanoic acid, succinimidyl ester (Biotin-XXSE, Invitrogen B-1606, Carlsbad, CA)
6. Maleimide-PEG2-biotin (200 mM in DMSO)
7. 0.5 M Iodoacetamide (in diH20; made fresh)
8. 0.3 M Dithiothreitol (in diH20; made fresh)
9. 1X Phosphate Buffered Saline, pH 7.2
10. 7.5% SDS-PAGE gel
11. Non-denaturing loading buffer
* Add solid SDS (tip of a scoopula) to the bottom of an eppendorf tube
* Add 18-19 µL of 1x PBS
* Add 2-1 µL of sample (for total volume of 20 µL)
* Boil at 95˚C for 3-5 min
* Immediately add a few crystals of solid sucrose; mix and melt
* Load on gel
12. 1M NaHCO3 (84.01 g/mol), dissolved in 1X PBS
13. Dye, in DMSO, at as high a concentration as possible (Stocks typically kept at [10
mM] in DMSO, -20oC)
14. IgG or ligand, minimum of 20 ug, at a concentration of 1 mg/mL in reaction

34

15. Tyrode’s live cell imaging buffer (also called Rab): 135 mM NaCl, 10 mM KCl, 0.4
mM MgCl2, 1 mM CaCl2, 10 mM Hepes, pH 7.2.

On the day of use, supplement this

solution with 20 mM glucose and 0.1% BSA.
16. Agarose (Amresco 9012-36-6)
17. 1x TBE buffer: 0.89 M Tris, 0.02M EDTA-Na2-salt, 0.89M Boric acid
2.2.4 Methods
2.2.4a General information
Proteins, particularly antibodies, may be purchased with carriers in solution for
storage. Removal of components like azides is essential to prevent competing side
reactions. Determination of protein concentration and methods for desalting and
purification may be necessary precursors to conjugation procedures. A summary of
available probes can be found in Appendix A.
1. Take Nanodrop® A280 reading of antibody to be used (to determine concentration)
and run small sample on a non-denaturing gel (to determine if antibody is degraded)
a. A 1 mg/mL concentration is desired – use Centricon concentrators (10,000
MWCO for full size antibodies) if necessary
i. Centricon concentrators:
1. Insert the Microcon reservoir (white section down) into
provided 1.5ml tube for waste collection.
2. Add sample (500 µL max) to reservoir without touching
membrane.
3. Spin sample at 14,000 x g for up to 30 min at RT (5-10
minute increments are recommended)
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4. Remove reservoir and place inverted into a new collection
tube.
5. Collect concentrated sample by spinning at 1000 x g for 3
min at RT
b. Spectrophotometry calculations (Beer-Lambert Law); for more useful
information,

refer

to:

www.piercenet.com/files/TR00006-Extinction-

coefficients.pdf
i. A = εcl
ii. εIgG ≈ 210,000 M-1cm-1
iii. ∴ εrIgG ≈ 105,000 M-1cm-1
c. To eliminate unwanted carrier molecules (BSA, Thimerosol, Azide),
exchange buffer using PD Spin Trap Columns or dialyze with MINI
Dialysis units against 1x PBS
i. PD Spin Trap Columns:
1. Vortex Microcon column briefly to resuspend column matrix
and break bottom closure off
2. Insert the Microcon column into provided 1.5ml tube for
waste collection, and unscrew cap slightly
3. Balance in microcentrifuge and spin at 800 x g for 1 min
4. Add 300 µL buffer (1x PBS) to equilibrate column without
touching matrix and spin again at 800 x g for 1 min
5. Repeat equilibration step (#4) for a total of 5 times
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6. Transfer column to 1.5 mL eppendorf tube and add sample
(<130 µL) to center of column without touching matrix; elute
with 800 x g for 2 min
7. Return sample to column and repeat spin to ensure all of
sample moves through column
2.2.4b Generating Fab fragments
Papain digestion cleaves the uppermost disulfide bond in the IgG hinge region
and produces 2 Fab fragments per catalytic event. Digestion of the IgG can be
optimized by changing the pH, duration, and temperature of the reaction. Cleavage
using pepsin will produce the bivalent F(ab’)2 fragment that can be further reduced to
attain Fab’ fragments that have two reactive sulfhydryl groups, however, this approach
will not be discussed.
IgG Cleavage
1. Overnight dialysis of the IgG to 1x PBS is carried out if the IgG is in another buffer or
comes with carriers like azide that can interfere with the reaction. A final
concentration of 2 mg/mL IgG is preferred for the enzymatic cleavage step.
2. A 1 mg/mL papain solution made from lyophilized powder is activated with 2 mM
EDTA and 10 mM DTT for 15 minutes at 37oC.
3. Digest enzyme using a 100:1 enzyme:substrate stoichiometric ratio for 1 hour at
25oC. A total volume of 2 mL is typically used.
4. Terminate the digestion reaction using iodoacetamide (ICH2CONH2, Sigma Pg 1350).
A final concentration of 20 mM is needed to arrest the papain reaction.
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5. Dialyze the sample overnight against 1x PBS to remove the iodoacetamide. Use
small dialyzer (Pierce Slide-A-Lyzer, 10,000 MWCO)
2.2.4c NHS-ester conjugation
Conjugation using reactive primary amines is attractive because of the ability to
increase the availability and reactivity of a target protein by modulating the pH. NHSester bioconjugation is typically performed at basic pH in a phosphate buffer (see Note
2.2). The protocol for biotinylation using this scheme is highlighted below; however, this
general approach can be implemented to derivatize a protein of interest with a
fluorophore or other linking group (see Note 2.3).
Biotinylation
QD-EGF may be purchased (Molecular Probes, Invitrogen, E3477) at a 1:1
stoichiometry and the EgB4 VHH can be produced as a singly biotinylated fragment
using the BirA expression system (Howarth et al., 2006; Roovers et al., 2007). A
protocol is provided below that can be used for biotinylation of proteins and has been
successfully implemented for the labeling of the erbB3 ligand, Neuregulin.
1. Add 20 µg of 1 mg/mL protein to a 2 mL reaction tube that contains a micro-magnetic
stir bar. Add 1M NaHCO3 1:10 to reaction’s final volume to raise the pH > 8.
2. Make a 4 mg/mL (7 mM) solution of biotin-XX-SE in DMSO. DMSO stocks of BiotinXX-SE can be stored at -20oC for later use.

Biotin-XX-SE can be dissolved in

aqueous buffer, but should be made immediately prior to the conjugation process, as
solutions of these compounds will gradually hydrolyze in water (See Note 2.4).
3. While gently stirring the solution, add the biotin-NHS solution to the reaction tube for
a 1:1 stoichiometric reaction ratio.
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4. Allow reaction to stir for 20 min at room temperature.
5. Prepare PD SpinTrap G-25 columns (GE Healthcare) spin columns at room
temperature as directed. Complete this step so that the final wash coincides with the
end of the reaction time (extended reaction will increased the labeling stoichiometry
of the final product). Ensure that the resin does not dry out. We have found that
separation performed at room temperature increases recovery from the column.
a. Resuspend resin by vortexing.
b. Remove storage buffer by centrifugation for 1 minute at 800 x g.
c. Wash column with 300 µL of appropriate buffer (1X PBS) and spin for 1 minute
at 800 x g; dispose of flow through and replace column in collection tube; repeat
these washes 5 times.
d. Apply 70-130 µL of sample to the center of the column, in a fresh collection tube.
e. Elute by centrifugation for 2 minutes at 800 x g; the final conjugate is in the
collection tube. This elution step should be repeated by taking the first runthrough and repeating the 2 minute centrifugation in order to increase recovery
of the labeled product.
6. Transfer the contents of the collection tube to a 0.5 mL centrifuge tube. Store at 4 °C.
7. Determine protein concentration: C=A280 / εL; where A280 is the absorbance at 280
nm, ε is the extinction coefficient for the protein, and L is the cuvette path length (1
cm).
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2.2.4d Maleimide thioether conjugation
Reactive sulfhydryl groups are less numerous in proteins than primary amines,
permitting advantageous specificity in conjugation. The ability to label the hinge region
of a reduced antibody permits a convenient approach for 1:1 labeling with only two
reactive groups at the hinge. A competitive reaction using iodoacetamide permits
labeling and capping of the monovalent form of the antibody that precludes reformation
of the bivalent IgG (see Note 2.5). The typical crosslinking through reactive maleimide
reagents involves the activation and use of either homo- or hetero-bifunctional
crosslinkers.
Conjugation using reactive hinge sulfhydrls
Proteins can be hinge-labeled using fluorescent dyes or, as described below,
biotin. The protocol described here is generally applicable to other thioether reactions.
1. Reduce antibody with 1 mM DTT for 30 min at room temp (100 µL reaction volume),
agitating periodically (avoid producing bubbles)
a. Final volume at end of complete protocol can be 130 µL
b. Example reaction:
98 µL 1 mg/mL antibody to be reduced
2 µL 50 mM DTT (diluted from 0.3M)
c. Desalt reaction using PD Spin Trap G-25 column equilibrated with PBS or
dialyze with MINI Dialysis columns for 4 hours against PBS
a. Remove all DTT as it will inhibit maleimide reaction
d. Incubate with Maleimide-PEG2-biotin (3:1 ratio) with 20 µM iodoacetamide for
1 hour on ice with occasional agitation (flick tube gently)
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a. Low level of iodoacetamide competes for free thiols helping to
accomplish 1:1 rIgG:biotin ratio
b. Example reaction:
100 µL rIgG antibody
1 µL 2 mM maleimide-PEG2- biotin (diluted)
1 µL 2 mM Iodoacetamide (diluted)
e. Add excess Iodoacetamide to bring the final concentration up to 20 mM and
leave on ice for another hour to complete capping process; again use
occasional agitation
a. Example reaction:
102 µL solvent
4.2 µL 500 mM Iodoacetamide
f. Clean up conjugate with PD Spin Trap G25 column equilibrated with PBS (or
with dialysis) and take A280 reading of sample on Nanodrop®
2.2.5 Characterization of probes
2.2.5a Determination of degree of labeling
Most labeling requires quantification of the degree of labeling (DOL) of probes,
with a 1:1 stoichiometry as the preferred ratio. The determination of DOL using
spectrophotometric absorption measurements is described below. The calculation is
based on absorption changes in the labeled protein that reflect contributions by the dye
or other moiety. The correction factor is related to the extinction coefficient of the label
at a given reference wavelength and the values for Alexa Fluor dyes are shown in Table
2.1 (see Note 2.6).
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•

Protein Concentration (M) = [A280 – (Adye conjugate*Correction Factor)]/εprotein

Table 2.1. Characteristics of Alexa dyes from Invitrogen.
-Moles of dye per mole protein = Adye conjugate/(εdye* ConcentrationProtein);
remember to multiply by dilution factor
2.2.5b Biotin quantitation
A kit is available to quantify the degree of IgE biotinylation (FluoReporter® Biotin
Quantitation Assay) using a 96-well format fluorescence reporter assay.

The

FluoReporter® system uses a fluorescent avidin reagent that is bound to quenching
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ligands. Biotin displaces the quencher, resulting in a fluorescent signal that is
proportional to the concentration of biotin added.
1. Optional: The IgE may be proteolytically cleaved to expose the biotin molecules
completely. If this step is included, use a biotinylated IgG that is included as a control.
We do not typically include this digestion step in our experiment.
2. Using a volume of 50 µL per well, serially dilute the biotinylated lysine standard to
cover the range of 0-80 pmol standard; repeat in triplicate.
3. Aliquot 50 µL of two-fold serially diluted the biotinylated IgE to get concentrations
within the sensitivity range of the assay.
4. Add the Biotective Green reagent to initiate the reaction; incubate for 5 minutes,
covered, at room temperature.
5. Immediately after the incubation, read fluorescence using 485 nm excitation and 530
nm emission using a fluorescent plate reader.
6. Biotinylated lysine data is fit to a quadratic equation to generate a standard curve
from which the concentration of biotin in the IgE samples can be determined.
7. The ratio of biotin concentration to that of IgE is the degree of labeling (DOL).
2.2.5c Immunofluorescent labeling
To test the probes that are made using NHS-ester and maleimide thioether
conjugation, labeling directly on cells can be implemented to ensure that ligands or
antibodies recognize their correct epitopes. However, this approach does not reflect
exact stoichiometry and other approaches (like spectrophotometric ones) are needed to
quantify degree of labeling. The general process of immunofluorescent (IF) labeling is
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outlined below, but each step can be modified in duration and concentration of reagents
in order to optimize results:
1. Cells are seeded on coverslips or in an 8-well chamber at a 50% confluency. Wash 3
times with live cell imaging buffer (Tyrode’s).
2. For live labeling, add a low concentration of fluorescent probe (for EGF ligand, a 100
nM concentration will be saturating for most cell lines) diluted in Tyrode’s buffer for 5
minutes. Exposure at room temperature or 37oC will permit internalization as early as 5
minutes; to retain erbB receptors at the membrane, perform this step on ice.
3. Wash cells 3 times with Tyrode’s buffer.
4. Fix cells using 4% PFA in 1 x PBS, Ph 7.4 for 15 minutes at room temperature.
5. Wash cell 3 times with 1 x PBS.
6. Add DAPI nucleic acid dye in 1 x PBS (1:5000 dilution is typical) in order to visualize
the nucleus.
7. Image using epifluorescence or confocal microcopy. The latter is especially useful to
observe the membrane staining that is expected for receptors at the membrane. Some
examples of labeling using fluorescent probes are show in Figures 2.3 and 2.4.
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Figure 2.3. Fluorescence microscopy images of whole cells. Cells are labeled with
fluorescent probes prepared by papain cleavage of an anti-erbB1 antibody and
conjugation to Alexa 647 dye using NHS-ester chemistry. a) CHO cells transfected with
GFP-erbB1, labeled with Fab fragments conjugated to Alexa 647 dye, and overlay.
These two rows show that there is some amount of Fab that can passively diffuse
through the plasma membrane, when labeled with this dye. b) A431 cells labeled with
VHH (Nanobody) fragments conjugated to QD647 colocalize with EGF QD585. This
panel shows colocalization at the cell surface and some cotransport of the QD probes
during endocytosis.
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Figure 2.4. Fluorescent labeling of cell lines. A) Monovalent Alexa488- and B)
Alexa647-Herceptin labeling of erbB2 SKBR3 cells. C) Herceptin QD655 labeling
oferbB2 SKBR3 cells. D) Nanobody (Anti-erbB1 VHH IIIa42) Alexa488 and E) Alexa647
labeling of A431 cells, 4oC. F) Nanobody Alexa647 labeling of A431 cells, 37oC. Some
internalization is observed. G) Reduced EGF (rEGF) QD655 labeling of A431 cells. H)
Labeling of A431 cells with rEGF QD655 and EGF QD585 shows colocalization and
some internalization after 5 minutes at 37oC. Nuclei stained with DAPI. Scale bar = 5
nm. Images taken on Zeiss LSM 510-META. Contrast enhanced.
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2.2.5d Fluorescent protein SDS-PAGE
Fluorescent constructs can be visualized using standard chromatographic
approaches. Separation of labeled probes on gels is useful in determining purity of
proteins, especially after reduction. An example gel is shown in Figure 2.5.
1. Save some untreated antibody to run on SDS-PAGE gel
2. After DTT and desalting (rIgG), remove some sample to run on SDS-PAGE gel
3. At completion of protocol (rIgG-biotin), remove some sample to run on SDS-PAGE
gel and for biotin quantitation
4. After incubation with streptavidin (rIgG-biotin-fluorophore), remove some for SDSPAGE gel
5. Gel = Antibody, rIgG, rIgG-biotin, rIgG-biotin-fluorophore
o Two 7.5% SDS-PAGE gels
o Stain one gel with Sypro Ruby (show protein bands) and scan with Fuji
Phosphorimager (show fluorescence)
o Transfer other gel to nitrocellulose and perform western blot with α-biotin
HRP antibody (1:100 dilution; Cell Signaling, #7075)
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Figure 2.5. Electrophoretic mobility of probes. A) SDS-PAGE of reduced labeled
antibodies. Alexa488- and Alexa647- labeled reduced anti- erbB1

(clone EGFR.1,

labeled as rEGFR.1) shows poor labeling and the susceptibility to reduction mentioned
above. Reduced Herceptin (rHerceptin, labeled as rH) shows a principle band at 75kDa,
indicative of hinge-reduced fragments. Black and white images coincide with laserimaged figures above them, respectively.
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2.2.5e Fluorescent QD agarose PAGE
QD probes can also be observed by determining relative shift on a discontinuous
agarose gel (Nehilla et al., 2005; Pons et al., 2006; Liu and Vu, 2007). An example of
QDs run on a gel is shown in Figure 2.6.
1. Cast a 1.75% agarose gel (w/v) in 100 mL 1x TBE by gently boiling the solution to
solubilize the agarose
2. After the 1.75% resolving gel sets, cut off a portion of the top of the gel to cast a 0.5%
agarose stacking gel.
3. Run agarose gel in 1x TGS buffer at 120 V for approximately 45 minutes using
samples as prepared for SDS-PAGE (described previously).

Figure 2.6. Relative mobility of QDs. QD-based probes were separated on a
discontinuous agarose gel. Samples, loaded from left to right are: Molecular Weight
Markers (Bio-Rad Precision Plus Standards), QD525, QD585, QD605, QD655, and
QD705.
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2.2.6 Notes
2.1. Using a concentration of 10 mM DTT, reduction occurs at the hinge of an IgG. A
higher concentration (100mM or higher) will fully reduce heavy and light chains.
2.2. Buffer pH and temperature can be modified in order to optimize degree of labeling.
TRIS buffers should be avoided when performing amine reactive conjugations. This
molecule contains reactive amine groups that can compete with the reaction.
2.3. NHS ester fluorescent dyes can be purchased from Invitrogen. An alternate
chemistry for the NHS reactive group is based on tetrafluorophenyl (TFP) moieties. This
other conjugation scheme may be applied using similar protocols and also works well
for linking to reactive primary amines.
2.4. Dissolving reactive groups and dyes in DMSO will permit longer storage.
Solubilizing in water is not recommended since hydrolysis occurs readily and precludes
further conjugations. Storage at -20oC in DMSO can be useful for up to 6 months.
Ultimately, reagents in DMSO must be diluted prior to incorporation in reactions. The
desired final concentration of DMSO is much less than 1% in order to avoid interference
with the conjugation.
2.5. DTT powder (Sigma 43815) is water soluble up to 50 mg/mL (0.3 M); can buy DTT
in solution at 1 M concentration (Sigma 646563); store at -20˚C. Iodoacetamide (Sigma
I1149) is water soluble up to 0.5 M; store at -20˚C. An alternative approach to biotinmaleimide is to reduce and cap antibody with iodoacetamide and then conjugate
antibody with NHS ester dye/biotin conjugates at a 1:1 ratio. Current use of this protocol
in our lab has indicated that the desalt columns retain some protein during use. While
we are testing to determine if running the sample through the column multiple times
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alleviates this problem, we are currently unsure if this is a feasible solution. As such,
minimizing the amount of columns used in the protocol, dialysis, and alternative
cleaving reagents (TCEP and βME) are being explored. Labeling using maleimide
chemistry should be performed at pH between 6.5 and 7.5. Basic pH can cause
competing reactions with primary amines. Thiols should be excluded from the reaction,
but can be used to quench the crosslinking and halt further labeling.
2.6. If spectrophotometric measurements are made, the dilution factor should be
included in this calculation.
2.3 Single quantum dot tracking and Hidden Markov Model analysis of erbB
dimerization
Modified from: Lidke, Low-Nam, Cutler, and Lidke, Determining FcεRI diffusional
dynamics via single quantum dot tracking. Methods Mol. Biol. Submitted.
2.3.1 Summary
Single particle tracking using fluorescent quantum dots (QDs) provides high
resolution spatial-temporal information on receptor dynamics that cannot be obtained
through traditional biochemical techniques. In particular, the high brightness and
photostability of QDs make them ideal probes for single particle tracking on living cells.
We use QD-labeled ligand- and antibody-based probes to investigate the dynamics of
erbB receptors. Herein are protocols for 1) coupling QDs to proteins that bind to erbB
receptors, 2) tracking individual QD-bound receptors and 3) analysis of one- and twocolor tracking data using several analytical approaches, including a three-state Hidden
Markov Model.
Keywords: erbB receptors, single particle tracking, quantum dots
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2.3.2 Introduction
Many events in cellular growth and development are initiated by the erbB family of
receptor tyrosine kinases (RTKs). There are four homologous members of the erbB
family: erbB1/EGFR/HER1, erbB2/HER2, erbB3, and erbB4. Canonical activation of
receptors requires ligand binding to the extracellular domain to stabilize the untethered
conformation and promote the formation of back-to-back dimers. A cascade of signal
transduction proceeds with the formation of an asymmetric dimer of the kinase domain
tails, transphosphorylation of cytoplasmic tyrosine residues and the recruitment of
adaptor proteins. Ultimately, downstream interactions lead to changes in the genetic
programs that control events like growth, differentiation, adhesion, and migration
(Lemmon and Schlessinger, 2010). Ligand-stabilized activation of erbB receptors is
associated with changes in receptor dynamics and cellular topography, suggesting
important roles for diffusion and interactions in signaling.
Single particle tracking (SPT) is a powerful tool for studying the subtleties of
protein behaviors and interactions. By measuring the motions of individual proteins,
SPT can reveal details of protein dynamics at the molecular level. Proteins of interest
are labeled at a sufficiently low density in order to resolve their individual positions with
high precision (Saxton and Jacobson, 1997). The use of bright and photostable
Quantum Dots (QDs) for SPT has extended the capabilities of this technique by
allowing for longer tracking times and facilitating multi-color measurements (Dahan et
al., 2003; Lidke et al., 2004; Lidke et al., 2005a; Andrews et al., 2008; Roullier et al.,
2009). Simultaneous multi-color tracking allows for direct comparison of protein
dynamics when different species are labeled with distinct QDs and can provide
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information about protein-protein interactions.

We have previously shown that QD-

labeled EGF ligand can bind erbB1 and can be used to track receptor dynamics in the
activated state (Lidke et al., 2004; Lidke et al., 2005a). The use of a monovalent
antibody fragment of a heavy-chain only antibody, called a nanobody (VHH), that does
not activate the receptor or compete for ligand binding is useful for studies of the
dynamics of the resting receptor. Here we describe methods collection and analysis of
SPT data. Information on the generation of erbB probes useful for tracking each
member of the family may be found in the chapter, “Antibody fragmentation and probe
conjugation chemistries.”
2.3.3 Materials
1.

Phosphate-buffered saline (PBS), pH 7.4 (Gibco 10010-023, Carlsbad, CA)

2.

Streptavidin-conjugated QDs (SAvQD) (Molecular Probes, Eugene, OR)

3.

Tyrode’s live cell imaging buffer (also called Rab): 135 mM NaCl, 10 mM KCl, 0.4
mM MgCl2, 1 mM CaCl2, 10 mM Hepes, pH 7.2. On the day of use, supplement this
solution with 20 mM glucose and 0.1% BSA.

4.

LabTek eight well cover slip chambers (Nunc 155411, Rochester, NY)

5.

Dulbecco’s Minimum Essential Medium (DMEM, Gibco 21063-045, Carlsbad, CA)
supplemented with 10% Fetal Bovine Serum (MEM/FBS) or other appropriate serum
for cells.

6.

Biotinylated protein in 1 X PBS, pH 7

7.

FluoReporter® Biotin Quantitation Assay (Molecular Probes F30751, Carlsbad, CA)

8.

Two color image splitter such as Cairn Optosplit (Faversham, UK), Optical Insights
Dual View (Santa Fe, NM), or four color QuadView image splitter (Optical Insights).
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9.

Appropriate emission filters and dichroics for QDs of interest (Chroma, Rockingham,
VT or Semrock, Rochester, NY)

10.

erbB expressing cells (A431, MCF7, MCF7 Her2 18, SKBR3, HeLa, and others)

2.3.4 Methods
2.3.4a Preparation of QD probes
A kit is available for SMCC activated QD conjugation to reactive thiols on reduced
proteins (Invitrogen, Carlsbad, CA). This kit works very well for hinge labeling of
antibodies that have been reduced between the heavy chains, as well as ligands that
have been reduced by DTT. The latter are gently reduced so that some refolding occurs
and permits binding to erbB receptors, but generally precludes activation (Diagaradjane
et al., 2008).
This protocol describes methods for conjugation to commercial SAvQDs (see Note
2.7).

Singly biotinylated EGF ligand is purchased or can be prepared using

bioconjugation of reactive primary amine groups with biotin-SE (see Chapter 2.1 for
details).

Monovalent 1:1 biotinlyated VHH is produced using the BirA expression

system.
3.1.2 QD-protein conjugation
1. Dilute SAvQDs to 90 nM in 100 µl of PBS+1%BSA.
2. Dilute Biotin-EGF or Biotin-VHH to 30 nM in 100 µl of PBS+1%BSA.
3. Add Biotin-protein to the SAvQD and gently mix several times with a micropipette,
being careful to avoid generating bubbles.
4. Incubate for at least 60 min at 4 °C with gentle agitation. The result is a 30 nM stock
of QD-Probe that can be stored at 4 °C for up to 2 weeks (see Note 2.8).
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2.3.4b Cell labeling and microscopy
Single particle tracking using the QD probes is performed in combinations in order
to observe 0:2, 1:2, and 2:2 ligand:erbB1 complex formation using the VHH and EGF
conjugates (see Note 2.9).
3.2.1 Labeling Cells
1. erbB expressing cells are plated in 8-well chambers 1 to 2 days prior to the
experiment in DMEM/FBS (or other appropriate media, see Note 2.10). An initial
density of 50,000 cells/well or 25,000 cells/well results in an appropriate density after
1 or 2 days, respectively.
2. Wash cells 2-3 times with 350 µl Tyrode’s live cell imaging buffer.
3. Label cells at a final concentration of 20 pM EGF-QD or 2-10 pM VhH in Tyrode’s.
a. For two-color QD tracking, label cells by simultaneously with a mixture of the two
QD probes (see Note 2.11).
4. Optional: Wash cells after 30 seconds to 1 minute in order to remove unbound QDs.
Ensure that there is at least 350 µL of imaging buffer in each well during imaging.
5. Optional: Add this step after QD-IgE labeling in cases where saturating nonfluorescent EGF(dark EGF) is required (i.e. for maximal activation of receptors). Add
100 nM EGF to each chamber.
Fiducial data acquisition
1. 5 uL of 1:10 dilution (in PBS or live cell imaging buffer) of 0.2 µm Tetraspeck beads
are dropped onto one well of an 8-well chambers slide and allowed to settle for 2
minutes. This well is washed 2-3X with live cell imaging buffer and left in buffer for

55

imaging. Using one well of an 8-well slide with cells in the center four wells increases
efficiency during imaging.
2. Take a Background image sequence (100 frames) without light going to the CCD.
The knob has light going to the eyepiece and all lights should be off. (Once at the
beginning of each imaging session)
3. Take a Beads photon calibration sequence (100 frames) using at least 4 beads in a
field of view. The sequence is taken with the beads out-of-focus to sample the dynamic
range of the detector. Using the Tetraspeck beads, longer integration times can be
used. (Once at the beginning of each imaging session)
4. Take a fiducial calibration series using the Tetraspeck beads using the MatLab
function fiducial_beads. (performed at the beginning and end of each chamber, see
Note 2.12)
5. A beads sequence is acquired to permit imaging with a live overlay. The sequence of
100 frames is summed and a border is used to frame each channel for input into the
function aligncrop.
Script:
bd = sum(sequence,[ ],3);
beads = aligncrop(bd,4,80);
%use calculate live overlay button in andorixon GUI
Single particle tracking
1. Place 8-well chamber containing erbB expressing cells on the microscope stage and
allow time for temperature equilibration. We use an inverted wide field microscope
(Olympus IX71) equipped with an objective heater (Bioptechs) to maintain
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temperature at 34-36 °C. Excitation is from a mercury lamp (436/10 nm BP filter) and
emission is collected by an electron multiplying CCD camera (emCCD, Andor iXon).
For two-color imaging, an image splitter that projects two color channels
simultaneously on the emCCD is used with appropriate QD emission filters. For
example, we use an OptoSplit II (Cairn Research) equipped with a 600 nm dichroic
and 655/40 nm and 585/20 BP emission filters (Chroma) (see Note 2.13). Locate a
single cell and focus on the apical membrane. A 60x water, 1.2 NA objective is
recommended to avoid aberrations induced by oil/water index of refraction mismatch.
2. Begin acquisition of time series. Data is typically collected at 20-33 frames per
second.

Longer exposure times give better signal-to-noise at the expense of

temporal resolution.
3. A single well can be imaged for up to 7 minutes in the presence of activating EGF but
should not be imaged longer than this as receptor internalization confounds data
acquisition.
2.3.5 Analysis
2.3.5a Single QD tracking
A 2D Gaussian is used to represent the microscope point spread function (PSF),
with σPSF values measured for each color channel using immobilized fluorophores on a
cover slip. See Figure 2.7 for more PSF details.

Localization accuracy is limited

primarily by the microscope PSF, the number of photons collected from the fluorophore,
and the background count rate (Smith et al., 2010). For image processing, we use and
recommend MATLAB (The MathWorks, Natick, MA) in combination with the freely
available DIPimage toolbox (Delft University of Technology, http://www.diplib.org/).
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Raw data is cropped into left and right channels using the function splitImage. All
tracking is done on unshifted data.
1) Convert CCD image data to photon counts (Lidke et al., 2005c).
a) Subtract the camera offset pixel-wise for each image frame. The camera
offset image is the mean image of ~ 1000 frames taken with no light on the CCD.
b) Divide the offset corrected images by the CCD gain. The gain can be found
as the slope of the variance vs. intensity plot generated from a stack of ~20
images of an identical object. The variance and intensity are calculated along
the 3rd dimension. Slightly out of focus fluorescent beads mounted on a cover
slip make a good, photostable test object. Gain calculation is implemented as
DIPimage function ‘cal_readnoise.’
2) Find coordinates of QDs.
a) Identify areas of interest. Initial segmentation of each image is performed by
subtracting a Gaussian filtered image with filter kernel σk=2*σPSF from a filtered
image with σk=σPSF. A threshold of the standard deviation across the resulting
image is used to identify candidate fit regions.
b) Maximum Likelihood Estimate of QD position, emission rate and background
count rate (Smith et al., 2010).

A box of ~ 6 * σPSF pixels centered around the

center of mass of each contiguous area found in part a) is used as a fitting region
for a single molecule fit.
c) Reject objects that are not single molecules. Objects that do not pass a shape
test or do not pass an emission rate threshold are removed from further analysis.
3) Build trajectories from QD coordinates (Andrews et al., 2008)
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a) Compile short, continuous trajectories. Starting with the first frame, all
coordinates found in the subsequent frame are compared to each set of
coordinates from the current frame. If they pass a threshold probability given by
P(r,Δt)=exp[-r2/(4DΔt)]), where P is typically 0.01, D is an estimated diffusion
constant, and r is the distance between coordinates, they are connected to build a
trajectory.

If more than one particle passes this threshold, the coordinate with

the highest P value is selected (see Note 2.14).
b) Connect short trajectories. The x,y,t coordinates at the beginning and end of
each short trajectory are used to repeatedly connect short trajectories into final
trajectories. Using the same equation as above, the threshold probability for this
step is typically 10-4. We also give an upper limit for the distance and time interval
between coordinates in order for two short trajectories to be joined into a longer
trajectory.

Figure 2.7. Example of Single QD-EGF Tracking. A) Images from one frame of twocolor QD-EGF tracking on the surface of SKBR3 cells showing each channel (QD655
on the left, QD585 on the right) as projected by the Optosplit. Inset on the lower left
shows the PSF fits of a single QD655. These images were acquired with excitation
intensity of 4.7 W/cm2 (436/10 BP), results in average photon counts of 314 and 172 for
QD655 and QD585, respectively. The localization error is then 24 nm for QD655 and
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36nm for QD585. B) Selected trajectories of erbB1 labeled with QD655-EGF (white) or
QD585-EGF (black) overlaid on the transmission image.
2.3.5b Calculation of diffusion coefficients
Once trajectories have been obtained from the time series, diffusion coefficients
(D) can be extracted. Here we outline the generation of mean square displacement
(MSD) plots, which can then be fit to models of diffusion (Andrews et al., 2008). The
best fit model reveals the type of motion (i.e. free, restricted, directed diffusion or
immobile) and the diffusion coefficients for each molecule (Figure 2.8A,B).

Using

trajectories from GPUSPT, diffusion coefficients (D) are extracted using the function
D1_3. From diffusion coefficients, cumulative probability analysis (CPA) permits
comparisons of the distribution of D values for different conditions by sorting and
binning measured D values. Median D is reported as the representative diffusion rate of
receptors tracked under each condition.
1. For each trajectory, generate an MSD plot (see Figure 2.8).
2. Fit to the appropriate model to obtain diffusion coefficient (D)
Free: MSD = offset + 4DΔt;
Restricted: MSD = offset + (L2/3)*(1-exp(-Δt / τ); τ=L2/12D;
Directed diffusion: MSD = offset + 4DΔt +v2Δt2;
where offset is the y-axis offset and related to the localization accuracy, Δt is time
interval, L is the length of one side of the area that the molecule is restricted in, and v is
transport velocity. The statistical error increases with large time intervals, therefore no
more than the first 25% of the MSD plot should be considered for fitting.
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3. To compare aggregate data, generate a Cumulative Probability Analysis (CPA) plot
(see Figure 2.8C). Due to the spread in values for SPT data, diffusion coefficients are
better represented by a CPA than by an average value (Ehrensperger et al., 2007).
Comparison of CPA plots for different conditions immediately reveals differences in
diffusional dynamics (Figure 2.8C). A CPA plot can be generated from fits to the above
models. To remove the influence of restricted diffusion from the calculation of D, fitting
the free diffusion model to the first few points of the MSD is often used. The number of
points used can vary; we use D1-3 while others report D2-4 or D1-5.
In particular, the example in Figure 2.8C shows relative diffusion for erbB1
receptors on A431 cells, tracked using QD-EGF, in the presence or absence of
PD153035 tyrosine kinase inhibitor and, furthermore, in the presence or absence of
pretreatment with the matrix metalloprotease (MMP) inhibitor, Batimastat. This drug is
used to prevent autocrine shedding of ligand from the cell surface. Results shown in this
plot demonstrate that autocrine shedding is not a marked factor in A431 cell behavior,
as seen in the high degree of similarity in receptor mobility in the presence or absence
of this treatment. As a result of this analysis, Batimastat was not used in A431 studies.
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Figure 2.8. Example of analysis of Single Particle Trajectories. A) Example trajectories
showing the four modes of motion that are observed for erbB receptors (Free,
Restricted, Directed, Immobile). B) An MSD plot for a single particle trajectory (grey
circles) shows that free diffusion (i.e. linear fit, solid black line) best represents the data.
Also shown are the shapes of curve obtained from restricted diffusion (--), immobile
molecules ( )װand directed diffusion (-⏐-). The inset highlights the differences between
the fits. C) CPA plot comparing QD-EGF behavior in the presence (red line) or absence
(blue line) of PD153035, where dashed lines are in the absence of Batimastat and solid
lines represent data following pretreatment with the MMP inhibitor. The leftward shift of
diffusion coefficients seen in the presence of QD-EGF indicates activation and slowing
of erbB1 receptors. The blue and red lines overlay almost perfectly, showing that
autocrine shedding of ligand is not a significant contributor to A431 erbB1 activation.
2.3.5c Two-channel overlay
To properly analyze two-color single QD tracking data (i.e. differentiating between
dimers and colocalized QDs), optimal interchannel registration is required.

Using

software to directly overlay data from each channel using just an image shift will result
in suboptimal interchannel colocalization since an image splitter may introduce nonuniform chromatic aberrations into the separate images projected onto the detector.
1. Collect calibration image(s) (see Note 2.15) A calibration image should consist of
single point sources spanning the field of view. Fiducial calibration data is optimal
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due to its well distributed sampling of the entire field of view and the ability to
optimize the localization accuracy of the point source(s) (Churchman et al., 2005)
(see Figure 2.9). It is important to obtain a test and training image for calibration in
order to define the localization accuracy achieved using an independent test set.
2. Localize calibration points in each channel using a 2D Gaussian PSF fit model. The
width of the microscope PSF is proportional to wavelength and therefore the PSF for
each channel will be different. Since localization accuracy is essential for optimal
colocalization, identifying the sigma for the 2D Gaussian PSF model for each
channel is recommended.
3. Train and test the calibration model
a. Identify a proper calibration model for your instrumental setup.

We use a

polynomial (specifically a+bx+cy+dxy where a,b,c,d are coefficients and x,y are
spatial coordinates) to describe the relationship between positions in each
channel. Other calibration models are also available (Churchman et al., 2005).
b. Use a training calibration image to build the model (find coefficients) and test the
calibration image to estimate the prediction accuracy of the calibration.

See

Figure 2.9 for more details on channel transformation. If calibration images are
acquired before and after data acquisition, then train the model with the preacquisition calibration and test it with the post-acquisition calibration data. This
will give insights into the instrument stability during the acquisition of
experimental data.
4. Apply calibration model to QD data. The coordinates obtained from single particle
tracking of raw data are corrected to correspond with the reference channel using
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the calibration model.

Trajectories should always be obtained from un-shifted

images

Figure 2.9. Fiducial Calibration Data Set. A) Fiducial bead data shown for each channel
using a single broad spectrum bead (200 nm Tetraspec Bead from Invitrogen) imaged
by stepping the stage (5 µm) to sample the entire emCCD. B) Analysis of the calibration
image shows the imaged positions for each channel, the linearly shifted channel 2 data,
and the transformed channel 2 data. This transformation vector is then used to
transform the channel 2 SPT data to allow overlay with channel 1 trajectories.
2.3.5d Correlated motion analysis
Pair-wise comparisons of two-color trajectories permit further description of receptor
behaviors, namely the presence of interactions whose lifetimes are longer than the
imaging acquisition time. This analysis shows the degree of correlated motion by
determining parameters for each candidate pair in sequential frames. The trajectories of
receptors during an interaction will be coordinated, as seen in a decrease in the
uncorrelated jump distance parameter (see Figure 2.10).
1. Determine initial separation between two trajectories; if this is less than a specified
cutoff (i.e. 500 nm), continue to analyze the candidate pair.
2. Uncorrelated jump distance is determined for all candidate pairs at each time step
using:

Di=│Ji-Ji(Ji·Jj) / (|Jj||Ji│) |, where J1i= r1i+1-r1i and J2i=r2i+1-r2i. │J i|

represents the magnitude of the displacement during a time step and ri is the
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position of a QD at time i (Andrews et al., 2008). The uncorrelated jump distance
parameters are averaged and binned in 50 nm separation intervals for plotting.

Figure 2.10. Pairwise Correlated Motion Analysis of Simulated Single Particle
Trajectories. A) A schematic of two-color QD tracking shows single molecules that are
initially separated, but in frame 3 form a dimer and continue to move in a coordinated
manner, reflecting the interaction between the receptors. B) and C) Simulated two
particle trajectories of receptors demonstrating uncorrelated and correlated motion,
respectively. Particle trajectories are plotted in three dimensions using coordinates and
time frame. D) Global analysis of many simulated trajectories demonstrates the trends
seen in the cases of correlated (black) and uncorrelated (grey) motion. In the former
case, as particles come within the interaction distance and move together, the
uncorrelated jump distance parameter markedly decreases. Simulation conditions
included 10 particles for each QD color, 5000 frames, diffusion coefficient = 0.07 µm2/s,
and a 25 nm interaction distance. Correlated motion analyses of erbB receptors can be
found in Chapters 3 and 4.
2.3.5e Movies
Color overlays can be made using cropped data; the true overlay is generated
using the transform from the fiducial calibration, but is very slow. This is done by looping
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over each frame using the function ch2_2_ch1. Rudimentary overlays can be made
using a simple lateral shift vector, determined using alignsplitim.
Script:
resultsdir='Z:\Shal\SPT Data\100108_A431_PD\Chamber1\';
codir='Z:\Shal\SPT Data\100108_A431_PD\Chamber1\ColorOverlays\';
mkdir(codir);
tformdir='Z:\Shal\SPT Data\100108_A431_PD\Chamber1\';
tformfile='FiducialCalibrationStart';
load([tformdir tformfile]);
Lfiles=dir([resultsdir 'L*']);
Rfiles=dir([resultsdir 'Ru*']);

for kk=1:size(Lfiles,1)
clear coloroverlay
load([resultsdir Lfiles(kk).name])
fn=Lfiles(kk).name;
load([resultsdir Rfiles(kk).name]);
for tt=0:999
ch1=squeeze(L(:,:,tt));
ch2=squeeze(Ru(:,:,tt));
[temp_ch1_out temp_ch2_out] = ch2_2_ch1(ch1,ch2,tform,0);

%

changed last input from 1 to 0 so that plots aren't generated every
time - should be faster.
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if tt == 0
ch1_out = newim([size(temp_ch1_out) size(L,3)]);
ch2_out = newim([size(temp_ch2_out) size(Ru,3)]);
end
ch1_out(:,:,tt) = temp_ch1_out;
ch2_out(:,:,tt) = temp_ch2_out;
end
co = joinchannels('RGB',stretch(ch1_out,50,100),stretch(ch2_out,50,100));
% you want to save this as you go through the loop or else will simply
overwrite it.
save([codir 'co_' fn],'co');
end
It is often easiest to view movies in .avi format. The coloroverlays can be converted, en
masse to .avi using the function writedisplayavi.
Script:
codir='Z:\Shal\SPT Data\100109_A431\Chamber1\ColorOverlays\';
cofiles=dir([codir 'co*']);
avidir='Z:\Shal\SPT Data\100109_A431\Chamber1\ColorOverlays\Avis\';
mkdir(avidir);
for kk=1:size(cofiles,1)
clear co
load([codir cofiles(kk).name]);
fn=cofiles(kk).name;
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co
writedisplayavi(1,[avidir fn '.avi'],20,'Cinepak');
close all
end

2.3.6 Hidden Markov Model data analysis
Pairwise trajectories from two-channel data are analyzed using a modified threestate Hidden Markov Model (HMM). Using this approach, the underlying state behavior
of interacting receptors can be fit using the known separation distances at each
timepoint. Initially, a simple, two-state model for monomeric or dimeric receptors was
employed to analyze data sets. After thorough analysis and the visualization of idealized
dimers from the bleedthrough of QD625 signals into both imaging channels
simultaneously, we determined that the two-state HMM could not comprehensively
explain our observations (for further details, please see Appendix C from Low-Nam, et
al.). The final HMM consists of three states (free or monomeric, domain co-confined, or
dimeric) for erbB receptors on cells. Our observations of single receptors on cells
permits not only determination of the interaction kinetics of dimerization, but also points
out the significant influence of domain arrangement and membrane architecture on
complex formation, molecular collisions, and signaling. A more complete explanation of
this approach and its derivation can be found in our manuscript, Low-Nam, et al.,
Chapter3.
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2.3.6a HMM data structure
For data to be evaluated in the HMM, it is helpful to reorganize the files so that all
the data of the same type (ie 2-color EGF) are in the same folder. Unlike the model
developed by Beausang and Nelson, we do not implement a transition matrix
(Beausang et al., 2007). The data are organized into a structure that includes path
information to the raw data, calibration files, and tracking results. This data structure is
augmented with each analysis step so that the pertinent information is linked and can
be retraced. The HMM functions are described below. A comprehensive script and all of
the functions needed for analysis are included in Appendix D.
HMM_LinkData:
Creates the HMMData format (.HMMDATA file type) and connects data files for
each acquisition (raw data, background and beads image, fiducial data sets). An
example of the data structure is seen in Figure 2.11.
HMM_Track
This function tracks data of the type HMMData using the SPT tracking functions
previously explained (Smith et al., 2010). Fiducial calibration and channel registration
are also performed. For further analysis data of the type HMMData_raw_ch1_tracks and
HMMData_shifted_ch2_tracks are on a common coordinate system and can be directly
compared (refer to Figure 2.11).
Data preprocessing and fitting
Dimer candidates are found using the function HMM_PreprocessStates. This
filtering determines which tracks come within a minimum distance cutoff (1 µm,
currently) and have at least 3 simultaneously valid frames – both characteristics are
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necessary for an interaction to be considered. To handle so much data, this pairwise
analysis is done in cycles, to prevent running out of memory. For pairs of trajectories
that meet the cutoffs, a vector of coordinates, valids, and localization accuracies is
saved along with a PairID number. A plot of the distances between the trajectories can
be generated, if desired; alternately, the distancepath parameter can be passed in as an
empty vector (for the two-state model only). A data type HMM_PreProcessData
(.HMMPP file type) is created. This structure is augmented in subsequent analyses and
an example of the results can be seen in Figure 2.11.
Candidate pairs are passed into the function PMatrix to determine the probabilities
of transitions using the function Pbr1r2. The likelihood of the current state, given state
the preceding one and the separation distance between the particles during that time
step, is determined, where receptors can only enter the bound state when they are
within the interaction distance (see Note 2.16). The Diffusive Hidden Markov Model is
run using the function HMM_FindRates. This only fits in the forward direction for a range
of Tau_BF and Tau_BB values (we do not employ the forward-backward algorithm as
we found that it did not improve the rate fits); plots are generated for the maximum
likelihood values of the rates and a mesh plot can be shown (for the two-state model
only).
Viterbi algorithm and plotting
After the reaction rates have been solved, the Viterbi algorithm (Viterbi, 1967) is
implemented in order to determine where sets of trajectories exhibit each type of state
behavior. The functions HMM_FindStates and HMM_StatesDist are used to assign
state values (3-free, 2-domain, 1-dimer) to each trajectory at each time step and ensure
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the

filling

of

the

State

Matrix

for

further

analyses.

The

function

HMM_PlotCandidates_3state can be used to plot candidate pairs. Plots for trajectories
in 3D, distance between tracks with a state trace overlay, and others are generated.
These plots can be useful to look through in order to find ideal pairs for making movies
or figures. An example of plots can be viewed in Figure 2.12. However, this can be a
time-intensive step because all candidate plots will be created and saved; plotting can
also be performed at a subsequent time and examples of plotting scripts can be found
in Appendix D.

Figure 2.11. Analysis structures include sub-structures, vectors, and paths. A. The
HMM_Data type is created in order to keep track of raw data and results from tracking.
B. The HMM_PreProcessData type shows the results of preprocessing, fitting, and
subsequent HMM analyses.
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Figure 2.12. Plotting of HMM results. A. 3D trajectories for all candidate pairs in a single
movie. Tracks are shown in red and green for QD655 and QD585, respectively. State
colors are overlayed for domain (magenta) and dimer (blue). When no state information
exists, the tracks are considered to be free. B. An example of a distance and state trace
for a pair see in 6A. The state trace shows all three states: free (red), domain
(magenta), and dimer (blue) over the black distance between tracks (in µm) for the 50
second acquisition.
Diffusion by state
Once the states have been determined, diffusion analysis can be performed, using
the Filled State information to separate mobility by state. D1_3 analysis cannot be
implemented due to insufficient information for short tracks. Instead, diffusion is
determined using Square Displacement analysis that uses all values for squared
displacement for a given time interval and fits the distribution, using a two-component
least squares regression (de Keijzer et al., 2008). Results shown in Figure 2.13 are
obtained using Pr2_3State.
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Figure 2.13. State-dependent diffusion analysis of HMMData tracks. Data from the
QD655 channel is analyzed using the Square Displacement approach. Using the state
matrix from HMM_StatesDist, the data are sorted by state and plotted as a cumulative
probability distribution of square displacements (r2). A two-component fit to the
distribution is used to determine the diffusion coefficient. As expected, the QD-EGF data
shown in this example display slowed diffusion from monomer-to-domain-to-dimer
states, observed as a leftward shift in the data.
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2.3.7 Notes
2.7. Labeling conditions can be optimized by first using a fluorescent (rather than biotin)
derivative of succinimidyl ester, such that the conjugation chemistry is the same and the
dye-to-protein ratio can be easily determined by spectrophotometric absorption
measurements.
2.8. QD-protein probes should be diluted to appropriate concentrations in imaging buffer
just before use since buffers containing divalent cations can cause SAvQD aggregation
over time.
2.9. Typical QD tracking is performed using two colors of the same protein. However,
the heterodimer is monitored using one color conjugated to VHH and the other to EGF.
It can be useful to check that the color choice does not alter the measured diffusion or
interactions, but evidence from our data suggests that the QD color does not affect the
measurement.
2.10. Cells are typical grown in media that does not contain the pH indicator, phenol
red. In the absence of this indicator, it is important to monitor the pH occasionally to
ensure that there are not substantial changes in this parameter. In particular, serum
starving cells in phenol free media is useful in minimizing cellular autofluorescence that
can often result from the retention of phenol red as small packets inside cellular
vesicles.
2.11. Although simultaneous addition of QDs to cells is often preferable in tracking of
erbB receptors, sequential labeling can be used to optimize density of labeling. When
adding QD solutions to a well for imaging, it is preferable to slowly add 50 µL of probe
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solution to 300 µL of cells in Tyrode’s in order to prevent a response elicited simply by
mechanical response to the solutions mixing.
2.12. For analysis, the first fiducial trn image should be used for calibration and the
second tst image for testing and error analysis.

It is beneficial to acquire fiducial

calibration as often as is feasible within the experimental conditions. If beads appear to
go out of focus during the acquisition of a fiducial image, then the microscope needs to
be refocused and the fiducial calibration image needs to be reacquired.
2.13. While QDs are highly photostable, illumination with intense light can increase QD
blinking and even lead to blue-shift and photodegredation of the QD emission.
Therefore, optimal illumination power (typically controlled through neutral density filters)
that maximizes QD signal but does not lead to blue-shifting should be determined for
each system. Channels are aligned and allowed to sit at least four hours (preferably
overnight) before imaging. The springs relax over time and are allowed to reach
equilibrium prior to data acquisition. The camera is controlled using the andorixon GUI
and data is saved using the lasercontroller GUI.
2.14. In single particle tracking, the parameters for single molecule thresholds and
trajectory connection probability thresholds should be optimized on a sub-set of data
and checked manually before proceeding with an automated analysis of larger data
sets.
2.15. We have observed sporadic instrumental drift when using an image splitter;
therefore, it is important to investigate stability when performing experiments in which
nanometer overlay accuracy is important. We have found it good practice to obtain a
calibration image both before and after data acquisition to ensure instrument stability.
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2.16. Two distances are involved in state characterizations using the HMM. The
interaction distance (ID) is defined by the crystal structure size of the erbB dimer,
including accounting for the size of the QD probes used to visualize the interaction. On
the other hand, the confinement zone size (domain distance, DD), is fit within the HMM
itself and requires looping the fitting routine over a range of DD values (typically
50:50:500; that is 50 to 500 nm at 50 nm intervals). Thus, domain sizes are not
predetermined, but extrapolated from the raw data.
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3.1 INTRODUCTION, RESULTS AND DISCUSSION
Ligand-induced

signaling

by

the

epidermal

growth

factor

receptor

(EGFR/HER1/erbB1) drives cell growth, adhesion and survival (Schlessinger, 2002).
Structural studies suggest that ligand binding stabilizes the extended extracellular
domain conformation, permitting formation of a back-to-back homodimer (Ferguson et
al., 2003) and initiating signaling. Outstanding questions in the field include the role of
preformed, unliganded dimers, (Chung et al., 2010; Hofman et al., 2010) relative
stability of dimers with different ligand-receptor stoichiometries (Sako et al., 2000; Lidke
et al., 2005a; Macdonald and Pike, 2008), and the receptor reaction kinetics within the
context of the membrane (Orr et al., 2005; Hsieh et al., 2008). Here, two-colour
quantum dot (QD) tracking is used to directly visualize erbB1 homodimerization on living
cells. Kinetic parameters were extracted from pairwise trajectories using a 3-state
Hidden Markov Model (HMM) that identifies transition rates between free, domainconfined, and dimer states. We present evidence that co-confinement in membrane
microdomains promotes repeated encounters between receptors, enhancing dimer
formation. We find that dimers composed of 2 ligand-bound receptors are long-lived and
their off rate (koff) is independent of kinase activity, while unliganded dimers have >4fold faster off rates.

Mobility decreases >6-fold when ligand-bound receptors form

dimers. Large changes in diffusion are not observed in the absence of ligand or
presence of kinase inhibitors, pointing to reduced mobility as a feature of signal
propagation.
Early estimates of erbB1 dimerization parameters relied on solution-based
measurements and the use of recombinant extracellular domains. In vitro approaches,
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including chemical crosslinking and small-angle x-ray scattering, have been coupled to
mathematical modeling for estimation of homodimer equilibrium dissociation constants
in the absence and presence of ligand (Sherrill and Kyte, 1996; Lemmon et al., 1997;
Kholodenko et al., 1999). The effects of receptor number and density on dimerization
behavior have also been considered by computational approaches (Shankaran et al.,
2006; Hsieh et al., 2008), supported by indirect evidence such as tyrosine
phosphorylation kinetics as well as recent fluorescence correlation analyses (Nagy et
al., 2010). These prior studies considered the ensemble, steady state behaviors of
erbB1 but do not address the stochastic nature of receptors encountering each other in
the fluid and dynamic landscape of the plasma membrane. In particular, they fail to
address accumulating evidence that the membrane is composed of heterogeneous
microdomains that can serve as transient confinement zones (Kusumi et al., 1993;
Simson et al., 1995) with the potential to influence the signaling process.
Sophisticated fluorescence imaging techniques have been used to investigate
features of erbB1 behavior, including receptor diffusion and clustering (Sako et al.,
2000; Ichinose et al., 2004; Lidke et al., 2004; Lidke et al., 2005a; Orr et al., 2005; Nagy
et al., 2010). EGF-bound quantum dots have permitted tracking of ligand-bound erbB1
homodimers and heterodimers on live cells, with an early focus on filopodial transport
and internalization kinetics (Lidke et al., 2004; Lidke et al., 2005a). These photostable
fluorescent nanoprobes have useful photophysical properties, such as broad excitation
and narrow emission spectra, permitting extended periods of observation and facilitating
simultaneous two-colour single particle tracking (SPT) (Lidke et al., 2005a; Andrews et
al., 2008; Roullier et al., 2009). Prior QD-EGF studies revealed that a 2:2 EGF:erbB1
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dimer was the predominant signaling competent complex (Lidke et al., 2005a). Here
new analytical methods were developed to quantify receptor dynamics, with an
emphasis on differences in diffusion and dimerization off rates related to receptor
occupancy and activation state.
Figure 3.1A illustrates our experimental approach using two-colour QD tracking to
follow the dynamics of endogenous erbB1 receptors on the apical surface of live A431
cells. Receptors were labeled with QDs conjugated to either EGF (Lidke et al., 2004) or
a non-activating, monovalent camelid anti-erbB1 antibody fragment (VHH) that does not
compete for EGF binding (bottom plane) (Hofman et al., 2008). Simultaneous, twocolour imaging was achieved using a beam splitter that projects QD655 (magenta) and
QD585 (green) emissions onto the emCCD (middle plane). Finally, a custom-designed
image registration method is used to map the relative positions of 585 and 655 QDs
over the time course of data acquisition (top plane).

As described in the

Supplementary Information, image registration was based on fiducial calibration of
pairwise images of immobilized, two-colour fluorescent beads(Churchman et al., 2005).
Fast computation of single molecule trajectories was accomplished using a GPU-based
approach, which identifies single molecule locations and builds trajectories using postprocessing algorithms (see Supplementary Information, Fig. S3.1 online) (Smith et al.,
2010). These data sets provided two types of information about receptor behavior.
First, diffusion coefficients were extracted from the trajectories of individual receptors
using well-established methods(de Keijzer et al., 2008). Second, novel computational
analyses of two-colour imaging data permitted measurement of dimerization and statedependent behavior .
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Figure 3.1B reports global changes in diffusion properties of erbB1 receptors under
different experimental conditions, represented as the probability distribution of squared
displacements (de Keijzer et al., 2008). Each curve is derived from single QD tracking
of thousands of diffusing receptors and shows the broad range of diffusional behaviors
for a given receptor state, with left-shifted plots being the slowest (see Supplementary
Information, Table S3.1 online). Ligand-bound receptors were tracked using either QDVHH probes in the presence of saturating concentrations of nonfluorescent EGF (10
nM) or picomolar concentrations of QD-EGF. These data show a strong relationship
between diffusion and activation state, with the resting receptors (QD-VHH, orange)
having a higher mobility than ligand-bound (QD-EGF, black) receptors. In the presence
of PD153035 that inhibits erbB1 kinase activity (Fry et al., 1994), ligand-bound
receptors displayed fast mobility (green), similar to resting diffusion. The slowed lateral
motility of ligand-bound receptors is thus linked to tyrosine phosphorylation, possibly
through protein scaffolding or signaling-induced changes in the local environment.
Importantly, the addition of dark EGF to QD-VHH-labeled cells results in slower diffusion
of the receptors, confirming that the QD-VHH does not interfere with ligand binding or
dimerization.
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Figure 3.1. Slowed diffusion as a function of receptor activation is revealed by single
QD tracking on the apical surface of A431 cells. (a) Following 4 hours of serum
starvation in the absence or presence of 1 µM PD15035, the activated and resting
erbB1 receptor were labeled and tracked on live A431 cells with either two colors of 2
pM QD-EGF, 20 pM QD-VHH, or a combination of each at 37oC, respectively. Bottom
plane: ErbB1 receptor cartoons (blue, not to scale) on the surface of an adherent cell on
a coverslip, with probes recognizing the tethered and extended conformations (EGF
ligand, blue; VHH, orange; QD655, magenta; QD585, green). Middle plane: Single
molecules were visualized in a QD655 or QD585 channel for up to 7 minutes after
stimulation. Top plane: Following SPT and image registration, trajectories are plotted on
the same coordinate system. Scale bar, 2 µm. (b) Cumulative probability plot of squared
displacement for each condition: QD-EGF (black), QD-VHH + non-fluorescent EGF
(purple), QD-VHH (orange), QD-VHH + PD153035 (green), and QD-EGF + PD153035
(blue). A rightward shift in distribution indicates increased diffusion. Fits for twocomponent square displacement analyses are provided as Supplementary information
(Table S3.3).
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Imaging of spectrally-distinct QDs allowed direct observation of receptor
associations.

As receptors approach each other, their relative motion reveals insights

into their interactions and the constraints imposed by membrane architecture. In Fig.
3.2A, QD-EGF585-erbB1 (green) and QD-EGF655-erbB1 (magenta) complexes are
observed to diffuse in close proximity for ~30 s before forming a stable dimer (white)
that persists until the end of the acquisition (see Supplementary Information, Video S3.1
online). Plots in Fig. 3.2B show the trajectories of each receptor (middle), as well as
their separation distance (bottom) over time.

Note the sharp drop to a separation

distance of ~50 nm that marks the dimerization event is accompanied by correlated
motion of the trajectories starting around t=30 s.

This 40-50 nm offset is consistent

with an estimate of the spacing between the centres of two QDs attached to the backto-back, ligand-bound erbB1 homodimer crystal (see Supplementary Information, Fig.
S3.4 online). Figures 3.2C-D show a representative encounter between one ligandbound and one resting erbB1. These receptors experience long durations of close
proximity (<500 nm), demonstrating the ability of membrane microdomains to co-confine
receptors (Kusumi et al., 1993; Andrews et al., 2008; Roullier et al., 2009). After 5-10 s
of co-confinement, the receptors move far apart as they escape from the domain.
These data show that dimerization events can be captured in real-time and also
illustrate the need to develop analytical tools that distinguish between close approach
and bona fide dimer events.
Correlated motion analysis offers a means to validate dimerization across large
data sets of two-colour trajectories (Fig. 3.2E-F; see Supplementary Information, Fig.
S3.2 online) (Andrews et al., 2008). This method reports receptor displacement (jump
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magnitude, red) and the degree of uncorrelated motion (blue) between receptors in the
population as a function of separation distance. Dimerized receptors are expected to
move together, exhibiting correlated motion. For ligand-bound receptors (Fig. 3.2E,F),
this is seen

as a reduction in uncorrelated jump distance at close distance. This

behavior is not altered by PD153035 treatment, confirming that EGF binding strongly
promotes dimer formation that is independent of kinase activity. We further address this
interesting observation in Figure 3.3 below. Of note, despite observations of close
approach between QD-VHH-erbB1 complexes, this analysis method showed no
correlated motion in the absence of ligand (Fig. 3.2G). These data indicate that dimers
between unliganded receptors must be of short duration compared to the time-scale of
these measurements (0.05 s). In contrast, interactions between one EGF-bound and
one unliganded receptor do demonstrate correlated motion (Fig. 3.2H).
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Figure 3.2. Direct visualization of erbB1 dimerization is captured by two-color SPT. (a)
Sample time series showing dimer formation (white) between QD585-EGF-erbB1
(green) and QD655-EGF-erbB1 (magenta). (b) Cartoon of tracking condition (top), 3D
trajectories (middle), and distance between receptors (bottom) as a function of time are
shown for the indicated receptors in (a). (c) Sample time series for QD655-EGF-erbB1
and QD585-VHH-erbB1 shows interactions for a 1:2 EGF:erbB1 dimer. (d) Cartoon of
tracking condition (top), 3D trajectories (middle), and distance between receptors
(bottom) as a function of time are shown for the receptors in (c). Scale bar, 0.5 µm. (e-h)
Ensemble correlated motion plots summarize all two-color data for EGF, EGF+PD, and
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VHH conditions. A decrease in uncorrelated jump distance (blue) at short separations
indicates that receptors are moving together. A concurrent drop in jump magnitude (red)
demonstrates decreased diffusion.

To extract dimerization kinetics, we developed a mathematical model based upon
a Hidden Markov Model (HMM) approach (Rabiner, 1989).

This method generates a

maximum likelihood estimate of the kinetic rate constants for transitions between states.
For a set of observables, in this case separation between two receptor trajectories, the
HMM is used to identify hidden states that reflect the underlying behaviors of the
proteins.
model:

In order to accurately represent the data, we implemented a three-state
free, domain-confined and dimer (see Fig. 3.3A,B and

Supplementary

Information, Fig. S3.5 online). Domains are considered to be cell surface regions that
may be mobile and provide a barrier to free diffusion, causing receptors to deflect off the
boundaries and facilitate repeated interactions between resident proteins. Although
domain composition is not explicitly considered in our model, these microdomains are
consistent with prior work describing “actin corrals” (Kusumi et al., 1993; Andrews et al.,
2008), “lipid rafts” (Chen et al., 2004) or “protein islands” (Lillemeier et al., 2006). The
model provides an objective fit for the size of confinement zones by optimizing error
terms. QD-EGF-bound receptors are the most constrained, with a Gaussian sigma of
150 nm (see see Supplementary Information,and Table S3.2 online).
Results in Figure 3.3C provide, for the first time, accurate measurement of intact
receptor dimer off rates. A summary of kinetic parameters derived from these data is
reported in Supplementary Information, Table S3.2.

Notably, koff for ligand-bound

homodimers are similar, regardless of treatment with the kinase inhibitor. Dimers that
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form between receptors in the absence of ligand (QD-VHHs) exhibit a >4 fold higher off
rate (see Supplementary Information, Video S3.2 online). We conclude that preformed
dimers are highly transient. Finally, dimers composed of one ligand-bound erbB1 and
one unoccupied receptor were also relatively unstable, with a 2-fold larger off rate than
dimers composed of two EGF-bound erbB1. Thus, EGF binding to both receptors in a
dimer is required for the most stable complex formation.
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Figure 3.3. Kinetics of homodimerization characterized by a three-state HMM reveal
activation state dependent off rates. (a) Definition of a dimer. Two-color receptors are fit
with localization accuracies (LA) for each channel; the white probability surface
represents the area within which a dimer is identified. The interaction distance (ID) is
defined by the crystal structure of the back-to-back erbB1, EGF bound dimer and the
diameters of the QDs (40-50 nm). (b) The three states are defined as Free, DomainConfined, and Dimer, based on observed separation. Six kinetic rates are fit for the
transitions between these states. (c) Off rates (s-1) for dimers fit using the three-state
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HMM. Off rate is defined as the sum of the rates of transitions between the dimer-todomain confined and dimer-to-free states.
As a final analysis step, the Viterbi algorithm was used to identify states within
candidate pair trajectories (see Supplementary Information, Fig. S3.5 online) based on
the kinetic parameters returned from the HMM (Forney, 1973). An example of such a
state path is shown in Fig. 3.4A. Here, two ligand-bound erbB1 are observed to explore
the same domain (magenta line) for up to 50 seconds, interspersed by multiple 10-15
second periods of dimer formation (blue line). This type of behavior was observed in
multiple experiments (see Supplementary Information, Fig.S3.5 and Videos S3.3,S3.4
online), underscoring the importance of co-confinement to foster repeated interactions
between the same pair of receptors.

It would be exceedingly rare to observe these

types of rebinding events in a well-mixed environment. A second type of behavior is
shown in Fig. 3.4B, where two receptors form a stable dimer at 28 sec that lasts
throughout the remainder of the acquisition period. We next determined the duration of
individual dimer events observed in our entire data set.

Fig. 3.4C reports the

distribution of dimer lifetimes for ligand-bound (QD-EGF) versus unoccupied (QD-VHH)
receptors. Note that less than 6% of dimers between unoccupied receptors last longer
than 4 s (Fig. 3.4C inset). In contrast, long-lived dimers are a striking feature of two
liganded receptors (>34% exceed 4 s).
From our state information, we were also able to determine the diffusion coefficient
for receptors identified as monomers, domain-confined or dimers under each
experimental condition (Fig. 3.4D, see Supplementary Information, Table S3.3 online).
Consistent with the correlated motion analysis (Fig. 3.2G), unoccupied receptors
retained fast mobility in all states. The most dramatic change in mobility is seen with
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signaling competent QD-EGF-bound dimers.

These complexes often become

immobile, with an average >6-fold reduction compared to the unconfined monomer
state. In the presence of PD153035, QD-EGF-erbB1 dimers only slow down by twofold, demonstrating that dimer diffusion is dependent on tyrosine kinase activity (see
Supplementary Information, Video S3.6 online).

Figure 3.4. State-dependent analysis of erbB1 behavior after HMM fitting reveals
underlying interaction mechanisms. (a) An example distance trace (black) for two QDEGF-bound receptors shows close approach punctuated by periods of excursion.
Domain state (2, purple) and dimer state (1, blue) are connected by green segments to
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show state path. This path is projected onto the x-axis to show the timeline of states
explored. Stills of the receptors involved in the interaction are inset. (b) Distance and
state trace for two QD-EGF bound receptors shows formation of a dimer (Free state in
red and others as aforementioned) that persists until the end of the acquisition. Scale
bars, 0.5 µm. (c) Normalized histogram of erbB1 dimer lifetimes for QDEGF (red) or
QD-VHH (yellow) homodimers, determined from Viterbi analysis. Inset shows the raw
number of long-lived dimers for each condition. Note that the long-lived dimer duration
may be underestimated due to the finite length of the time series. (d) Summary of
diffusion coefficients for EGF, EGF+PD, VHH, and VHH+PD conditions following
characterization of states by HMM and Viterbi analyses.
The mechanism of erbB1 homodimer immobilization, seen only for signaling
competent complexes, is unknown. However, analysis of diffusional behavior within
domains suggests a receptor-dependent change in the local environment.

Ligand-

bound erbB1 monomers slow by a factor of 2 when in the domain state. While this is
consistent with earlier reports of slower protein diffusion within microdomains (Daumas
et al., 2003; Douglass and Vale, 2005; Roullier et al., 2009), the distinction here is that
HMM analysis specifically identifies pairs of receptors that are co-confined.

Notably,

ligand-bound but kinase-inhibited monomers do not demonstrate as dramatic a change
in diffusion when co-confined. These data suggest that domains containing signaling
competent erbB1 have subtly different properties and, further, that the short but
repeated dimer events observed within domains (Fig. 3.4A) may generate signals.
These signals could influence diffusion through creating barriers (ie, protein scaffolding),
promoting cytoskeletal assembly or by lipid raft coalescence(Hofman et al., 2008)
The technical advantages afforded by two-colour quantum dot tracking have
permitted us to resolve several outstanding questions related to erbB1 biology. First, we
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show that there is not a simple relationship between diffusion and dimer status. SPT
using probes that distinguish between unoccupied and ligand-bound receptors revealed
the full range of diffusive behavior for monomers and dimers under all experimental
conditions (Fig. 3.1B, Fig. 3.4D).

By distinguishing between different states, we

calculate a diffusion rate for unoccupied erbB1 monomers of 0.05 µm2/s. There is only
a slight change in diffusion for the short-lived dimers that form between two unoccupied
receptors (0.038 µ m2/s). Importantly, we are able to report that signaling competent,
ligand-bound dimers slow dramatically (0.005 µ m2/s) compared to ligand-bound dimers
whose kinase domains are inhibited by PD153035 (0.019 µ m2/s). These data contradict
the primary assumption of Chung et al (Chung et al., 2010) that 2-fold changes in erbB1
diffusion can be used as the sole criteria for identifying dimers. Thus, reduced mobility
is a complex reflection of stability and size of the protein aggregate as well as signalingmediated changes in the local environment.
Second, we are now able to compare off rates for dimers formed on the surface of
live cells. We show that dimers composed of 2EGF:2erbB1 are the most stable,
confirming predictions based a large prior body of evidence (Schlessinger, 2002). This
is inconsistent with at least one important aspect of the negative cooperativity model
recently proposed by others (Macdonald and Pike, 2008), which predicts that two EGFbound monomers should have the lowest interaction affinity. Furthermore, we see that
dimers composed of 1EGF:2erbB1 are short lived (koff = 0.738 s-1) while dimers
between unoccupied receptors are even more transient (koff = 1.24 s-1).

Considering

the short lifetime, we predict that these complexes are relatively weak at initiating signal
transduction. This is consistent with reports of inactive, unliganded dimers (Jura et al.,
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2009a; Hofman et al., 2010). Since homodimers of EGF-bound receptors demonstrate
the longest lived interactions and the ability to remodel their local environment, we
suggest that dimers constitute the minimal signaling competent unit, consistent with
other reports (Lemmon et al., 1997; Lidke et al., 2005a; Zhang et al., 2006b).
Finally, this work addresses a long standing debate about roles for membrane
organisation in promoting signal initiation (Chen et al., 2004). We show that EGF-bound
monomer pairs can repeatedly encounter each other within surface domains, with
sequential periods of dimerization. Since encounters between proteins are diffusionlimited, stochastic processes, this cannot be explained without evoking contributions of
membrane compartmentalization. EGF-bound monomers exhibit reduced mobility within
domains only in the absence of kinase inhibitors. We speculate that repeated dimer
events can achieve a degree of signaling that alters the local environment, which in turn
slows receptors and promotes rebinding.
The new quantitative methods described here capture dynamic receptor
interactions at the single molecule level, providing detail that is averaged out in
traditional methods.

Since dimerization is a common mechanism for signal initiation,

our approach can be applied across many receptor systems to further our
understanding of dimerization kinetics, receptor mobility and membrane structure
influences on regulating signal transduction.
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3.2 MATERIALS AND METHODS
3.2.1 Reagents
Biotinylated EGF was purchased at a 1:1 stoichiometry (Invitrogen, Carlsbad, CA) and
singly biotinylated VHH fragment EGb4 was produced using the BirA expression system
(Roovers et al., 2007). Biotin-EGF or biotin-VHH were conjugated to Qdot® 655 or
Qdot® 585 streptavidin conjugate (Invitrogen, Carlsbad, CA) in PBS + 1% BSA to
generate stock solutions of 30 nM 1:1 monovalent QD-conjugates (Lidke et al., 2004).
Stock solutions were stored at 4°C and used for up to two weeks. Biotin-EGF was
conjugated to Qdot® 625 streptavidin for bleedthrough experiments. Experiments with
PD153035 (Tocris Bioscience, Ellisville, MO) were performed at a final concentration of
1 µM inhibitor.
3.2.2 Cell culture
A431 Human Epithelial carcinoma cells were cultured in Dulbecco’s Modified Eagle’s
Medium without phenol red (Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal
bovine serum (FBS; Invitrogen, Carlsbad, CA) and penicillin and streptomycin. For live
cell imaging, cells were plated in 8-well Lab-Tek chambers (Nunc, Rochester, NY) and
allowed to reach up to 50% confluency before experimentation.
3.2.3 Cell treatment for SPT experiments.
Cells in Lab-Tek chambers were imaged in Tyrode’s supplemented with 0.1% BSA and
20 mM glucose. Prior to imaging, cells were serum starved in Dulbecco’s Modified
Eagle’s Medium lacking FBS for four hours. Experiments with PD153035 were
performed after serum starvation including 1 µM inhibitor and live cell imaging buffer
also included 1 µM PD153035.
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3.2.4 Fluorescence Microscopy
Wide field imaging for SPT was performed using an Olympus IX71 inverted microscope
equipped with a 60× 1.2 N.A. water objective. Wide field excitation was provided by a
mercury lamp with either a 436 /10 nm BP excitation filter and a 50/50 neutral density
filter. Emission was collected by an electron multiplying CCD camera (Andor iXon 887)
using a QuadView image splitter (Optical Insights) to simultaneously image two
spectrally distinct QDs. QD emission was collected using a 600 nm dichroic and the
appropriate emission filters, 655/40nm and 585/20 BP (Chroma, Rockingham, VT). A
single pixel is equivalent to 267 nm. The sample temperature (34-36 °C) was
maintained by an objective heater (Bioptechs, Butler, PA).
3.2.5 Image Processing
All image processing was performed using Matlab (The MathWorks, Inc., Natick, MA) in
conjunction with the image processing library DIPImage (Delft University of
Technology).

For descriptions of specific analysis routines see Supplementary

Information.
3.2.6 GPU Single Particle Tracking and Track Elongation
Images were acquired at 20 fames/s for a total of 1,000 frames. Single molecule
localization and trajectory connection were carried out as previously described(Smith et
al., 2010). Complete derivation of the track elongation algorithm is provided in
Supporting Online Text.
To elongate short tracks, the positions (

and

) with the smallest

for temporally

independent tracks are compared using equation 6. Temporally independent tracks
with the best p-value that pass a user-defined cutoff are augmented for form an

95

elongated trajectory. Due to temporal independence of short trajectories, the cutoff and
for track elongation can be relaxed slightly from those used in the initial connection
algorithm without introducing artifacts. This process is repeated until no temporally
independent tracks that pass the cutoff remain. An example comparison of short and
elongated trajectories is shown in Supplemental Figure S1.
3.2.7 Square Displacement Analysis
Diffusion analysis of trajectories was performed by square displacement analysis and
two-component fitting, as previously described(de Keijzer et al., 2008).
3.2.8 Correlated Motion Analysis
The degree of correlation between pairwise trajectories was determined as previously
described(Andrews et al., 2008).
3.2.9 Fiducial Data Acquisition and Image Registration
See supplemental text for mathematical details. Images were registered using a
calibration image of multi–fluorophore fluorescent beads (0.2 µm Tetraspeck, Invitrogen,
Carlsbad, CA) that have an emission spectrum covering the two spectral windows. The
camera was sampled by moving a single bead across the field of view using a
mechanical stage (Prior Pro Scan II, Rockland, MA) to obtain good sampling over the
field of view. A fiducial data set was acquired at the beginning and end of each chamber
tested. Corresponding beads are identified in each channel and fit to a polynomial
calibration model. (Churchman et al., 2005).
3.2.10 Hidden Markov Model
See supplemental text for mathematical details. We use a three state model: 1) Dimer;
2) Domain; 3) Free. The observed parameter in the hidden Markov model is the
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separation. For the dimer and domain model, the distribution of the displacements
between the QDs is modeled by a zero mean Gaussian distribution in each (x,y)
dimension using σ dimer and, σdomain respectively. The resulting observed distribution of
displacements is a convolution of the actual displacements and the errors in
measurement, which are also assumed to contribute as unbiased Gaussian
distributions. The value σdimer is taken as that expected from combining information from
crystal structure measurements and the size of QDs, whereas σ domain is varied to find
the best fit across all data sets of a specific condition. For the Free model, the
probability density is calculated as a function of the observed distance in the previous
frame and a characteristic diffusion constant.
The set of rate constants is found by maximizing the likelihood over all interactions of
two QDs for a specific condition, The errors on each parameter are given as standard
errors and are calculated as (Hi,i-1)-1/2 where H is the Hessian matrix of the negative loglikelihood and i denotes one of the estimated rate constants. Given the set of rate
parameters found in the estimation step, the Viterbi algorithm(Forney, 1973) is used to
identify the most likely state within individual QD interactions.
3.2.11 Statistical Analysis
Errors in two-component fits for square displacement are reported as 95% confidence
intervals.
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4.1 Specific contributions
This chapter is a manuscript submitted to Molecular Biology of the Cell by coauthors Dr. Mara Steinkamp and Dr. Shujie Yang. The focus of the paper is evidence
for catalytic activity by the kinase domain of erbB3. Biochemical studies were carried
out by the co-authors that demonstrate the ability for erbB3 immunocomplexes to
phosphorylate an exogenous substrate and the dependence of such activity of erbB3
ligand binding and interactions with erbB2. A new hypothesis was developed that
suggested that erbB3 catalytic activity may result from the series of interactions
involving ligand-induced conformational changes and heterodimer formation.
I contributed single particle tracking probe development, experiments and
analysis to demonstrate the formation of erbB2/erbB3 and erbB3/erbB3 complexes on
live cells. Specifically, I developed the protocols to biotinylate the heregulin ligand for
labeling of erbB3 with streptavidin-QD-ligand complexes and refined the maleimide
thioether protocol labeling of reduced Herceptin as a monovalent label for erbB2. With
Dr. Mara Steinkamp, we characterized these probes biochemically to ensure no
perturbation of normal physiology. Single particle tracking experiments, mainly on
SKBR3 cells, were carried out by Dr. Mara Steinkamp and myself. I completed all
tracking, computational analysis, and plotting of live cell data. The observation of these
erbB complexes on cells provides evidence in support of the model from biochemical
data and further demonstrates the stability of erbB3 homodimers.
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4.2 SUMMARY
Previously considered a “dead” kinase, erbB3 is implicated in escape from erbBtargeted cancer therapies.

ErbB3 phosphorylation is shown to be largely erbB2-

dependent, based on studies in SKBR3 cells treated with antibodies that block the
erbB2 dimerization arm or with lapatinib. Intact, phosphorylated erbB3 has significant
tyrosine kinase activity as measured in immune complexes from HRG-stimulated cells.
ErbB3 kinase activity was confirmed in transfected CHO cells expressing gain-offunction (erbB3E933Q) or ATP-binding (erbB3R819A) mutants. Novel mechanistic insight
comes from live cell, two-color single particle tracking experiments using quantum dot
(QD) probes. These studies document short-lived erbB2/erbB3 heterodimers and long
lived erbB3 homodimers. We propose a model in which transient heterodimers permit
transphosphorylation of erbB3 by erbB2.

Persistent signaling is likely sustained by

stable erbB3 homodimers that scaffold PI 3-kinase and phosphorylate cellular
substrates.

The model is supported by electron microscopy studies showing that

erbB3/PI-3K signaling patches have disproportionally low amounts of erbB2.

4.3 SIGNIFICANCE
ErbB3 expression is implicated in the failure of EGFR and erbB2-targeted cancer
therapies. This finding was surprising since erbB3 has classically been thought of as
kinase dead and dependent on an active family member for its function. Our work
reveals that intact erbB3 has independent kinase activity. Furthermore, single particle
tracking data suggest that erbB2/erbB3 heterodimers, originally thought to be the
functional signaling unit, are transient, while erbB3 homodimers are stable. Thus during
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erbB2-targeted therapy, ErbB3 might still form signaling competent homodimers that
encourage tumor growth. Identification of a novel gain-of-function mutation in a breast
cancer cell line also indicates that erbB3 function could be enhanced by mutations in
cancer. Therefore, directly targeting erbB3 may be of great therapeutic value.

4.4 HIGHLIGHTS
•

ErbB3 requires erbB2 to become activated.

•

Once activated, immunoprecipitated erbB3 can independently phosphorylate a
substrate.

•

ErbB3 forms short lived heterodimers with erbB2, while erbB3 homodimers are
long lived.

4.5 INTRODUCTION
Epidermal growth factor receptor (EGFR/erbB1) and erbB2 genes are often
amplified or mutated in cancers, particularly non-small cell lung cancer and breast
cancer, making these receptors important molecular targets for cancer therapy
(Wieduwilt and Moasser, 2008).

Lung adenocarcinomas harboring erbB1 kinase

domain mutations strongly correlate with clinical response to gefitinib (Iressa) and
erlotinib (Tarceva) (Paez et al., 2004). However, tumors often become refractory to
treatment.

ErbB3, a closely related family member, is often co-expressed in these

cancers and has been implicated in escape from both EGFR and erbB2-targeted
therapies (Engelman et al., 2007; Sergina et al., 2007).
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ErbB3 was previously thought to be catalytically inactive and thus only able to
function as a heterodimer (Guy et al., 1994; Sierke et al., 1997). In the classic view of
erbB3 signaling, ligand binding to erbB3 leads to heterodimerization with “kinasecompetent” erbB family members (e.g. erbB2) or even members of other receptor
tyrosine kinase families (e.g. MET) (Engelman et al., 2007). The dimerizing partner is
then considered to be solely responsible for transphosphorylation of YXXM motifs in
erbB3 with subsequent recruitment of PI3-kinase and other erbB3 binding partners
(Yarden and Sliwkowski, 2001). However, a recent report by Lemmon and colleagues
challenged the notion that erbB3 is a “dead” kinase by demonstrating that the isolated
erbB3 intracellular domain (ICD) is capable of weak autophosphorylation (Shi et al.,
2010).

These data support the hypothesis that erbB3 homodimers are functional

signaling complexes. In this report, we provide the first evidence for ligand-mediated
upregulation of erbB3 kinase activity measured in immune complexes containing intact
erbB3 receptors. We further show that SKBR3 breast cancer cells harbor a gain-offunction erbB3 somatic mutation in the kinase domain, which is particularly significant
because the substitution occurs on a cytoplasmic dimerization interface where it
enhances erbB3 kinase activity and sensitivity to ligand. Our results strengthen the
argument that erbB3 is itself a legitimate therapeutic target {Sithanandam, 2008;
VanHook, 2010} and yet raise new and important questions. Foremost of these is the
relative importance of erbB3 heterodimers and homodimers to both signal initiation and
signal propagation.
We approach these questions using a combination of single molecule tracking and
electron microscopy, technologies that together provide nanoscale information about
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the dynamics of receptor-receptor interactions (SPT) and the changes in spatial
organization over time (EM).

Bright, photostable QD probes were used for single

particle tracking of erbB3 and erbB2 receptors (Lidke et al., 2004; Andrews et al., 2008;
Andrews et al., 2009), capturing the diffusion-limited interactions between individual
proteins in real time. ErbB2-erbB3 heterodimers are shown to be relatively short-lived,
compared to more stable erbB3 homodimers. This sub-second temporal information is
complemented by nanometer-scale spatial resolution of erbB3 signaling patches in
native membranes, obtained using immunoelectron microscopy techniques (Yang et al.,
2007). Results are consistent with a model where transient interactions between erbB3
and erbB2 are followed by heterodimer dissociation and formation of signaling domains
composed predominantly of erbB3 homodimers and downstream signaling partners,
such as PI 3-kinase.

4.6 RESULTS
4.6.1 ErbB3 immune complexes contain HRG-induced tyrosine kinase activity
The SKBR3 breast cancer cell line expresses EGFR, erbB2 and erbB3, providing
an appropriate model system to study erbB family interactions. We previously reported
levels of erbB surface expression in this cell line by flow cytometry (~200,000 erbB1, 2
million erbB2, 70,000 erbB3 per cell) and developed a non-radioactive, microplatebased peptide substrate assay to measure kinase activity in EGFR and erbB2 immune
complexes (Yang et al., 2007). Figure 4.1A (top panel) reports results using erbB3
immune complexes, documenting significant tyrosine kinase activity that reached
maximal levels within 2 minutes of stimulation with the erbB3 ligand, heregulin (HRG).
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Increased kinase activity with HRG treatment was accompanied by an increase in
erbB3 phosphorylation (Figure 4.1A, lower panel).

Remarkably, when identically

prepared erbB3 immune complexes were subjected to SDS-PAGE and blotted for
erbB1 or erbB2, no significant co-precipitation of either receptor was detected (Figure
4.1B).

ErbB1 or erbB2 immunoprecipitates served as positive controls in these

experiments.
4.6.2 Kinase activity in ErbB3 immune complexes is not attributed to associated
ErbB2, EGFR or Src kinases
We next used a pharmacological approach to characterize tyrosine kinase activity
present in erbB3 immune complexes, by adding known ATP-binding competitive
inhibitors directly to the in vitro kinase reaction.

Marked inhibition of erbB3 kinase

activity was seen with the broad specificity inhibitor, staurosporine (Figure 4.1C) (Fabian
et al., 2005), but not with the selective EGFR inhibitor AG1478, the erbB2 inhibitor
AG879, the dual EGFR/erbB2 inhibitor PD153035, the Src family inhibitor PP2 (data not
shown).
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Figure 4.1. Robust tyrosine kinase activity in erbB3 immune complexes correlate with
erbB2-dependent

HRG-induced

erbB3

phosphorylation.

(A)

ErbB3

was

immunoprecipitated from SKBR3 cells after 2 hr serum starvation (0) with or without the
indicated treatment interval with 12 nM HRG. Immune complexes were evaluated for
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kinase activity by in vitro K-LISA using an EAY peptide substrate (top panel) or
subjected to SDS-PAGE, followed by immunoblotting with PY antibody (lower panel).
Bars are the mean of three replicates +/- standard deviation. (B) Other erbB family
members are not present in erbB3 immunoprecipitates. Where indicated, cells were
stimulated with 3.2 nM HRG, lysed using 1% NP-40 and immunoprecipitated using
ErbB3-specific antibodies. Samples were subjected to SDS-PAGE, followed by
immunoblotting with an anti-EGFR antibody that recognizes both EGFR and erbB2
(Santa Cruz sc-O3), erbB2-specific (RB9040-P, Neomarkers, Fremont CA) or erbB3specifc (Santa Cruz sc-285) antibodies. (C) Treatment with staurosporine reduces
erbB3 kinase activity.

erbB3 was immunoprecipitated from SKBR3 cells after 2 hr

serum starvation and left untreated (-HRG) or treated with HRG (3.2 nM) for 2 min. In
vitro kinase activity of erbB3 immune complexes was then measured by K-LISA. 1 µM
staurosporine was added directly to the kinase reaction.

Rabbit IgG was used as a

negative control to determine levels of non-specific kinase activity contributed from
protein lysates in the K-LISA assay. See also Figure S1.

We considered the possibility that activity in erbB3 immune complexes might be
explained by SH2-mediated recruitment of cytoplasmic tyrosine kinases. To address
this, we used a commercial SH2 protein array to screen for potential phospho-erbB3
binding partners in SKBR3 cells that might be pulled down with erbB3 in
immunoprecipitates (Supplemental Figure 4.1).

This array includes SH2-domains

derived from thirteen cytoplasmic tyrosine kinases (Abl, Csk, BTK, Zap-70 and all Srcfamily members). Arrays were incubated with cell lysates prepared from HRG-activated
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SKBR3 cells, followed by antibody-based probing of the membranes for detection of
erbB3 or erbB2. None of the SH2-domains derived from cytoplasmic tyrosine kinases
bound to phospho-erbB3 (Supplemental Figure 4.1). Only the SH2-domain of the p85
subunit of PI 3-kinase, already well established as the primary binding partner for
phospho-erbB3 (Hellyer et al., 2001), captured erbB3 to a significant amount. To rule
out any contributions from associated PI 3-kinase, which has serine kinase activity
(Dhand et al.), we directly added wortmannin (10 nM) directly to the erbB3 kinase
reaction; this irreversible inhibitor of Class I PI 3-kinases had no effect on erbB3 kinase
activity (data not shown). Together, these results strongly support the conclusion that
potential candidates (EGFR, erbB2, Src kinase, PI3K) are not responsible for the
tyrosine kinase activity present in erbB3 immune complexes and that this activity is
likely due to erbB3 itself.

4.6.3 SKBR3 cells express both erbB3(WT) and a kinase domain mutant
erbB3E933Q
Oncogenic mutations in erbB1, erbB2 and erbB4 are well established (Paez et al.,
2004; Lee et al., 2006; Soung et al., 2006), leading us to speculate that the high erbB3
kinase activity in SKBR3 cells could be due to a mutant form of erbB3. Using PCRbased sequencing of cDNA, we found that SKBR3 cells express two alleles of erbB3,
the wild type (WT) erbB3 and a mutant form with a single kinase domain substitution
(E933Q) (Figure 4.2A). This mutation lies within the C-lobe dimerization surface of the
kinase domain (Figure 4.2B) (Zhang et al., 2006a). Site-directed mutagenesis was
used to introduce this substitution into an existing expression vector for an erbB3-mCit
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fusion protein. Wildtype erbB3-mCit or E933Q erbB3-mCit were stably transfected into
CHO (Chinese Hamster Ovary) cells and colonies were selected based on surface
expression of erbB3-mCit (Supplemental Figure 4.2).
4.6.4 ErbB3E933Q is a novel gain-of-function mutant
Characterization of the CHO transfectants showed that erbB3E933Q-mCit was more
sensitive to lower concentrations of ligand than erbB3WT-mCit, as evidenced by
increased levels of phospho-erbB3, coprecipiation of PI 3-kinase and by increased
phosphoAkt levels at the lowest HRG doses (Supplemental Figure 4.2). Figure 4.2D
also demonstrates that the erbB3E933Q mutation also enhances kinase activity. In this
experiment, erbB3 immune complexes were isolated from CHO cells expressing either
erbB3WT-mCit or erbB3E933Q-mCit and used as a source of receptor for the in vitro
kinase activity. Western blots show comparable amounts of erbB3 in the immune
complexes. Wildtype erbB3, isolated from the CHO transfectants, showed significant
basal activity, typically with little or no increase in activity after HRG-induced
phosphorylation.

Overall

activity

in

erbB3E933Q-mCit

immune

complexes

was

consistently higher than wildtype, with modest upregulation following the addition of
HRG (erbB3E933Q-mCit +HRG showed activity 1.5 fold above WT, p-value = 0.01by
Student’s t-test).
4.6.5 ErbB3R819A has diminished kinase activity
If erbB3 is a bona-fide kinase, then mutating key residues in the kinase domain
should reduce erbB3 kinase activity. Alignment of the catalytic domains of the four erbB
receptors shows the divergence of erbB3 from the other family members, but also
highlights conserved motifs that remain intact (Figure 4.2C). The conserved catalytic
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aspartic acid has been altered to an asparagine in erbB3 (D813 in EGFR to N815 in
erbB3). However, Shi et al. recently demonstrated that erbB3 can compensate for loss
of the catalytic base by using an alternate reaction pathway to catalyze phosphoryl
transfer (Shi et al., 2010). Other features important for kinase activity are conserved in
erbB3, including an AAR motif that is important for ATP binding. In EGFR, mutation of
the arginine at position 817 to alanine reduced ATP binding and kinase activity (Chan
and Gill, 1996).

We engineered a mutation of the homologous arginine (R819) to

alanine in the erbB3-mCit expression vector and developed stably-transfected CHO
cells expressing erbB3R819A-mCit at the surface.

Lysates from erbB3WT-mCit and

erbB3R819A-mCit cell lines were prepared with or without HRG stimulation, normalized
based upon mCit fluorescence, and used for preparation of anti-erbB3 immune
complexes and in vitro kinase assays. Although phosphorylation of erbB3R819A-mCit in
response to HRG treatment was comparable to WT erbB3 (Figure 4.2E), there was
markedly reduced kinase activity in the erbB3R819A-mCit immune complexes.

These

results are again consistent with the conclusion that the kinase activity in erbB3 immune
complexes can be attributed to erbB3 itself.
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Figure 4.2. SKBR3 cells carry a heterozygous mutation in the kinase domain of erbB3,
which affects downstream signaling. (A) DNA sequencing of erbB3 in SKBR3 cells
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revealed a heterozygous G to C mutation at position 3047 of erbB3 (Genbank ID:
NM_001982); this results in an amino acid substitution E933Q in the erbB3 kinase
domain. (B,C) Alignment of two segments of the erbB family kinase domains.

(B)

Aligned sequence containing the C-lobe dimerization surface where the SKBR3
mutation E933Q is located. Hydrophobic residues predicted to lie on the surface are
highlighted in blue (Zhang et al., 2006b). Three residues including E933 that differ
between erbB3 and EGFR or erbB4 are highlighted (yellow). (C) Sequence surrounding
the catalytic site of the kinase domain. Conserved bases shown to affect EGFR kinase
activity are highlighted in green.

The catalytic D813 in EGFR is substituted with

asparagine in erbB3 (arrow). The AAR and DFG motifs are conserved in all four family
members. The R819A mutation introduced into ErbB3 is shown (asterisk). (D, E) In
vitro erbB3 tyrosine kinase activity in CHO transfectants. ErbB3 activity was measured
by K-LISA in erbB3 immunoprecipitates prepared from cell lysates before or after 2 min
stimulation with 3.2 nM HRG. Western blots in these panels show the phosphorylation
status of erbB3 protein in IP samples from the same experiment. Values represent the
mean value of immunoprecipitates assayed in triplicate and error bars indicate standard
deviation. ErbB3 E933Q expressed in CHO cells shows increased kinase activity in the
K-LISA assay (D) while erbB3 R819A has reduced basal activity (E). See also Figure
S2.
4.6.6 ErbB2 mediates activation of ErbB3
Since erbB2 is a known dimerizing partner for erbB3, we next treated SKBR3 cells
with three distinct erbB2 inhibitors to evaluate their effects on HRG-induced erbB3
phosphorylation.

Thirty minute pretreatment of SKBR3 cells with lapatinib, a dual

EGFR/erbB2 small-molecule tyrosine kinase inhibitor, dramatically lowered HRGinduced erbB3 phosphorylation (PY1289) (Figure 4.3A), indicating that erbB3
phosphorylation is largely dependent on erbB2. Lapatinib treatment also reduced erbB2
phosphorylation (PY1248). Pretreatment of cells with lapatinib also reduced erbB2 and
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erbB3 kinase activity (Figure 4.3B). ErbB2 kinase activity was only reduced by ~50%
possibly due to the reversible nature of lapatinib inhibition. However, erbB3 kinase
activity was essentially abolished. These data support the concept that erbB3 requires
erbB2 for activation.
We next compared results after 1 hr pretreatment with 100 nM 2C4, the mouse
monoclonal antibody from which the drug Pertuzumab was derived(Adams et al., 2006).
This antibody, which blocks the erbB2 dimerization arm (Franklin et al., 2004), is shown
here to block HRG-mediated upregulation of erbB3 phosphorylation (PY1289) by ~75%
(Figure 4.3C).

Note that 2C4 treatment had negligible effects on erbB2

phosphorylation. We speculate that erbB2 homodimers may actually be stabilized by
the bivalent antibody and further, that the dimer can be active despite the bulky antibody
bridging the two dimerization arms.
It should be noted that the relative expression levels of the two erbB receptors
differ significantly in the two cell lines used for these studies, providing a useful
comparison for possible effects of receptor density. SKBR3 cells express at least 30
fold more erbB2 than erbB3, while the CHO transfectants express many fold fewer
erbB2 than erbB3 (Yang et al., 2007). To establish dependency of erbB3 activation on
erbB2, even when erbB2 is in low abundance, CHO transfectants were also pretreated
with the 2C4 antibody prior to HRG stimulation. Here again, 2C4 treatment blocked
phosphorylation of tyrosine 1289 in both WT and E933Q forms of erbB3 by at least 50%
(Supplemental Figure 4.3). It also substantially reduced activation of the PI3K pathway,
as evidenced by diminished phosphorylation of Akt. Thus, erbB2 participates in erbB3
activation even when it is largely outnumbered by erbB3.
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Figure 4.3D reports data comparing another erbB2-specific therapeutic antibody,
Trastuzumab (also known as Herceptin) (Carter et al., 1992).

The binding site for

Trastuzumab is distinct from 2C4, in that it binds to the juxtamembrane region of the
erbB2 extracellular domain (Cho et al., 2003) and therefore is less likely to interfere with
dimerization. SKBR3 cells were pretreated for 30 minutes with either intact (bivalent)
trastuzumab or reduced (monovalent) trastuzumab linked to a QDot to determine
whether this antibody would alter erbB3 activation under our experimental conditions.
Unlike 2C4, trastuzumab in either form failed to significantly affect HRG-induced erbB3
phosphorylation (Figure 4.3D).

These data are in close agreement with previous

studies on trastuzumab (Agus et al., 2002; Diermeier et al., 2005).

This lack of

inhibition by trastuzumab is important for the experiments shown in Figure 4.4.
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Figure 4.3. ErbB3 activation is ErbB2 dependent. (A) Lapatinib inhibition of ErbB3
phosphorylation in SKBR3 cells. SKBR3 cells were serum-starved for 4hr then treated
+/- 500 nM Lapatinib for 30 minutes then +/- 12 nM HRG for 2 min. Aliquots of lysates
were separated by SDS-PAGE, followed by immunoblotting with PY1289-erbB3 or
PY1248-erbB2 phospho-specific antibodies or antibodies to detect total erbB3 or erbB2
as indicated. (B) Pretreatment of SKBR3 cells with Lapatinib reduces erbB2 and erbB3
kinase activity in the K-LISA assay. SKBR3 cells were serum-starved for 4hr +/- 500
nM Lapatinib, followed by immunoprecipitation with anti-erbB2 or erbB3 antibodies.
Washed beads were used as a source of enzyme for K-LISA, where kinase activity is
reported as changes in 450nm absorbance of the chromagen substrate. (C) The antierbB2 antibody, 2C4, reduces HRG-dependent erbB3 phosphorylation in SKBR3 cells.
SKBR3 cells were serum-starved for 2hr prior to treatments. The key is as follows:
untreated (-); treated for 1 hr with 100 nM 2C4 (2C4); stimulated with 12 nM HRG for 2
min. (+ HRG); or treated for 1hr with 100 nM 2C4 and stimulated with 12 nM HRG for 2
min. (2C4 + HRG). Aliquots of lysates were separated by SDS-PAGE, followed by
immunoblotting with phospho-specific antibodies or antibodies to detect total erbB3 and
erbB2. (D) Pretreatment of cells with the anti-erbB2 antibody Trastuzumab has little
effect on HRG-dependent erbB3 phosphorylation in SKBR3 cells. SKBR3 cells were
serum-starved for 4 hr and treated with intact or reduced (monovalent) Trastuzumab for
30 min before stimulation with 12 nM NRG. Quantification of the band intensities was
performed and the ratio of perbB3 to total erbB3 is shown in the graphs below the
westerns in A, C and D.
4.6.7 Single particle tracking reveals short lived ErbB2/ErbB3 heterodimers and
long lived ErbB3 homodimers.
Although most consider the active signaling complex for erbB3 to be an
erbB2/erbB3 heterodimer, the in vitro kinase assays above suggest that erbB3 can form
active homodimers. As a first step in measuring dimer composition on the surface of
live cells, we designed a novel set of single particle tracking probes. To prepare probes
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for ligand-bound erbB3, we biotinylated HRG for coupling to commercial streptavidinQDs (emission peaks at 585 or 655nm). The HRG QDot probe behaved similarly to
unlabeled NRG, increasing phophorylated erbB3 in SKBR3 cells when they were
stimulated with ligand for 2 minutes (Supplemental Figure 4.4). To detect individual
erbB2 receptors, we directly conjugated QDs to reduced trastuzumab using maleimide
thioether chemistry. It should be noted that we found the reduced form of trastuzumab,
prepared according to published methods (Tada et al., 2007), to be more stable than
the Fab form of the antibody. Importantly, as shown in Figure 4.3D, this monovalent
reagent binds erbB2 but does not block its ability to activate erbB3.
Representative experiments using these probes to capture homo- and heterodimer
events are shown in Figure 4.4A,B. Each plot shows the fluctuating distance between a
nearby pair of receptors during the observation period, as they diffuse across the
surface of live SKBR3 cells. Dotted lines mark the theoretical distance between two
QDs in a dimer complex. This estimate ranges from 45-48 nm, based on the published
structural information for the erbB extracellular domains when bound to ligand or to
trastuzumab (Supplemental Figure 4.5).

The plot in Figure 4.4A documents the

formation of an erbB3 homodimer, which occurs approximately 6 seconds into the
image acquisition period. Insets in Figure 4A show that spectral overlap of the 2 QDs
occurs at the onset of dimer formation. The dimer is persistent, maintaining an average
50 nm separation distance throughout the remainder of the time series (>45 seconds).
Additional examples are shown in Supplemental Figure 4.6A.

Importantly, erbB3

homodimerization was readily observed with the majority of events persisting beyond
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the end of the acquisition period.

Thus, erbB3 homodimers are common events and

their interaction times are long.
In contrast, Figure 4.4B illustrates representative examples of erbB3/erbB2
heterodimers, which were predominantly short-lived.

The stochasticity of these

interactions is apparent from comparisons with additional dimer events, illustrated in
Supplemental Figure 4.6B.
The image series in Figure 4.4A,B provide visual, real-time documentation of
individual dimer events.

For quantitation of entire datasets for the two distinct

conditions, each containing thousands of 2-color trajectories, we applied two
independent methods of measuring receptor interactions as a function of separation
distance (Figure 4.4 C,D) (Andrews et al., 2008). In the first analysis method (blue line),
we report the magnitude of the uncorrelated jump distance (UJD) vector for each pair of
receptor trajectories as a function of their proximity.

This method is based on the

concept that, when two receptors form a dimer, their motion becomes correlated and
UJD decreases. Thus, in the top panel, the sharp decrease in the UJD (blue line) at
short

separation

distance

(<100

nm)

is

compelling

evidence

for

erbB3

homodimerization. This phenomenon is much less dramatic for analysis of the twocolor erbB2/erbB3 dataset (Figure 4.4D), consistent with the short duration of the
heterodimers.
The red line in these plots reports analysis of a second criteria for dimerization,
which is the jump magnitude (ie, mobility) of receptors as a function of proximity
between pairs. As expected, 2-color tracking of erbB3 bound to QD ligand shows a
sharp decrease in mobility at short separation distances, consistent with prior reports of
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slower mobility for dimerized receptors (Roullier et al., 2009). The reduction in jump
magnitude for 2-color tracking of erbB3-erbB2 is very slight at short distances. This
also supports our conclusion that individual erbB2 molecules interact transiently with
erbB3.
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Figure 4.4. Single particle tracking detects long lived ErbB3 homodimers and short lived
ErbB2/ErbB3 heterodimers and ErbB2 homodimers.

(A-C) Receptor dimerization

behavior can be seen by monitoring the distance between two QD-tagged proteins over
time. Shown are representative examples for erbB3 homodimers (A), erbB2/erbB3 (B)
and erbB2 heterodimers (C). Further examples can be found in Supplemental Figure
4.6. The dashed line represents the estimated dimer separation distance (50 nm, see
Supplemental Figure 4.5). Insets show the images of the nearby pairs at specific time
frames.

Scale bar, 1 micron.

(D-G).

Uncorrelated jump distance (red) and jump

magnitude (blue) are plotted as a function of separation distance for each of the 3
datasets, comprised of thousands of 2-color trajectories for each experimental
condition.
4.6.8 Heregulin treatment leads to formation of ErbB3-PI3K signaling clusters,
with limited recruitment of ErbB2.
Prior work in SKBR3 cells first demonstrated that HRG treatment leads to
reorganization of erbB3 in the plasma membrane, seen as a transition from singlets and
small clusters (2-7 receptors) to large signaling patches containing tens to hundreds of
receptors (Yang et al., 2007). This result is highly reproducible, as shown in Figure
4.5A, where a large cluster of erbB3 can be observed after double labeling of a plasma
membrane sheet ripped from an activated SKBR3 cell. In this image, erbB3 is labeled
with large (10 nm) immunogold particles while erbB2 is labeled with small (5 nm) gold
particles.

The relative distributions of these two labels are depicted in the

corresponding 2-color distribution map (Figure 5B; erbB2 red, erbB3 green). Although
there are a small number of ErbB2 gold particles within the erbB3 patch, application of
the Ripley’s bivariant test indicates that their colocalization is not significant (Figure
4.5C).

Figure 4.5D shows that erbB3 also forms large signaling patches after
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transfection into CHO cells, where expression levels exceed that of endogenous erbB2
several fold. The Hopkins statistic (accompanying plot) confirms that erbB3 clustering is
statistically significant in HRG-stimulated CHO cells. Images in Figure 4.5E,F show
results after double labeling of activated CHO cell membranes for erbB3 (10 nm) and
the p85 subunit of PI 3-kinase (5 nM). PI3K is strongly recruited to the erbB clusters in
both erbB3WT-mCit and erbB3E933Q-mCit transfectants.

Colocalization of ErbB3 and

PI3K in HRG-treated membranes was confirmed using the Ripley’s bivariant statistic
(plots corresponding to Fig 4.5E,F) .
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Figure 4.5. Colocalization of membrane-associated ErbB3 with ErbB2 and p85. (A) EM
image of a membrane sheet prepared from SKBR3 cells that were serum starved for
4hr and then stimulated with 12 nM HRG for 2 min. After fixation, sheets were labeled
from the inside with antibodies to the cytoplasmic tails of erbB3 (10 nm gold) and erbB2
(5 nm gold). (B) Two-color representation of the different distribution of erb3 (green) and
erbB2 (red), corresponding to immunogold particle positions in the image shown at left
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in (A). Particle distributions were captured using a plug-in for ImageJ (Zhang et al.,
2006a). (C) Ripley’s bivariate analysis indicating a lack of co-localization for Erb2 and
ErbB3 in the image in (A). (D-F) Transfected CHO cells were serum-starved for 2 hrs.
Cells were then stimulated with 3.2 nM HRG for 2 or 5 min. Membrane sheets were
prepared from CHO-ErbB3 (WT) cells or CHO-erbB3E933Q as indicated, fixed and then
labeled with immunogold reagents against erbB3 alone (D) or in combination with
immunogold reagents against the p85 subunit of PI 3-kinase (E, F). Bars = 0.1µm.
Plots below show results of spatial statistics tests for clustering (Hopkins) and colocalization (Ripley’s bivariate analysis), as applied to images in D-F. Hopkins analyses
for erbB3 confirm that clusters in HRG-stimulated cells are significantly different from
random. The Ripley’s test confirms co-clustering of erbB3 and PI 3-kinase after HRG.
4.7 DISCUSSION
ErbB3 has been considered a unique member of the erbB family based upon
reports of negligible tyrosine kinase activity (Guy et al., 1994; Sierke et al., 1997).
However, this conclusion was based on studies that either occurred before the
discovery of erbB3 ligands, preventing evaluation of ligand-induced changes in erbB3
activity (Carraway et al., 1994);(Guy et al., 1994), or that assessed HRG-dependent
effects in the absence of other erbBs (Sierke et al., 1997).

Our study uniquely

evaluates ligand-dependent activation for endogenous erbB3, expressed in combination
with other erbB family members and with direct measurement of tyrosine kinase activity
in immune complexes bearing the intact erbB3 receptor. Our finding that the intact
erbB3 has the ability to phosphorylate an exogenous substrate follows very recent proof
of autophosphorylation activity of the erbB3 (ICD) when clustered in vesicles (Shi et al.,
2010). It differs from both Shi et al (2010) and Jura et al (2009), who found the erbB3
ICD to be incapable of phosphorylating an exogenous substrate (Jura et al., 2009b; Shi
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et al., 2010).

Methodology is clearly a key component to our success, since the data

strongly support the conclusion that the intact erbB3 receptor is catalytically competent
once activated in the membranes of live cells that co-express erbB3 dimerization
partners.
We further describe the novel discovery of a naturally occurring erbB3 gain-offunction mutation, E933Q, expressed in the aggressive SKBR3 breast cancer cell line.
This amino acid occupies a key position in the C-lobe of the erbB3 kinase domain, lying
on the surface precisely where the C-lobe of one monomer contacts the N-lobe of
another monomer in the asymmetrical dimerization model (Monsey et al.). Mutation of
the sequence

933

ENI935 to ADS enhanced its ability to activate erbB4, leading to the

hypothesis that mutations at this interface enhance allosteric activation of the receiving
partner in the dimer (Monsey et al.). We note that E933Q has increased sensitivity to
low levels of ligand and increased kinase activity (Fig. 4.3; Fig. S4.2) when transfected
into CHO cells, which express low levels of hamster erbB2. It is tempting to think that
this

mutation

may

similarly

promote

erbB2/erbB3

interactions

or

erbB3

homodimerization to enhance erbB3 activity. Although oncogenic mutations in ErbB1,
erbB2 and erbB4 are well established (Paez et al., 2004; Lee et al., 2006; Soung et al.,
2006), erbB3 kinase domain mutations appear to be relatively rare (Jeong et al., 2006).
The most extensive study to date, based upon a tyrosine kinase “transcriptome”
analysis of 254 established tumor cell lines, found only a few amino acid substitutions
which were outside of the erbB3 kinase domain (Ruhe et al., 2007). Considering the
discovery of this new gain-of-function mutation, a more extensive evaluation of erbB3
kinase domain mutations in epithelial tumors may be worthwhile.
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In this study, we take advantage of our capabilities in single particle tracking (Lidke
et al., 2005b; Andrews et al., 2008; Andrews et al., 2009) to provide definitive evidence
that erbB3 forms stable homodimers. This approach is one of several powerful new
imaging technologies that enable the acquisition of quantitative information about
protein-protein interactions and spatial organization (Lidke and Wilson, 2009; Dehmelt
and Bastiaens, 2010).

Based upon this new evidence, we propose a modification of

the traditional erbB3 signaling model that relies solely on signaling through erbB2/erbB3
heterodimers (Figure 4.6). We propose that transient heterodimerization enables erbB3
activation through trans-phosphorylation, but the bulk of signaling may occur through
erbB3 homodimers that form after dissociation of the heterodimer partners.

This

proposal is compatible with the lateral signaling hypothesis proposed by others (GrausPorta et al., 1997).
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Figure 4.6. A model of ErbB2/ErbB3 interactions leading to activated ErbB3
homodimers.

In the absence of HRG, both erbB2 and erbB3 exist primarily as

monomers and erbB3 rests in a tethered conformation. Upon stimulation with HRG,
erbB3 undergoes a conformational change which frees its dimerization arm and
facilitates transient heterodimerization with erbB2.
phosphorylation of erbB3’s cytoplasmic tail.

ErbB2 activates erbB3 through

Following dissociation from erbB2,

activated erbB3 monomers then diffuse and form functional homodimers.

Because

phosphorylated erbB3 has increased kinase activity, erbB3 is capable of activating other
erbB3 receptors and/or phosphorylating cytoplasmic signaling partners.
It is likely that erbB2 is not the only heterodimerizing partner capable of activating
erbB3 in transient complexes, since coupling with another transmembrane tyrosine
kinase receptor, Met, has also been reported (Beerli et al., 1995; Campiglio et al., 1999;
Engelman et al., 2007). One important aspect of the new transient interaction model is
the reduced reliance on equivalent (or greater) levels of expression of erbB3 dimerizing
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partners, since multiple erbB3 receptors could potentially be activated by a single
e4.rbB2 receptor.

For example, we observed that erbB3 activation is significant in

transfected CHO cells where it is several times more abundant than endogenous erbB2.
The erbB2-blocking antibody (2C4) inhibits HRG-induced erbB3 phosphorylation to a
similar degree (about 75%) in CHO cells and in SKRB3 cells where the several million
erbB2 outnumber erbB3 many fold. The humanized anti-erbB2 therapeutic antibody,
Pertuzumab, was derived from 2C4 (Adams et al., 2006). We speculate that residual
erbB3 activation, in the absence of ErbB2 as e heterodimerizing partner, may possibly
be attributed to erbB3’s own kinase activity providing one possible mechanism for tumor
resistance.
Another unique feature of our studies is the direct visualization of erbB3 “signaling
clusters” by immunoelectron microscopy of membrane sheets ripped from cells after 2-5
min. stimulus with HRG. The images in Figure 4.5 show that erbB3 is the predominant
erbB receptor species in these signaling patches, lending additional support for the
concept that persistent signaling occurs through erbB3 homointeractions.

These

studies call for a revision of the erbB3 pre-oligomerization model of Landgraf and
colleagues, where preexisting inactive erbB3 oligomers were proposed to dissociate
upon ligand binding to promote heterodimerization (Landgraf and Eisenberg, 2000; Kani
et al., 2005). Instead, we observed that erbB3 clusters were small in resting cells,
ranging in size up to seven receptors, while HRG treatment resulted in formation of
clusters with hundreds of erbB3 receptors(Yang et al., 2007). If inactive erbB3
oligomers exist, they must be composed of dimers or limited to only a few receptors per
oligomer.

We note that erbB2-erbB3 patches are morphologically unlike other known
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membrane domains, such as caveolae that have previously been implicated as
destinations for signaling proteins (Yamabhai and Anderson, 2002).

These “dark

patches” may represent pre-existing membrane domains with properties that are
attractive to activated receptors and are consistent with the “protein islands hypothesis”,
stemming from prior work in T cells (Lillemeier et al., 2006).

The molecular profile of

these patches remains unidentified to date, although we found strong labeling for the
p85 subunit of PI3K in the patches following HRG treatment (Figure 4.4C and 4.4E).
In summary, we demonstrate that intact erbB3 immune complexes have HRGdependent kinase activity that catalyzes the phosphorylation of an exogenous substrate
in vivo. This kinase activity correlates with erbB3 phosphorylation, which is dependent
on an active erbB2. However, erbB2/erbB3 heterodimers are not the source of catalytic
activity since erbB2 is not present in erbB3 immunoprecipitates used as a source of
enzyme in the assay. Also, erbB2 is not required in a 1:1 ratio since erbB3 signals
robustly to the PI3K-Akt cell survival pathway even when artificially introduced into CHO
cells that express a small amount of endogenous erbB2 and no other members of the
erbB family. HRG-dependent erbB3 signaling requires erbB2 participation for activation
of erbB3, but may thereafter form kinase-active, signaling-competent erbB3
homodimers.

ErbB3 signaling output can be amplified by a novel gain-of-function

substitution in the erbB3 kinase domain or reduced by mutagenesis of the AAR motif in
the catalytic region. These results suggest that erbB3 may have both co-dependent
and independent roles in tumor survival and is itself a potential therapeutic target in
some cancers.
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4.8 MATERIALS AND METHODS
4.8.1 Cell Lines, Reagents
SKBR3 cells were cultured in McCoy’s media, 10% FBS with penicillin/streptomycine
and 2 mM L-glutamine.

For live cell imaging, cells were plated in 8-well Lab-Tek

chambers (Nunc, Rochester, NY) and allowed to reach up to 50% confluency before
experimentation. CHO cells were cultured in DMEM, 10% FBS (Hyclone) with penicillinstreptomycin, 2 mM L-glutamine. EGF was from Biomedical Technologies (Stoughton,
Massachusetts).

For western and K-LISA experiments, Heregulin 1-β1 from US

Biological (Swampscott, Massachusetts) was used to stimulate cells in culture.
Staurosporine and EGFR antibodies were from Calbiochem (La Jolla, California).
Lapatinib was from LC laboratories (Woburn, Massachusetts). Anti-EGFR SC-03 was
from Santa Cruz Biotechnology (Santa Cruz, California). ErbB2 antibodies RB9040 and
MS-325 were from Labvision (Fremont, California); erbB3 antibodies SC-285 and SC415 and p85 antibodies SC-1637, SC-423 were from Santa Cruz; p85 06-497 antibody
was from UBI (Lake Placid, New York).

Antibodies for phospho-(Y1248)-erbB2,

phospho(Y1289)-erbB3, phospho(S473)-Akt and total Akt (#9272) were from Cell
Signaling (Danvers, Massachusetts); HRP-conjugated PY20 antibodies were from BD
Biosciences (San Jose, California). For single particle tracking, recombinant human
NRG1-beta 1/HRG1-beta 1 extracellular domain (R&D Systems) was singly biotinylated
using NHS-ester conjugation chemistry (Biotin-XX, sulfosuccinimidyl ester, Invitrogen).
Biotinylated HRG was conjugated to Qdot® 655 or Qdot® 585 streptavidin conjugate
(Invitrogen) in PBS + 1% BSA to generate stock solutions of 30 nM 1:1 monovalent QD-
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conjugates. Reduced Herceptin-Qdot® 655 or Qdot® 585 were produced using
maleimide chemistry with commercial Antibody Conjugation Kits (Invitrogen).
4.8.2 Sequencing ErbB3
mRNA was extracted from SKBR3 cells using the RNeasy Mini Kit (QIAGEN,
Chartsworth, California). Pairs of primers were designed to span the ErbB3 tyrosine
kinase domain:
5’-CTCTGGACCCCAGTGAGAAG-3’ and 5’-GGGAGTACAAATTGCCAAGG-3’;
5’-GGTCAGCCACACCAAAATCT-3’ and 5’- CAGATACCGTGGTGGGTCTC-3’.
After amplification using a QIAGEN One-step RT-PCR kit, PCR products were
separated by agarose gel electrophoresis, extracted with the QIAquick gel extraction kit,
and sequenced using the above primer sets.
4.8.3 Site-directed mutagenesis and transfection
The human v-erb-b2 homolog 3 (erbB3) WT gene fused to mCitrine (mCit; a monomeric
YFP variant) was previously introduced into the pcDNA6 vector (Lidke et al., 2004).
The E933Q and R819A mutations were introduced into pcDNA6 ErbB3 mCitrine by sitedirected mutagenesis using the Quick-Change Site Directed Mutagenesis kit
(Stratagene, Santa Clara California).

PAGE-purified mutagenesis primers and their

reverse compliment were obtained from Invitrogen or Integrated DNA Technologies
(Coralville, Iowa). Sequence of the sense primers were:
E933Q: 5’-CAAGTGTTGGATGATTGATCAGAACATTCGCCCAAC-3’
R819A: 5’-CATAGAAACCTGGCTGCCGCAAACGTGCTACTCAAGTC-3’
Plasmids were transfected into CHO cells using Lipofectamine 2000 (Invitrogen).
Blasticidin-resistant transfectants expressing visible erbB3-mCit were sorted by Moflo
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(UNM Flow Cytometry facility), followed by colony selection in 96 well plates and visual
inspection of clones expressing erbB3-mCit on the cell surface.
Alignment of the kinase domains of the EGFR family utilized the program ClustalW
available on the EMBL-EBI website (Larkin et al., 2007).
4.8.4 Western blotting and immunoprecipitation analyses
Cells were serum-starved (2-4 hours) then stimulated with ligands -/+ inhibitors as
reported in legends. Cells were solubilized in cold NP-40 lysis buffer (Yang et al., 2007).
Protein concentrations in cleared lysates were measured by BCA assay (Pierce,
Rockford, Illinois). For the kinase assay in Figure 2D, relative amounts of erbB3-mCit
protein per sample were measured using the Qubit fluorometer (Invitrogen).

For

immunoprecipitation, supernatants were preincubated with Protein A-beads (Amersham
GE Healthcare, Chicago, Illinois) followed by incubation at 4°C with primary antibodies.
Proteins in washed immune complexes were denatured and separated by SDS-PAGE,
transferred to nitrocellulose membranes, probed with primary and HRP-conjugated
secondary antibodies and detected by the ECL method (Pierce).
4.8.5 In vitro tyrosine kinase assay
Kinase activity in bead-bound immune complexes was measured using commercially
available K-LISA EAY kits (Calbiochem, La Jolla, California) or ELISA plates coated inhouse with 1 µg/ml EAY peptide and blocked with BSA. Beads bound to rabbit IgG,
incubated under identical conditions with cell lysates and subsequent washes, served
as a negative control. Aliquots of precipitate/slurry were transferred in triplicate to wells
of K-LISA strips, followed by incubation +/- inhibitors according to the manufacturer’s
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protocol. Significance of data from six independent experiments was determined using
Student’s t-test.
4.8.6 SH2-domain array capture assay
Lysates were prepared from serum-starved SKBR3 cells after stimulation with HRG
(12nM, 2min). TranSignal phosphotyrosine profiling arrays (Panomics, Redwood City,
California) were sequentially incubated with clarified lysates, erbB3 or erbB2 specific
antibodies, and HRP-conjugated second antibodies. Reactive spots were visualized by
the ECL method (Pierce) and reported in the Supplement.
4.8.7 Single particle tracking (SPT), Image Registration and Analysis
Cells in 8-well Lab-Tek chambers (Nunc, Rochester, NY) were imaged in Tyrode’s
buffer supplemented with 0.1% BSA, 20 mM glucose. Prior to imaging, cells were
serum starved for 4 hr in McCoy’s Medium lacking FBS. Experiments with lapatinib
(Eton Biosciences Inc., San Diego, CA.) were performed after an additional 30 min
incubation in serum-free media with 500 nM inhibitor; drug was also present during
imaging. Images were acquired at 20 frames/s using an Olympus IX71 inverted
microscope equipped with a 60x 1.2 N.A. water objective and objective heater
(Bioptechs, Butler, PA) to maintain sample temperature at 34-36 °C. Wide field
excitation was provided by a mercury lamp with a 436 /10 nm BP excitation filter.
Emission was collected by an electron multiplying CCD camera (Andor iXon 887) using
a QuadView image splitter (Optical Insights) to simultaneously image the QD585
(585/20) BP and QD655 (655/40nm) probes. Image processing was performed using
Matlab (The MathWorks, Inc., Natick, MA) functions in conjunction with the image
processing software DIPImage (Delft University of Technology).
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Single molecule

localization and trajectory elongation were performed as previously described (Smith et
al., 2010). Two channel images were registered as described previously (Churchman et
al., 2005). Pairwise trajectories were analyzed to determine the degree of correlated
motion as previously described (Andrews et al., 2008).
4.8.8 Electron Microscopy
Detailed methods have been described (Wilson et al., 2000; Wilson et al., 2007). Cells
on glass cover slips were incubated +/- stimuli (37°C), fixed with 0.5-2% PFA and
membrane sheets were prepared as in (Yang et al., 2007). At least two experiments
were performed for each condition, for which at least ten images were acquired on a
Hitachi H-7500 transmission electron microscope. Spatial statistical analyses used the
Hopkins test for clustering and Ripley’s K bivariate function for co-clustering (Haase,
1995; Wilson et al., 2004; Zhang et al., 2006a).
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CHAPTER 5: DISCUSSION AND IMPLICATIONS
5.1 SUMMARY
The studies shown here address the roles of diffusion and dimerization kinetics in
regulating erbB receptor signaling. ErbB dimer formation and local membrane
reorganization are critical features of signal initiation, but have been difficult to resolve,
especially in the live cell context. We developed a suite of tools that specifically address
the roles of diffusion, interaction kinetics, and membrane topography in erbB receptor
dynamics. Most importantly, these approaches exceed the capabilities of previous
approaches through improved spatial and temporal resolution. A number of studies
have been conducted on intact erbB receptors at the single molecule level but have
been unable to directly visualize the formation of dimers and use these events to
characterize the reaction kinetics (Sako, 2000 Orr, 2005, Lidke, 2004, Lidke, 2005,
Chung, 2010).
5.1.1 Significance of new HMM Method
The Hidden Markov Model extracts rate constants for receptor transitions
between free, domain-confined, and dimerized states. The novelty of this approach is
that the HMM assumes a kinetic model for the underlying biological progress whose
rate constants are unknown. By using our large data sets from SPT, we can determine
a maximum likelihood estimate of the kinetics of the system. This represents an
important methodological advance for quantitation of state-dependent behaviors. The
off rate is a useful parameter that reflects the full range of physiologically relevant dimer
lifetimes. The potential of improved computational models to inform our mechanistic
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understanding of erbB dynamics, using parameters from live cell measurements, is
discussed in section 5.2.3.
Another useful feature of this approach is the determination of the confinement
zone using changes in state behavior. This is an improvement over the traditional mean
square displacement (MSD) analysis (Kusumi, 1993). The large sample size analyzed
by the HMM approach better approximates the size of these regions of the membrane
than typical MSD calculations, which rely on behaviors of individual trajectories. In the
emerging era of single molecule biochemistry, this method clearly demonstrates the
potential of SPT to determine the dynamic interactions between species. The HMM
represents a statistically rigorous approach that addresses the challenges of studying
live cell protein-protein dynamics.
5.1.2 Significance of erbB1 results
In work focused on the formation of erbB1 homodimers, we demonstrate that
ligand binding determines dimer stability, regardless of the activation status of the
kinase domain. The importance of local environment composition and organization is
underscored by our unique observation of repeated dimer events between two
receptors. Kinase-inhibited receptors do not show a significant change in mobility when
co-confined, regardless of ligand addition. We show that 2 EGF:2 erbB1 homodimers
display slowed mobility in the domain state, highlighting the role for membrane
partitioning at the onset of signaling. Immobilization appears to be a feature of signal
propagation as seen in signaling competent, ligand-bound dimers whose mobility slows
more than 6-fold compared to the monomer state.
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This work also addresses many of the important hypotheses that remain
unresolved in the erbB1 field. First, the presence of dimers in the absence of ligand was
detected, which supports the concept that preformed dimers can and do occur.
However, these species displayed the shortest lifetime and did not demonstrate
correlated motion. These results suggest that such 0 ligand:2 erbB1 complexes are
weakly associated and are unlikely to initiate signaling, consistent with reports for
nonsignaling predimers (Hofman, 2010). Signaling by preformed dimers may be highly
receptor density dependent (Clayton, 2005, Gadella, 1995, Chung, 2010, Nagy, 2010).
Second, we observe that dimers that are composed of two liganded receptors are
the most stable. This calls for reinterpretation of the negative cooperativity model, which
suggests the lowered binding affinity of a 1:2 ligand: erbB1 dimer for ligand
(MacDonald, 2010). Our results of short lived 1:2 dimers suggest that, if negative
cooperativity exists, the contribution to erbB1 signaling may be limited due to the short
duration of this state (Figure 5.1). In addition, dimers are the result of occupied
monomers that encounter one another in a manner that is promoted by membrane
confinement. Dimers with a single ligand will be expected to dissociate and upon
binding of a second ligand, will form the more stable 2:2 dimers.
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Figure 5.1. Dynamics of erbB1 receptors on cells are affected by dimer off rates and
ligand activation. A) In the resting state, receptors are on the surface in the tethered or
extended conformation. Preformed dimers (0:2 ligand:erbB1) may also be present in the
absence of the ligand, but koff is high for this complex. B) Following addition of ligand,
occupied monomers, unoccupied receptors, and dimeric complexes exist. The 2:2 dimer
has the smallest off rate, whereas the 1:2 dimer has an intermediate koff. C) Liganded
dimers may demonstrate repeated encounters within a domain and multiple dimer
events. Alternately, long lived dimers undergo transphosphorylation (red circles) and
signal downstream through adaptor proteins. D) Negative cooperativity suggests that
1:2 dimers will have a lowered affinity for the second ligand binding event. Our data
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shows that these dimers have an intermediate off rate, suggesting that dissociation is
favored over binding of a 2nd ligand. E) If the unliganded receptor from the 1:2 complex
binds another ligand, these receptors may exhibit the behavior shown in (C).
5.1.3 Significance of erbB2 and erbB3 results
We also used our new Hidden Markov Model approach to study the misfits of the
erbB family: erbB2 and erbB3. These members have been of great interest, especially
for their putative roles in mechanisms of carcinogenesis. Colleagues in the laboratory
(Yang

and

Steinkamp)

demonstrated

that

erbB3

complexes

catalyze

the

phosphorylation of a peptide substrate, in an erbB2- and ligand-dependent manner.
Importantly, this activity is not associated with other erbB receptors or other coprecipitated proteins. These results alone constitute a paradigm shift in erbB signaling
with kinase activity directly associated with erbB3 receptors.
From our single particle tracking measurements, the model of short lived erbB2erbB3 heterodimers preceding the formation of signaling competent, long lived erbB3
homodimers is supported by both dimer event lengths from HMM and correlated motion
analyses (Figure 4.6). A feature of this model that may carry disease significance is that
a 1:1 ratio of erbB2:erbB3 receptors is not requisite, suggesting that even a small
number of erbB2 receptors can effect a robust erbB3 signaling response. Our ability to
characterize the kinetics of these dimer events points to the potential of this approach to
understanding erbB-related mechanisms of oncogenesis. We expect to apply these
techniques, in particular, to understanding the molecular basis of erbB3-mediated
escape from erbB-targeted therapies.
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5.2 PERSPECTIVE AND FUTURE STUDIES
5.2.1. erbB receptor homo- and hetero-dimer formation and signaling
Despite decades of study, the erbB receptors remain the focus of ongoing
research. As early as the 1980s, the erbB1 gene was shown to be overexpressed in
primary brain tumors (Libermann, 1985) and the hyperactivity associated with high
receptor density is implicated in poor clinical outcomes (Slamon, 1989). The roles of
these membrane proteins as regulators of important cellular functions have motivated
detailed investigations of the molecular mechanisms that govern their function. Since
the discovery of ligand-induced dimerization as the first step in erbB signal transduction
(Ullrich, 1990), the formation of these complexes has been a subject of keen interest.
Using the approaches we have developed, the combinatorial complexity of dimer
formation can be interrogated in a variety of cell types, including those expressing erbB
mutants. In particular, density dependent effects of receptor ratios on diffusion and
interaction kinetics could provide insight into fundamental mechanisms of aberrant erbB
signaling.
The studies presented here provide previously unattainable molecular detail of
erbB receptor dimerization. An essential question remains regarding the threshold
lifetime for a dimer before successful transphosphorylation, adaptor protein recruitment
(Pawson, 2004, Schlessinger, 2003), and signaling occur. Some short dimer lifetimes
were observed, as well as repeated interactions of receptors for variable times. The
short

lifetime

associated

with

erbB2-erbB3

heterodimers

may

require

rapid

phosphorylation in order to activate the erbB3 kinase. It is important to understand if
these short or punctuated interactions actively signal. A possibility is that the activity of
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phosphatases leads to dephosphorylation of tyrosine residues, precluding downstream
events. The timescale of this feedback could determine the productivity of short lived
dimers. Additionally, the downregulation of signaling through endocytosis may be
occurring during the events that are observed. This mechanism has been demonstrated
to occur in response to ligand stimulation, using both clathrin-dependent and clathrinindependent entry routes (Sadowski, 2009, Sorkin, 2009, Xiao, 2008). It will be
important to determine if 1:2 and 2:2 ligand:receptor dimers have equivalent
internalization kinetics.
The need to specifically correlate the kinase activity of the receptor with the
dimerization event is a significant challenge. As a starting place to address this question
in intact cells, techniques using fixation can be employed to monitor the phosphorylation
status of dimerized receptors. The Lidke laboratory is developing an approach based on
combining imaging and microfluidic technologies to quickly flow in a fixative and
crosslink a cell following the observation of dimerization by our standard QD protocol.
Using this method, cells can be halted in time, permeabilized, and fluorescently labeled
antibodies can be flowed into the chamber and show not only the phosphorylation
status of the receptor, but can also be used to detect which, if any, adaptor proteins
have been recruited to the site of receptor interaction. Unfortunately, this approach
precludes the correlation of ongoing dimerization events and receptor diffusion with
downstream signaling in real time. Regardless, this is an important first step in
characterizing the dimers we observe using SPT techniques.
Ultimately, the ability to report kinase activity in real time will be the preferred
means to corroborate dimerization with receptor phosphorylation. Some efforts have
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been made to overcome the requirement to make ex post facto observations of kinase
activity. An example is the use of biosensors based on the incorporation of a synthetic
fluorophore whose optical properties are modulated by the phosphorylation status of its
associated protein (Sharma et al., 2008). As probes, labels, and imaging modalities
continue to advance, this goal may be realized and will permit the concurrent
observation of dimers and phosphorylation, providing unequivocal mechanistic evidence
for the activation of these complexes. This will also be invaluable in verifying or
disproving the mechanism of lateral signaling propagation as the spread of
phosphorylated residues may be more directly associated with the erbB receptors
involved.
5.2.2 Membrane organization and receptor partitioning
The results presented in this work have significant implications for understanding
erbB receptor dynamics, with particular insights into the impact of the cell membrane on
protein-protein interactions. The features of receptor diffusion and interaction kinetics
are critically influenced by the lateral organization of the plasma membrane. The
viscosity of this complex environment has led to diffusion measurements of
transmembrane proteins that are an order of magnitude slower than those observed in
artificial membranes (Kusumi, 2005, Bacia, 2004). This decreased mobility could be due
to protein-protein interactions (Douglass, 2005), cytoskeletal confinement (Kusumi,
1993, Jacobson, 1995, Andrews, 2009), or lipid microdomains (Simons, 1997). A role
for residency time in membrane domains of specific composition to regulate receptor
signaling is of great interest to the cell biology community.
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In SPT studies of erbB receptors, Orr, et al. found that perturbation of actin and
cholesterol has differential effects on erbB1 and erbB2. Depletion of cellular cholesterol
induced confinement of both receptors, but actin depolymerization only affected erbB1,
increasing its diffusion (Orr, 2005). These result suggest differential partitioning of the
orphan

receptor,

erbB2

from

erbB1,

which

may

have

important

functional

consequences. My colleagues in the Wilson laboratory have used membrane sheets
and immunoelectron microscopy to show that large patches of erbB3 receptors
following stimulation with heregulin. The exclusion of erbB2 from these patches further
indicates membrane reorganization as a critical feature of signaling. This is consistent
with earlier results that show cell surface microdomains that co-confine erbB1 receptors
and whose composition is affected by the activation status of the complex. Taken
together, these results indicate a special role for membrane components in providing
unique environments for the members of the erbB family. Receptor clustering upon
activation may precede signaling and internalization; the reconciliation of the sequence
of events that lead to the formation of these patches on the membrane remains a topic
of great interest.
In an ongoing effort to map the cell membrane, experiments to determine the
effects of choleseterol depletion and actin disassembly on erbB dimerization kinetics
should be explored. Actin treadmilling has already been shown to play a role in normal
mechanisms of activated erbB1 function (Lidke, 2005) and may stabilize dimers through
direct interactions. In fact, interactions with the cytoskeleton may lead to immobilization
of the receptor for signaling and, ultimately, endocytosis (Rijken, 1995, Xiao, 2008). The
tools we developed in this dissertation project can be readily applied to these studies.
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One potential approach is to use Latrunculin A to depolymerize actin. Partial extraction
of cholesterol with methyl-beta-cyclodextrin is another approach that avoids the
complications resulting from the total depletion of cholesterol (Owen et al., 2006).
5.2.3 Implications for erbB-target therapies
Current therapies targeting the erbB receptors fall into two broad classes: small
molecule tyrosine kinase inhibitors and monoclonal antibodies that interfere with
receptor activation. The single molecule approaches we developed provide a unique
framework to characterize the mechanism of action for these kinds of pharmacological
agents. We demonstrated the use of an ATP competitive inhibitor, PD153035, in the
erbB1 studies. These efforts not only showed effects of the drug on receptor diffusion,
but also furthered our understanding that an active kinase domain plays a minimal role
in erbB1 homodimer stability. The analysis of drugs can be extended to other receptor
antagonists. Two engineered antibodies of interest are MM-111 and MM121 that target
erbB3. Efforts to label and study these agents are underway and are expected to
provide mechanistic insight into their function. Our results also suggest an important
therapeutic avenue for treating erbB related diseases, namely through the development
of agents that affect receptor localization. A role for agents that disrupt the changes in
lateral organization associated with signaling dimers could have great clinical value.
5.2.4 Computational modeling – a useful next step
Computational models of erbB network behaviors can be useful in predictions of
signaling outcomes. A number of models already exist and have provided insight into
the effects of network components on signaling outcomes (Kholodenko et al., 1999;
Hsieh et al., 2008; Dehmelt and Bastiaens, 2010). However, these models may fall
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short when using parameters derived from only solution-based measurements (Rates
from literature are summarized in Appendix F). The diffusive and kinetic parameters we
have extrapolated from live cell observations of erbB receptors will improve the potential
of these models. Systems biology models that are motivated by our parameters have
utility as platforms to test hypotheses difficult to execute in the lab, as well as to
simulate therapeutic paradigms.
In collaboration with the Edwards group and other colleagues at the UNM STMC,
we plan to use the values from our measurements to improve an existing stochastic
computational model for erbB1 signaling and, ultimately, extend its variables to include
erbB2 and erbB3 components. The benefit of using this in silico approach is in the
abilities to allow simulations to reach equilibrium and to observe the entire receptor
population, not simply those that are QD labeled in SPT experiments. We are interested
in how receptors behave at steady state, following activation, and in monitoring the
downstream outputs. One goal is to test the predictions of the new model in this chapter
(Figure 5.1), by populating a stochastic simulation with receptors and providing a
stimulus.

We expect that, at equilibrium, the system will be minimally affected by

negative cooperativity. Receptors are expected to have the most productive interactions
when both monomers in a dimer are bound to ligand.
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5.3 CONCLUSIONS
In this work, we have described erbB diffusion and dimerization kinetics with
mechanistic

details

that

were

previously

unattainable.

In

particular,

these

measurements were made on live cells, under physiologically relevant conditions. We
have elucidated new features of erbB signaling, including the repeated interactions of
erbB1 receptors and the successful formation of long lived erbB3 homodimers. The
sophisticated approaches we developed and implemented, both experimental and
analytical, provide the spatial and temporal resolution necessary to visualize and
quantify receptor mobility, dimer off rates, and state-dependent behaviors. These
techniques have addressed a number of questions in the erbB field and permit the
detailed investigation of many other interesting cellular phenomena.
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APPENDIX B – FLUORESCENT PROBES
Probe
EGF QD585
EGF QD625
EGF QD655
EGF QD705

Fluorophore &
Chemistry
SAvQD585
SAvQD625
SAvQD655
SAvQD705

erbB1
erbB1
erbB1
erbB1

maleimide QD585

erbB1 non-activating
erbB1 non-activating

erbB1 (domain I)

maleimide QD655
Alexa488
C5
maleimide
Alexa488
NHS
ester
Alexa647
NHS
ester
Alexa488
NHS
ester
Alexa647
NHS
ester

erbB1 (domain I)

SAvQD585

Non-EGF Competing

erbB1 (domain I)

Non-EGF Competing

erbB3 ligand (8 kDa)

SAvQD655
Alexa488
NHS
ester
Alexa647
NHS
ester
Alexa488
C5
maleimide
maleimide QD585
maleimide QD655
Alexa647
NHS
ester

erbB3 ligand (8 kDa)

SAvQD585

erbB3 ligand (8 kDa)

erbB1 (domain III)

SAvQD655
Alexa488
ester
Alexa647
ester

erbB1 (domain III)

SAvQD585

EGF Competing

erbB1 (domain III)

SAvQD655

EGF Competing

rEGF QD655

Epitope
erbB1 ligand
erbB1 ligand
erbB1 ligand
erbB1 ligand
reduced
erbB1
ligand
reduced
erbB1
ligand

13A9 A488

erbB1

ERBB1.1 A488

erbB1

ERBB1.1 A647
VHH(EGb4)
A488
VHH(EGb4)
A647
VHH(EGb4)
QD585
VHH(EGb4)
QD655
Herceptin
A488
Herceptin
A647

erbB1

rH A488
rH QD585
rH QD655
Heregulin
A647
Heregulin
QD585
Heregulin
QD655
VHH(EGa)
A488
VHH(EGa)
A647
VHH(EGa)
QD585
VHH(EGa)
QD655

erbB2
erbB2
erbB2

rEGF QD585

erbB1 (domain I)

erbB2
erbB2

erbB1 (domain III)
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Activity
activating
activating
activating
activating

Non-EGF Competing
Non-EGF Competing
Non-EGF Competing
Non-EGF Competing
Non-EGF Competing

erbB2 Inhibitor
erbB2 Inhibitor
Reduced erbB2 Inhibitor
Reduced erbB2 Inhibitor
Reduced erbB2 Inhibitor
erbB3 activating (EGF-like
domain of ligand)
erbB3
activating
(extracelluar domain)
erbB3
activating
(extracelluar domain)

NHS
EGF Competing
NHS
EGF Competing

APPENDIX C: SUPPLEMENTARY INFORMATION FOR CH. 3
Abbreviations
EGF, epidermal growth factor; erbB1, erythroblastic leukemia viral oncogene homolog 1
or epidermal growth factor receptor; HMM, Hidden Markov Model; SD, square
displacement; QD, quantum dot; SPT, single particle tracking; VHH, nanobody
Materials and Methods
Reagents. Biotinylated EGF was purchased at a 1:1 stoichiometry (Invitrogen,
Carlsbad, CA) and singly biotinylated VHH fragment EGb4 was produced using the BirA
expression system (Roovers et al., 2007). Biotin-EGF or biotin-VHH were conjugated to
Qdot® 655 or Qdot® 585 streptavidin conjugate (Invitrogen, Carlsbad, CA) in PBS + 1%
BSA to generate stock solutions of 30 nM 1:1 monovalent QD-conjugates (Lidke et al.,
2004). Stock solutions were stored at 4°C and used for up to two weeks. Biotin-EGF
was conjugated to Qdot® 625 streptavidin for bleedthrough experiments. Experiments
with PD153035 (Tocris Bioscience, Ellisville, MO) were performed at a final
concentration of 1 µM inhibitor.
Cell culture. A431 Human Epithelial carcinoma cells were cultured in Dulbecco’s
Modified Eagle’s Medium without phenol red (Sigma-Aldrich, St. Louis, MO)
supplemented with 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA) and
penicillin and streptomycin. For live cell imaging, cells were plated in 8-well Lab-Tek
chambers (Nunc, Rochester, NY) and allowed to reach up to 50% confluency before
experimentation.
Cell treatment for SPT experiments. Cells in Lab-Tek chambers were imaged in
Tyrode’s supplemented with 0.1% BSA and 20 mM glucose. Prior to imaging, cells
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were serum starved in Dulbecco’s Modified Eagle’s Medium lacking FBS for four
hours. Experiments with PD153035 were performed after serum starvation including1
µM inhibitor and live cell imaging buffer also included 1 µM PD153035.
Fluorescence Microscopy. Wide field imaging for SPT was performed using an
Olympus IX71 inverted microscope equipped with a 60× 1.2 N.A. water objective. Wide
field excitation was provided by a mercury lamp with either a 436 /10 nm BP excitation
filter and a 50/50 neutral density filter. Emission was collected by an electron
multiplying CCD camera (Andor iXon 887) using a QuadView image splitter (Optical
Insights) to simultaneously image two spectrally distinct QDs. QD emission was
collected using a 600 nm dichroic and the appropriate emission filters, 655/40nm and
585/20 BP (Chroma, Rockingham, VT). A single pixel is equivalent to 267 nm. The
sample temperature (34-36 °C) was maintained by an objective heater (Bioptechs,
Butler, PA).
Image Processing. All image processing was performed using Matlab (The
MathWorks, Inc., Natick, MA) in conjunction with the image processing library DIPImage
(Delft University of Technology). For descriptions of specific analysis routines see
Supplementary Information.
GPU Single Particle Tracking and Track Elongation. Images were acquired at 20
fames/s for a total of 1,000 frames. Single molecule localization and trajectory
connection were carried out as previously described (Smith et al., 2010). Complete
derivation of the track elongation algorithm is provided in Supporting Online Text.
To elongate short tracks, the positions (

and

) with the smallest

for

temporally independent tracks are compared using equation 6. Temporally independent
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tracks with the best p-value that pass a user-defined cutoff are augmented for form an
elongated trajectory. Due to temporal independence of short trajectories, the cutoff and
for track elongation can be relaxed slightly from those used in the initial connection
algorithm without introducing artifacts. This process is repeated until no temporally
independent tracks that pass the cutoff remain. An example comparison of short and
elongated trajectories is shown in Supplemental Figure S1.
Squared Displacement Analysis. Diffusion analysis of trajectories was performed by
square displacement analysis and two-component fitting, as previously described (de
Keijzer et al., 2008).
Correlated Motion Analysis. The degree of correlation between pairwise trajectories
was determined as previously described (Andrews et al., 2008).
Fiducial Data Acquisition and Image Registration. Images were registered using a
calibration image of multi–fluorophore fluorescent beads (0.2 µm Tetraspeck, Invitrogen,
Carlsbad, CA) that have an emission spectrum covering the two spectral windows. The
camera was sampled by moving a single bead across the field of view using a
mechanical stage (Prior Pro Scan II, Rockland, MA) to obtain good sampling over the
field of view. A fiducial data set was acquired at the beginning and end of each chamber
tested. Corresponding beads are identified in each channel and fit to a polynomial
calibration model. (Churchman et al., 2005).
After direct experimental comparison, no significant difference between using a locally
weighted method and the polynomial method discussed below was observed. The
polynomial calibration model used is shown in equation 1 (eqn. 1).
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eqn. 1

In equation 1, the
and

location of the nth bead in channels 1 and 2 are indicated by

. Several polynomials were tested for the calibration and the polynomial shown

in equation 1 appeared to sufficiently describe the channel overlay without over fitting.
Equation 1 is shown in matrix notation in equation 2.
eqn. 2
The coefficients

can be solved for using equation 3.
eqn. 3

Similarly, the coefficients

for the

locations can be solved for using equation 4.
eqn. 4

Equation 2 can then be used to transform the localization of single molecules in channel
2 to the properly aligned coordinates in channel 1.
The fiducial calibration image acquired prior to the experiment is used to estimate
the model coefficients with equations 3 and 4. The fiducial registration error is shown in
equation 5.
eqn. 5
The fiducial registration error of the post experiment fiducial calibration image is used to
estimate the accuracy of the channel overlay. Using two independent calibration images
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collected before and after experiments to train and test the model, allows for a more
accurate estimate of the error in the channel overlay during the experimental
acquisition. An example of a fiducial data set and the accompanying transformation can
be found in fig. S1.
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SUPPORTING TEXT

Optimizing SPT Trajectories
Optimized elongation of single particle trajectories provides the necessary
temporal resolution for kinetic fitting. Longer tracks are necessary to correlate
motion in separate channels over an extended period of time and in order to determine
the duration of protein-protein association. In order to elongate optimized initial short
tracks, temporally independent tracks are identified (fig. S1C).
Particles are fit using a 2 dimensional Gaussian estimate of the microscope point
spread function. Algorithms for single molecule localization are implemented on the
GPU architecture. Short tracks are connected using homemade software comparing
positions (

) of all single particles in frame i with all single particles positions (

frame i+j. A probability of

and

) in

being the same particle in different time frames is

estimated using equation 6.
eqn. 6
D is an estimated diffusion constant,

is the time between the observation in frame i

and frame i+j. In accordance with literature values (Lidke et al., 2005a; Orr et al., 2005)
0.1 was used for the estimated diffusion constant. Upper limits for the p-value and
are user-defined parameters utilized to facilitate temporal connectivity.

Hidden Markov Model
A two-state HMM is insufficient to describe observed erbB1 behaviors. Our first
analytical model of erbB1 homoassociation was the simplest, two-state model for
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protein-protein interactions in which the states were free (state = 0) or dimer (state = 1).
The initial estimate of the Interaction Distance (ID) was based on the crystal structure of
the back-to-back erbB1 homodimer (fig. S5) and set to 50 nm. Using this value for the
dimer distance, many dimerization events were seen to be interrupted by short breaks,
yet the same two receptors would return to the dimer state. This indicated the need for a
third, domain-confined, state to completely describe the data (fig. S4).
To ensure that the apparent fluctuations in distance were due to receptor
separation

and

not

artifacts

in

the

measurement,

we

performed

two-color

measurements using a QD625-EGF probe using whose emission is simultaneously
registered in both 585 nm and 655 nm imaging channels (fig. S5). These “perfect dimer”
single molecule events demonstrated consistent separation over time that was
equivalent to the sum of the localization accuracies of the particles (40-60 nm). This
shows that our image registration was very accurate and that the observed fluctuations
in separation were genuine. This also confirms that the rigorous 50 nm definition of ID
could be used in our analyses.
The three-state HMM permits fitting of transitions rates and domain size. The
unexpected distance fluctuation behavior, taken together with the high precision image
registration, led us to define a third, domain state. Using the three-state HMM, we can fit
both the transition rates between states and the Gaussian sigma for the domain size.
These fits are summarized in table S2 below. The domain is smallest for the ligandbound and signaling competent receptors. Interestingly, there are not large differences
between the other domain sizes, suggesting that reorganization and consolidation of the
domain changes as a function of signaling propagation.
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Using the three-state HMM, many states and types of interactions are observed.
Examples of state traces are shown in figure S6, including a long lived QD-EGF (fig.
S6A) dimer and the formation of a dimer that subsequently demonstrated the repeated
reflection and return behavior previously discussed (fig. S6B). Other examples include
exploration of all three interaction states, across several conditions (fig. S6D-F). Another
interesting behavior is seen in figure S6C in which there is excursion and return of two
ligand-bound receptors between the domain and free states, suggesting a second level
of confinement.
A final advantage of our three-state HMM is the ability to take advantage of the
state characterizations in order to determine the diffusion coefficients of erbB1 in each
state, as shown in Figure 4. Complete results for this analysis under each tracking
condition are summarized in table S3.
A complete derivation of the three-state HMM follows.
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Figure S3.1. Calibration of alignment is performed routinely and optimized track
elongation is achieved using spatial and temporal independence. (A) A fiducial
calibration series is acquired using the two-channel set-up and is analyzed in order to
determine the transformation vector. The subsequent fiducial data series is acquired
following data collection and its error can be used to assess drift in the system during
the elapsed time. Top left: Raw data; Bottom left: Lateral shift overlay (RMSE = 0.64
pixels = 171 nm); Right: Interpolated overlay (Fiducial registration error = 0.07 pixels =
18.6 nm). (B) A trajectory, shown in purple, from QD-EGF SPT is shown as connected
from four shorter tracks, delineated in red, yellow, green, and blue.
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Figure S3.2. Correlated motion analysis of erbB1 shows activation state dependence.
Results of correlated motion analyses for VHH + dark EGF (A) and VHH + PD153035
(B) conditions. A decrease in uncorrelated jump distance (blue) at short separations
indicates that receptors are moving together. A concurrent drop in jump magnitude (red)
demonstrates decreased diffusion. Although there were fewer candidate pairs and
dimers observed for QD-VHH + dEGF, non-fluorescent ligand nevertheless induces
correlated motion (A). The smaller number of candidate pairs is expected due to the low
level of labeling and the saturating levels of ligand, precluding a high frequency of close
approach of QD-labeled erbB1 receptors. Interestingly, resting receptors in the
presence of the PD153035 inhibitor also showed a degree of correlated motion, even in
the absence of ligand (B). These results are consistent with a mechanism for the small
molecule drug that confers an intermediate affinity for ligand (9), suggesting a change in
the extracellular conformation of erbB1.
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Figure S3.3. HMM analysis of a simulated receptor pair. The observed separation
(black) is used to find the transition rate constants. The found rates are then used to find
the most likely state at each time point. The found state, dimer, domain, or free are
indicated by blue, magenta, and red, respectively. The known underlying state is shown
in gray.
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Figure S3.4. ErbB1 receptors experience periods of close approach, punctuated by
episodes of separation of up to hundreds of nanometers. (A) and (B) Examples of twocolor QD-EGF tracking show dimer events, interrupted periods of larger separation. (C)
and (D) Examples of interaction, separation, and return were also detected in other
conditions. QD-EGF in the presence of PD153035 and QD-VHH are shown,
respectively. Domain (2, purple) and Dimer (1, blue) states are connected by green
segments to show the state path. This path is projected onto the x-axis to show the
timeline of states explored.
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Figure S3.5. Optimized image registration is confirmed using bleedthrough of QD625
signal and permits strict definition of dimer distance. (A) Data collected using an
QD625-EGF probe whose fluorescence signal appears simultaneously in both imaging
channels demonstrates a “perfect dimer” (stills are inset; scale bar = 0.5 µm). The
separation distance is constant over time and does not show the fluctuations observed
in two-color tracking data sets. The observed offset of 40-60 nm reflects high precision
channel registration; differences were only due to small errors in the single molecule
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localization of each particle. (B) and (C) Further examples of “perfect dimers” observed
using QD625-EGF in the presence of the PD153035 inhibitor show that there is no
effect of diffusion or activation state on image registration. (D) The dimer distance is
based on the 3.3 Å crystal structure of the erbB1 extracellular domain ligand bound
dimer and estimates of QD radii from previous measurements (10,11).
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Figure S3.6. State characterization of erbB1 interactions shows formation of resting,
activated, and signaling-incompetent homodimers. (A)-(D) Examples of QD-EGF
tracking analyzed using the three-state HMM. In panel (B), the dimer that is observed at
the end of the acquisition subsequently experiences punctuated interactions, as seen in
Figure S9A. (E) and (F): Examples of interactions in other conditions. QD-EGF in the
presence of PD153035 and QD-VHH are shown, respectively. Free (red), Domain
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(purple) and dimer (1, blue) states are connected by green segments to show the state
path. This path is projected onto the x-axis to show the timeline of states explored.
Label

Status of erbB1

QD-EGF
QD-EGF
+QD-VHH

Activated
Ligand bound
receptor

QD-VHH
+dEGF
QD-EGF
+PD
QD-VHH

95% Confidence Interval
([* 1E-02] µm^2/s)
3.83-3.84

397546

3.60

3.60-3.61

93472

Excess ligand
Ligand bound
and inhibited
Resting

3.97

3.96-3.97

109510

5.29
5.10

5.28-5.29
5.09-5.10

89223
214007

Resting receptor

5.57

5.56-5.58

56943

Inhibited

6.28

6.28-6.28

197059

Combined ligand bound
and resting receptors

3.85

3.85-3.86

228134

QD-VHH
+QD-EGF
QD-VHH
+PD
QD-EGF
+QD-VHH

N

D
[* 1E-02] (µm^2/s)
3.84

Table S3.1. Single color diffusion measurements of erbB1 under different conditions.
Data for each condition shows tracking label (probe tracked in bold), the activation state
of the labeled erbB1 receptors, diffusion coefficient (D) of the mobile component, the
95% confidence interval for the mobile component fit, and the number of square jumps
used in the fit (N).
Probe

Additional
Reagent(s)

Notes

Condition

Free
→
Dimer

Free
→
Domain

Domain
→
Dimer

Domain
→
Free

Dimer
→
Domain

Dimer
→
Free

k dimer
off (s-1)

QD-EGF

None

ID=50;
DD=150

Activated

4.78E-06
3.02E-06

5.14E-03
6.69E-04

8.45E-03
9.44E-04

1.21E-02
2.93E-04

1.36E-02
6.11E-04

7.94E-13
2.67E-05

2.73E-01
1.22E-2

QD-VHH

None

ID=50;
DD=250

Resting

3.15E-05
1.00E-03

8.26E-03
1.03E-03

5.42E-03
6.49E-03

1.83E-02
4.91E-04

6.19E-02
6.36E-04

1.36E-04
4.65E-05

1.24E+00
1.28E-2

QD-EGF

1uM
PD153035

ID=50;
DD=200

Inhibited

1.40E-14
7.04E-04

6.28E-03
2.29E-03

6.93E-03
2.41E-03

2.27E-02
6.44E-04

1.22E-02
1.30E-03

4.95E-04
1.80E-06

2.53E-01
2.60E-2

QD-VHH

1uM
PD153039

ID=50;
DD=250

Inhibited

3.55E-05
1.91E-05

9.36E-03
1.21E-03

7.58E-03
7.60E-03

2.32E-02
5.17E-04

8.32E-02
7.62E-04

8.78E-12
5.55E-05

1.66E+00
1.53E-2

QD-EGF
+
QD-VHH

None

ID=50;
DD=250

Activated and
Resting

9.97E-15
8.91E-03

6.13E-03
7.22E-04

2.91E-03
2.19E-03

8.74E-03
4.97E-04

1.37E-02
4.38E-04

2.32E-02
1.45E-06

7.38E-01
8.76E-3

Table S3.2. Three-state HMM fitting results. Domain size and HMM kinetic rates
change by condition. Condition reflects the state of the erbB1 receptors that are being
tracked by the probes, shown in bold. Transition rates are shown in units of frames-1.
The value of k dimer off is the sum of the transitions from dimer-to-domain and dimer-tofree. Error in fits is shown in red.
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Free State
Label

Status of erbB1

QD-EGF
QD-EGF
+QD-VHH
QD-VHH
+dEGF
QD-EGF
+PD
QD-VHH
QD-VHH
+QD-EGF
QD-VHH
+PD

Activated
Ligand bound
receptor

D
[* 1E-02] (µm^2/s)
3.90

95% Confidence Interval
([* 1E-02] µm^2/s)
3.9-3.91

N
382897

3.12

3.12-3.12

168345

Excess ligand
Ligand bound
and inhibited
Resting

4.00

3.99-4.00

107039

5.33
5.12

5.32-5.33
5.11-5.12

87117
208720

Resting receptor

5.63

5.62-5.63

54414

Inhibited

6.32

6.31-6.32

191133

D
[* 1E-02] (µm^2/s)
1.99

95% Confidence Interval
([* 1E-02] µm^2/s)
1.98-2.00

N
8628

2.41

2.38-2.44

2361

Excess ligand
Ligand bound
and inhibited
Resting

2.59

2.55-2.63

2080

4.23
4.32

4.15-4.30
4.30-4.34

1372
4683

Resting receptor

3.94

3.91-3.97

2375

Inhibited

5.25

5.23-5.27

5345

D
[* 1E-02] (µm^2/s)
0.563

95% Confidence Interval
([* 1E-02] µm^2/s)
0.555-0.571

N
6021

0.777

0.729-0.825

485

Excess ligand
Ligand bound
and inhibited
Resting

0.977

0.822-1.13

391

1.91
3.88

1.88-1.94
3.84-3.94

734
604

Resting receptor

1.80

1.58-2.01
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Inhibited

4.18

3.74-4.63

581

Domain State
Label
Status of erbB1
QD-EGF
QD-EGF
+QD-VHH
QD-VHH
+dEGF
QD-EGF
+PD
QD-VHH
QD-VHH
+QD-EGF
QD-VHH
+PD

Activated
Ligand bound
receptor

Dimer State
Label
Status of erbB1
QD-EGF
QD-EGF
+QD-VHH
QD-VHH
+dEGF
QD-EGF
+PD
QD-VHH
QD-VHH
+QD-EGF
QD-VHH
+PD

Activated
Ligand bound
receptor

Table S3.3. State-dependent diffusion of erbB1 by condition demonstrates slowing
upon entering domain and dimerization. Data for each condition shows tracking label
(probe tracked in bold), the activation state of the labeled erbB1, diffusion coefficient (D)
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of the mobile component, the 95% confidence interval for the mobile component fit, and
the number of square jumps used in the fit (N).
Supporting Movies
Movie 3.1. Formation of a QD-EGF ligand bound 2:2 erbB1 homodimer that
approaches, interacts, and remains together for the remainder of the acquisition. This
movie accompanies the interaction shown in Fig. 3.2A and 3.2B and the state trace and
stills in Fig. 3.4B. The coordinate for each single molecule fit is shown as a green
(QD585) or magenta circle (QD655) within the fluorescent spot. A colored tail for each
particle shows a track of the previous 15 coordinates. The final frame shows the entire
trajectory for each receptor of interest. Movies have been Gaussian filtered (sigma =
0.7) and contrast enhanced. Playback speed is 40 frames per second (fps) and is
equivalent to 2 times real time.
Movie 3.2. A short lived resting 1:1 erbB1 homodimer visualized using two-color QDVHH. The movie corresponds to the state trace shown in Fig. S3.6F. Color scheme,
comet tail, filtering, and payback speed are as previously mentioned for Movie 3.1.
Movie 3.3. Formation of a ligand bound 2:2 erbB1 homodimer. The movie corresponds
to the state trace shown in Fig. S3.6B. Notice that the two receptors remain separated
for the majority of the movie, before initial overlap of the signals. Color scheme, comet
tail, filtering, and payback speed are as previously mentioned for Movie 3.1.
Movie 3.4. Continued observation of the dimer formed in Movie 3.3 shows ligand bound
erbB1 receptors that experience periods of separation and return. Notice that sustained
spectral overlap is not apparent and magenta and green signals can be distinguished as
the receptors diffuse. Color scheme, comet tail, filtering, and payback speed are as
previously mentioned for Movie 3.1.
Movie 3.5. A long lived QD-EGF labeled 2:2 erbB1 homodimer that persists for the
entire 50 second acquisition. The movie corresponds to the state trace shown in Fig.
S3.6A. Color scheme, comet tail, filtering, and payback speed are as previously
mentioned for Movie 3.1.
Movie 3.6. Interactions between QD-EGF labeled receptors in the presence of 1 mM
PD153035. The movie corresponds to the state trace shown in Fig. S3.6E. Notice the
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large region explored by the green receptor, in particular, and the very brief spectral
overlap toward the end of the sequence. Color scheme, comet tail, filtering, and
payback speed are as previously mentioned for Movie 3.1.
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APPENDIX D – MATLAB SCRIPTS AND FUNCTIONS
%Dissertation Appendix
%MatLab scripts and functions for SPT analyses
%Shalini Low-Nam
%The scripts and functions contained in this appendix were principally written by S.
Low-Nam, P. Cutler, and K. Lidke. Many components of this code reflect the effort of
multiple authors and are the subject of ongoing edits. This code represents the state of
analyses at the time of the publication of this dissertation. Author contributions are
documented for most functions.
%Example: EGF analysis for A431 cells data
%%
%% Tracking
% Create tracking and saving directories (change these each time)
topdir='Z:\Shal\SPT Data\GroupedData_A431_Final';
saveDir = [topdir '\HMM Final\HMM EGF\'];
figDir = [saveDir 'figures\'];
mkdir(saveDir)
mkdir(figDir)
%%Link Data to create HMM_Data structure
%%Each structure contains paths to raw data, calibration files, etc
%%Results from later analyses can be appended onto the structure`
clear all
close all
%Folders of raw data
topdir='Z:\Shal\SPT Data\GroupedData_A431_Final';
saveDir = [topdir '\HMM Final\HMM EGF\'];
figDir = [saveDir 'figures\'];
condition = 'QD EGF';
fileCondition = 'EGF';
datadir{1}=[topdir '\EGF\091214\Chamber3\'];
datadir{2}=[topdir '\EGF\091214\Chamber4\'];
datadir{3}=[topdir '\EGF\091214\Chamber5\'];
datadir{4}=[topdir '\EGF\091216\Chamber1\'];
datadir{5}=[topdir '\EGF\091216\Chamber3\'];
datadir{6}=[topdir '\EGF\100611\Chamber1\'];
datadir{7}=[topdir '\EGF\100611\Chamber2\'];
datadir{8}=[topdir '\EGF\100614\Chamber1\'];
count = 0;
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for jj = 1:length(datadir)
Files=dir([datadir{jj} fileCondition '*.mat']);
bgFile = dir([datadir{jj} 'Background-*.mat']);
bgn = [datadir{jj} bgFile.name];
bdFile = dir([datadir{jj} 'Beads*.mat']);
bdn = [datadir{jj} bdFile.name];
bdAlignFiles = dir([datadir{jj} 'fiducial-*.mat']);
bdAlign = [datadir{jj} bdAlignFiles(1).name];
bdAlign1 = [datadir{jj} bdAlignFiles(2).name];
for ii=1:size(Files,1)
fn=[datadir{jj} Files(ii).name];
disp(fn)
try
HMM_Data(ii)
HMM_LinkData(topdir,saveDir,figDir,fn,bgn,bdAlign,bdAlign1,bdn,0.266667,0.05,[1
1],condition);
catch ME
count = count+1;
HMM_Error(count).ME = ME;
HMM_Error(count).fileNum = ii;
save([saveDir 'HMM_Error.HMM_Error'],'HMM_Error')
end
end
end

=

%%Tracking script:
clear all
close all
%Create parameters for tracking and use SPTracking (Smith, et al., Nature Methods
2009)
topdir='Z:\Shal\SPT Data\GroupedData_A431_Final';
saveDir = [topdir '\HMM Final\HMM EGF\'];
psf1 = 0.7382;
psf2 = 0.7021;
D = 0.05;
MinPhotons1 = 100;
MinPhotons2 = 100;
MinTrackLength = 10;
MaxJump = 10;
MaxTjump = 20;
cutoff1 = 0.1;
cutoff2 = 0.1;
iDiv = -1.5;
cmaxjump = 10;
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cmaxTjump = 40;
coverlap = 5;
cpValue = 0.01;
cnstd = 4;
cplotflag = 0;
HMM_Params = HMM_CreateParams([psf1 psf2],D,[MinPhotons1 MinPhotons2],...
MinTrackLength,MaxJump,MaxTjump,cutoff1,cutoff2,iDiv,cmaxjump,cmaxTjump,...
coverlap,cpValue,cnstd,[saveDir 'Params.HMMParams']);
Files=dir([saveDir '*.HMMData']);
if exist([saveDir 'HMM_Error.HMM_Error'],'file')
load([saveDir 'HMM_Error.HMM_Error'],'-mat')
count = length(HMM_Error);
else
count = 0;
end
save([saveDir 'tempFiles'])
for ii=1:size(Files,1)
try
close all
clear HMM_Data
fn=[saveDir Files(ii).name]
disp('making short tracks')
HMM_Data = HMM_Track(fn,[saveDir '\Params.HMMParams']);
close all
save(fn,'HMM_Data')
catch ME
count = count+1;
HMM_Error(count).ME = ME;
HMM_Error(count).fileNum = ii;
disp(Files(HMM_Error(count).fileNum).name);
disp(getReport(HMM_Error(count).ME));
save([saveDir 'HMM_Error.HMM_Error'],'HMM_Error')
close all
clear all
topdir='Z:\Shal\SPT Data\GroupedData_A431_Final';
saveDir = [topdir '\HMM Final\HMM EGF\'];
load([saveDir 'tempFiles'])
load([saveDir 'HMM_Error.HMM_Error'],'-mat')
count = length(HMM_Error);
end
end
function varargout = HMM_LinkData(varargin)
% HMM_LinkData create HMM_Data file for HMM_Track
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%
% HMM_Data = HMM_LinkData(topdir,saveDir,figDir,DataFile,bgn,bdAlign,bdAlign1,...
%
bdn,pixelSize,TimeStep,ch_bin,condition);
%
% INPUTS
% TreeDir - main directory SaveDir, FigDir, DataFile, and all ather
%
associated files must be within TreeDir or a subfolder of
%
TreeDir
% SaveDir - directory in which to save HMM_Data file
% FigDir - directory in which to save resultant figures
% DataFile - raw data file
% BGfile - file containing backgroud sequence
% Bead_Align - file containing pre experiment fiducial data
% Bead_Align1 - file containing post experiment fiducial data
% Bead_Gain - file containing gain calibration sequence of beads
% PixelSize - size of pixels in image (microns). Default 0.266667.
% TimeStep - time between each frame. Default 0.01
% ch_bin - binary vector corresponding to channels (length 1,2 or 4).
%
Default [1 1].
% DataConditions - string with on of the conditions defined on the first
%
line of HMM_LinkData code. Indicates experimental treatment.
% OUTPUTS
% HMM_Data - HMM_Data structure. Data structure also saved in
%
HMM_DataFile
%
% see also HMM_CreateParams and HMM_Track
conditions ={'QD EGF','QD Nanobody','QD EGF + PD','QD Nanobody + PD',...
'QD Nanobody + dEGF','QD Nanobody + dEGF + PD','QD EGF + dEGF',...
'QD EGF + dEGF + PD','QD EGF + QD VhH','QD EGF + QD VhH + PD','QD EGF +
PFA','QD Neu','Sim','QD625','QD rH'};
d = struct('menu','HMM',...
'display','HMM Link Data',...
'inparams',struct('name',{'TreeDir','Save_Dir','Fig_Dir','DataFile','BGFile','Bead_Align','Be
ad_Align2','Bead_Gain','PixelSize','TimeStep','ch_bin','DataConditions'},...
'description',{'Top Tree Directory','Save Directory','Figure Directory','Raw Data
File','Background File',...
'Bead Alignment File Before','Bead Alignment File After','Bead Gain
File','PixelSize','TimeStep','binary vector corresponding to channels (length 1,2 or
4)','Data Conditions'},...
'type',
{'indir','indir','indir','infile','infile','infile','infile','infile','array','array','array','option'},...
'dim_check', {0,0,0,0,0,0,0,0,0,0,{[1 1],[1 2],[1 4]},0},...
'range_check',{'*.*','*.*','*.mat','*.mat','*.mat','*.mat','*.mat','*.mat',[],[],[],conditions},...
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'required', {0,0,0,0,0,0,0,0,0,0,0,0},...
'default', {'','','','','','','','',16/60,.01,[1 1],conditions{1}}...
),...
'outparams',struct('name',{'HMM_Data'},...
'description',{'HMM Data Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[TreeDir, SaveDir, FigDir , DataFile , BGFile , Bead_Align , Bead_Align1 , Bead_Gain
,PixelSize,TimeStep, ch_bin, DataConditions ] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Parse Inputs
n=size(TreeDir,2)-1;
HMM_Data.TreeDir=TreeDir;
if ~strcmp(TreeDir(end),'\')
HMM_Data.TreeDir=[TreeDir '\'];
end
HMM_Data.DataFile=DataFile(n+2:end);
HMM_Data.BGFile=BGFile(n+2:end);
HMM_Data.Bead_Align=Bead_Align(n+2:end);
HMM_Data.Bead_Align1=Bead_Align1(n+2:end);
HMM_Data.SaveDir=SaveDir;
if ~strcmp(SaveDir(end),'\')
HMM_Data.SaveDir=[SaveDir '\'];
end
HMM_Data.FigDir=FigDir;
if ~strcmp(FigDir(end),'\')
HMM_Data.FigDir=[FigDir '\'];
end
HMM_Data.Bead_Gain=Bead_Gain(n+2:end);
HMM_Data.PixelSize=PixelSize;
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HMM_Data.TimeStep=TimeStep;
HMM_Data.ch_bin=ch_bin;
HMM_Data.DataConditions=DataConditions;
HMM_Data.Dconvert = 1/PixelSize^2*TimeStep;
%% Calculate Gain and Background
% Performed in HMM_Track using GainBGCorrectFile PJC 03/19/10
% maxframes=20;
% bg=load([HMM_Data.TreeDir HMM_Data.BGFile]);
% gain=load([HMM_Data.TreeDir HMM_Data.Bead_Gain]);
%
out
=
cal_readnoise(gain.sequence(:,:,0:min([size(gain.sequence,3)
maxframes])),bg.sequence,100,-1,0);
%
% close all
% HMM_Data.BGImage=mean(bg.sequence,[],[3]);
% HMM_Data.CCDGain=out(2);
% clear bg gain
%% Calculate Shift
% align=load([HMM_Data.TreeDir HMM_Data.Bead_Align]);
if sum(HMM_Data.ch_bin) == 1
HMM_Data.tform = [];
else
options=set_im_transformOptions;
options = set_im_transformOptions(options,'meritcutoff',.9);
[ostd,tform]
=
chOverlaySTD([HMM_Data.TreeDir
HMM_Data.Bead_Align],[HMM_Data.TreeDir
HMM_Data.Bead_Align],HMM_Data.ch_bin,options);
% tform = im_transform_gauss(align.trn,options);
% options=set_im_transformOptions(options,'tform');
HMM_Data.tform=tform;
temp = findstr('\',HMM_Data.Bead_Align);
if isempty(temp)
temp=0;
end
saveas(1,[HMM_Data.FigDir HMM_Data.Bead_Align(temp(end)+1:end-4)],'fig')
saveas(1,[HMM_Data.FigDir HMM_Data.Bead_Align(temp(end)+1:end-4)],'png')
saveas(2,[HMM_Data.FigDir HMM_Data.Bead_Align1(temp(end)+1:end-4)],'fig')
saveas(2,[HMM_Data.FigDir HMM_Data.Bead_Align1(temp(end)+1:end-4)],'png')
close all
end
%% Write output
tmp=max(strfind(HMM_Data.DataFile,'\'));
if isempty(tmp) tmp=0; end
tmp=tmp+1;
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save([HMM_Data.SaveDir HMM_Data.DataFile(tmp:end-4) '.HMMData'] , 'HMM_Data');
varargout{1}=HMM_Data;
function varargout = HMM_CreateParams(varargin)
% HMM_CreateParams create HMM_Params file for HMM_Track
%
%
HMM_Params
HMM_CreateParams(GPUSPT_PSF,GPUSPT_Dest,GPUSPT_MinPhotons,...
% GPUSPT_MinTrackLength,GPUSPT_MaxJump,GPUSPT_MaxTimeJump,...
% GPUSPT_Cutoff1,GPUSPT_Cutoff2,GPUSPT_iDiv,CONNECT_MaxJump,...
% CONNECT_MaxTimeJump,CONNECT_Overlap,CONNECT_Cutoff,...
% CONNECT_nstd,HMM_Param_File);
%
% INPUTS
% GPUSPT_PSF - vector of sigmas for all channels. Default [1 1].
%
(psfsigma input for GPUSPT)
% GPUSPT_Dest - estimated diffusion coefficient um^2/s. Default 0.05.
%
(D input for GPUSPT)
% GPUSPT_MinPhotons - vector of min photons allowed for each channel.
%
Default [100 100]. (Ncutoff for GPUSPT)
% GPUSPT_MinTrackLength - minimum number of coordinates for a good track.
%
(goodframes input for GPUSPT)
% GPUSPT_MaxJump - max spatial (pixel) jump between 'on' frames.
%
Default 10. (maxjump input for GPUSPT)
% GPUSPT_MaxTimeJump - maximum allowed 'off' frames. Default 20.
%
(maxTjump input for GPUSPT)
% GPUSPT_Cutoff1 - initial diffusion cutoff. Default 0.1. (diffcutoff1
%
input for GPUSPT)
% GPUSPT_Cutoff2 - secondary diffusion cutoff. Default 0.1. (diffcutoff2
%
input for GPUSPT)
% GPUSPT_iDiv - minimum acceptace of particle for log likelihood value.
%
Default -1. (iDiv input for GPUSPT)
% CONNECT_MaxJump - max spatial (pixel) jump between 'on' frame. Default 10.
%
(maxjump input for connectTracks)
% CONNECT_MaxTimeJump - maximum allowed 'off' frames. Default 40.
%
(maxTjump input for connectTracks)
% CONNECT_Overlap - temporal overlap allowed. Default 5. (overlap input
%
for connectTracks)
% CONNECT_Cutoff - diffusion cutoff. Default 0.01. (input for connectTracks)
% CONNECT_nstd - number of standard deviations to use in connecting
%
tracks. Default 4. (nstd input for connectTracks)
% HMM_Param_File - file in which to save HMM_Params structure.
% OUTPUTS
% HMM_Params - HMM_Params structure. HMM_Params structure also saved in
%
HMM_Param_File
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=

%
% Note: for testing or simple usage HMM_Param_File can be set to [cd
'\Params.HMMParams']
%
% see also GPUSPT, HMM_LinkData, and HMM_Track
%updated by Pat Cutler 4/1/10 for ability to handle 1,2, or 4 ch data
d = struct('menu','HMM',...
'display','HMM Create Parameter Set',...
'inparams',struct('name',{'GPUSPT_PSF','GPUSPT_Dest','GPUSPT_MinPhotons',...
'GPUSPT_MinTrackLength','GPUSPT_MaxJump','GPUSPT_MaxTimeJump','GPUSPT_
Cutoff1',...
'GPUSPT_Cutoff2','GPUSPT_iDiv','CONNECT_MaxJump','CONNECT_MaxTimeJump','
CONNECT_Overlap',...
'CONNECT_Cutoff','CONNECT_nstd','HMM_Param_File'},...
'description',{'GPUSPT_PSF','GPUSPT_Dest','GPUSPT_MinPhotons',...
'GPUSPT_MinTrackLength','GPUSPT_MaxJump','GPUSPT_MaxTimeJump','GPUSPT_
Cutoff1',...
'GPUSPT_Cutoff2','GPUSPT_iDiv','CONNECT_MaxJump','CONNECT_MaxTimeJump','
CONNECT_Overlap',...
'CONNECT_Cutoff','CONNECT_nstd','HMM_Param Output File'},...
'type',
{'array','array','array','array','array','array','array','array',...
'array','array','array','array','array','array','outfile'},...
'dim_check', {{[1 1],[1 2],[1 4]},0,{[1 1],[1 2],[1 4]},0,0,0,0,0,0,0,0,0,0,0,0},...
'range_check',{[],[],[],[],[],[],[],[],[],[],[],[],[],[],'*.HMMParams'},...
'required', {0,0,0,0,0,0,0,0,0,0,0,0,0,0,0},...
'default', {[1 1],.05,[100 100],10,10,20,.1,.1,-1,10,40,5,0.01,4,''}...
),...
'outparams',struct('name',{'HMM_Params'},...
'description',{'HMM Parameter Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
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[GPUSPT_PSF,GPUSPT_Dest,GPUSPT_MinPhotons,...
GPUSPT_MinTrackLength,GPUSPT_MaxJump,GPUSPT_MaxTimeJump,GPUSPT_Cu
toff1,...
GPUSPT_Cutoff2,GPUSPT_iDiv,CONNECT_MaxJump,CONNECT_MaxTimeJump,CO
NNECT_Overlap,...
CONNECT_Cutoff,CONNECT_nstd,HMM_Param_File] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
HMM_Params.GPUSPT_PSF=GPUSPT_PSF;
HMM_Params.GPUSPT_Dest=GPUSPT_Dest;
HMM_Params.GPUSPT_MinPhotons=GPUSPT_MinPhotons;
HMM_Params.GPUSPT_MinTrackLength=GPUSPT_MinTrackLength;
HMM_Params.GPUSPT_MaxJump=GPUSPT_MaxJump;
HMM_Params.GPUSPT_MaxTimeJump=GPUSPT_MaxTimeJump;
HMM_Params.GPUSPT_Cutoff1=GPUSPT_Cutoff1;
HMM_Params.GPUSPT_Cutoff2=GPUSPT_Cutoff2;
HMM_Params.GPUSPT_iDiv=GPUSPT_iDiv;
HMM_Params.CONNECT_MaxJump=CONNECT_MaxJump;
HMM_Params.CONNECT_MaxTimeJump=CONNECT_MaxTimeJump;
HMM_Params.CONNECT_Overlap=CONNECT_Overlap;
HMM_Params.CONNECT_Cutoff=CONNECT_Cutoff;
HMM_Params.CONNECT_nstd=CONNECT_nstd;
save(HMM_Param_File,'HMM_Params');
varargout{1}=HMM_Params;
function varargout = HMM_Track(varargin)
% HMM_TRACK track data in linked in HMM_Data using HMM_Params
%
% HMM_Data = HMM_Track(HMM_DataFile,HMM_ParamsFile);
%
% INPUTS
% HMM_DataFile - name of HMM_Data file. Created using HMM_LinkData
% HMM_ParamsFile - name of HMM_Params file. Created using HMM_CreateParams
% OUTPUTS
% HMM_Data - HMM_Data structure. Data structure also saved in
%
HMM_DataFile
%
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% see also HMM_LinkData and HMM_CreateParams
% updated by Pat Cutler 4/1/10 for ability to handle 1,2, or 4 ch data
% !!!point transformation is no longer performed within this function!!!
% changed by Shalini Low-nam 08/40/2010 so that all HMM functions are
% consistent: transformation done within this function (not done in SPTData
% functions)
d = struct('menu','HMM',...
'display','HMM Track Data',...
'inparams',struct('name',{'HMM_Data','HMM_Params'},...
'description',{'HMM Data File','HMM Parameter File'},...
'type',
{'infile','infile'},...
'dim_check', {0,0},...
'range_check',{'*.HMMData','*.HMMParams'},...
'required', {0,0},...
'default', {'',''}...
),...
'outparams',struct('name',{'HMM_Data'},...
'description',{'Modified HMM Data Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_Data,HMM_Params] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Load, Split and Background, Gain correct
load(HMM_Data,'-mat');
load(HMM_Params,'-mat');
% Usage of GainBGCorrectFile updated PJC 03/19/10
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% rawdata=load([HMM_Data.TreeDir HMM_Data.DataFile]);
%
% try
% bgim=HMM_Data.BGImage;
% catch
% bg=load([HMM_Data.TreeDir HMM_Data.BGFile]);
% bgim=mean(bg.sequence,[],[3]);
% end
% s=GainBGCorrect(rawdata.sequence,bgim,HMM_Data.CCDGain);
if strcmp(HMM_Data.DataConditions,'Sim')
temp=load([HMM_Data.TreeDir HMM_Data.DataFile]);
s=temp.sequence;
clear temp
else
s=
GainBGCorrectFile([HMM_Data.TreeDir
HMM_Data.DataFile],[HMM_Data.TreeDir HMM_Data.Bead_Gain],[HMM_Data.TreeDir
HMM_Data.BGFile]);
end
close all
if length(HMM_Data.ch_bin) == 2
[ch{1},ch{2}] = splitImage(s,5,HMM_Data.ch_bin,0);
else if length(HMM_Data.ch_bin) == 4
[ch{1},ch{2},ch{3},ch{4}] = splitImage4ch(s,5,0);
else
ch{1} = s;
end
end
%% Tracking
HMM_Params;
D=HMM_Params.GPUSPT_Dest;
PSF=HMM_Params.GPUSPT_PSF;
iDiv=HMM_Params.GPUSPT_iDiv;
GF=HMM_Params.GPUSPT_MinTrackLength;
Psz=HMM_Data.PixelSize;
TS=HMM_Data.TimeStep;
MaxJ=HMM_Params.GPUSPT_MaxJump;
MaxTJ=HMM_Params.GPUSPT_MaxTimeJump;
mask=0;
Nc=HMM_Params.GPUSPT_MinPhotons;
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dc1=HMM_Params.GPUSPT_Cutoff1;
dc2=HMM_Params.GPUSPT_Cutoff2;
srange=[.5 1.5];
idx = find(HMM_Data.ch_bin);
for ii = idx
clear GPUgaussMLE connectcoords
disp(['making short tracks ch' num2str(ii)])
%%June 1, 2010; call GPUSPT_sigma to get out sigma at each coordinate
[tracks,intensities,valids,LL,LA,Sigma] = GPUSPT_sigma(ch(Paez et al.),...
D,PSF(ii),HMM_Params.GPUSPT_iDiv,GF,Psz,TS,MaxJ,MaxTJ,mask,Nc(ii),dc1,dc2,sr
ange);
disp(['connecting short tracks ch' num2str(ii)])
[tracks,LA,intensities,Sigma] = connectTracks(tracks,LA,intensities,Sigma,...
HMM_Params.GPUSPT_Dest*HMM_Data.Dconvert,HMM_Data.TimeStep,HMM_Para
ms.CONNECT_MaxJump,...
HMM_Params.CONNECT_MaxTimeJump,HMM_Params.CONNECT_Overlap,...
HMM_Params.CONNECT_Cutoff,HMM_Params.CONNECT_nstd,0);
valids = logical(tracks(:,:,1));
% intensities(~valids) = 0;
% [ch1_tracks,ch1_intensities,ch1_valids,ch1_iDiv,ch1_LA,co1] = GPUSPT(ch1,...
% D,PSF,iDiv,GF,Psz,TS,MaxJ,MaxTJ,mask,Nc,dc1,dc2,srange);
eval(['HMM_Data.raw_ch' num2str(ii) '_tracks=tracks;'])
eval(['HMM_Data.ch' num2str(ii) '_intensities=intensities;'])
eval(['HMM_Data.ch' num2str(ii) '_valids=valids;'])
eval(['HMM_Data.ch' num2str(ii) '_LA=LA;'])
eval(['HMM_Data.ch' num2str(ii) '_sigma=Sigma;'])
% if length(size(LA))==3
%
eval(['HMM_Data.ch' num2str(ii) '_LA=LA(:,:,1);'])
% else
%
eval(['HMM_Data.ch' num2str(ii) '_LA=0;'])
% end
close all
end
plotHMM_Data(HMM_Data,1);
% PSF=HMM_Params.GPUSPT_PSF_R; %%August 4 - What are these?
% Nc=HMM_Params.GPUSPT_MinPhotons_R;
clear GPUgaussMLE connectcoords
% [raw_ch2_tracks,ch2_intensities,ch2_valids,ch2_iDiv,ch2_LA] = GPUSPT(ch2,...
% D,PSF,iDiv,GF,Psz,TS,MaxJ,MaxTJ,mask,Nc,dc1,dc2,srange);
% [ch2_tracks,ch2_intensities,ch2_valids,ch2_iDiv,ch2_LA,co2] = GPUSPT(ch2,...
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%

D,PSF,iDiv,GF,Psz,TS,MaxJ,MaxTJ,mask,Nc,dc1,dc2,srange);

close all
% co1
% co2
% HMM_Data.ch1_tracks=ch1_tracks;
%
% HMM_Data.raw_ch1_tracks=ch1_tracks;
% HMM_Data.ch1_intensities=ch1_intensities;
% HMM_Data.ch1_valids=ch1_valids;
% HMM_Data.ch1_coloroverlay=co1; %Shal
% if length(size(HMM_Data.ch1_LA))==3 %check
% HMM_Data.ch1_LA=HMM_Data.ch1_LA(:,:,1);
% else
% HMM_Data.ch1_LA=0;
% end
for jj=1:size(HMM_Data.raw_ch2_tracks,1)
Rxch2=HMM_Data.raw_ch2_tracks(jj,:,1)';
Rych2=HMM_Data.raw_ch2_tracks(jj,:,2)';
[x y]=point_transform(Rxch2,Rych2,HMM_Data.tform);
x(~HMM_Data.ch2_valids(jj,:)) = 0;
y(~HMM_Data.ch2_valids(jj,:)) = 0;
HMM_Data.shifted_ch2_tracks(jj,:,:)=[x y]; % this might need re-arrangement
end
% HMM_Data.shifted_ch2_tracks=s_ch2_tracks;
% HMM_Data.ch2_intensities=ch2_intensities;
% HMM_Data.ch2_valids=ch2_valids;
%HMM_Data.ch2_coloroverlay=co2; %Shal
% length(size(HMM_Data.ch2_LA)) %check
% pause
% if length(size(HMM_Data.ch2_LA))==3
% HMM_Data.ch2_LA=HMM_Data.ch2_LA(:,:,1);
% else
% HMM_Data.ch2_LA=0;
% end
tmp=max(strfind(HMM_Data.DataFile,'\'));
if isempty(tmp) tmp=0; end
tmp=tmp+1;
save([HMM_Data.SaveDir HMM_Data.DataFile(tmp:end-4) '.HMMData'] , 'HMM_Data');
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varargout{1}=HMM_Data;
function varargout = GPUSPT_sigma(varargin)
%GPUSPT uses fast GPU localization for single particle tracking (output sigma)
%
[tracks,intensities,valids,iDiv,LA,Sigma,coloroverlay]=GPUSPT_sigma(in,D,psfsigma,iDi
v,goodframes,pixelsize,timestep,maxjump,maxTjump,mask)
%
% INPUT:
% in:
3D time series (required)
% D:
Estimated diffusion constant in micron^2/s (default=1)
% psfsigma: 2D Gaussian PSF sigma (default=1)
% iDiv:
Minimum accepted log liklihood value (default=-1)
% goodframes: minimum number of coordinates in a returned track (default=100)
% pixelsize: Linear pixel size in microns (default=1)
% timestep: Timestep in seconds (default=1)
% maxjump: Maximum allowed spatial jump between nearest 'on' frames
% maxTjump: Maximum allowed 'off' frames in a trajectory (default=10)
% mask:
2D binary mask
% Ncutoff
[min_photons max_photons]
% diffcutoff1 initial diffusion cutoff
% diffcutoff2 secondary diffusion cutoff
% sigmarange range of allowed, fitted sigma values default=[0.5 1.5]
% OUTPUT:
% tracks:
Coordinate array in pixels and frames [particle#,time,coords]
% intensities: Estimated emission rate (photons/frame) [particle#,time]
% valids:
[particle#,time]
% iDiv:
[particle#,time]
% LA:
[particle#,time]
% Sigma:
psf for each coordinate [particle#,time]
% coloroverlay: Green:data, Red: found emitters
%
% EXAMPLE:
%
%
% Dependencies:
% GPUgaussMLEFinal
% connectcoords
% GaussianSeries
% cMakeSubregions
% (C) Copyright 2008
Department of Physics and Astonomy
% All rights reserved
University of New Mexico
%
Albuquerque, New Mexico
%
USA
%

184

% Keith Lidke, December 2008
%%Shal, 02.16.2010 to get sigmas at each coordinate
d = struct('menu','Tracking',...
'display','GPU Tracking',...
'inparams',struct('name',{'in','D','psfsigma','iDiv','goodframes','pixelsize','timestep',...
'maxjump','maxTjump','mask','Ncutoff','diffcutoff1','diffcutoff2','sigmarange'},...
'description',{'Input Series (blank for test)','Estimated Diffustion Const.
(um^2/s)','Gausian PSF sigma','iDivergence Threshold',...
'minimum length of track to return','Pixel size (um)','Time step (s)',...
'max allowed jump (pixels)','max allowed time jump (frames)','mask',...
'Min allowed object photons','threshold probablity 1','threshold probablity 2','Sigma
Range'},...
'type',
{'image','array','array','array','array','array','array','array','array','image','array','array','array
','array'},...
'dim_check', {0,0,0,0,0,0,0,0,0,0,0,0,0,-1},...
'range_check',{[],[],[],[],[],[],[],[],[],[],[],[],[],[]},...
'required', {1,0,0,0,0,0,0,0,0,0,0,0,0,0},...
'default', {'',1,1,-1,100,1,1,10,33,'0',50,.01,.001,[0.5 1.5]}...
),...
'outparams',struct('name',{'tracks','intensities','valids','iDiv','LA','Sigma','coloroverlay'},...
'description',{'Found
coordinates','track
intensities','track
validity','iDivergences','Calculated Accurcacies','psf for each coordinate','color
overlay'},...
'type',{'array','array','array','array','array','array','image'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[in,D,psfsigma,iDiv,goodframes,pixelsize,timestep,maxjump,maxTjump,mask,Ncutoff,dif
fcutoff1,diffcutoff2,sigmarange] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
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end
end
clear varargin
if isempty(in)
in=noise(gaussf(noise(newim)>3)*200);
goodframes=1;
end
%% find how may regions
if length(size(in))<3
in=repmat(in,[1 1 1]);
end
fprintf('finding candidates...\n')
tic
x=0;
y=0;
z=0;
s=std(in);
T=size(in,3);
for ii=1:size(in,3)
tmp=in(:,:,ii-1);
tmp=gaussf(tmp,[1 1 0]*psfsigma)-gaussf(tmp,[1 1 0]*2*psfsigma);
tmp=tmp>(.5*s);
msr = measure(squeeze(tmp),squeeze(in(:,:,ii-1)),{'Gravity','Size'},[],1,0,0);
if isempty(msr);continue;end
c=msr.Gravity';
SZmask=(msr.Size>3)';
x=cat(1,x,c(SZmask,1));
y=cat(1,y,c(SZmask,2));
z=cat(1,z,c(SZmask,1)*0+ii-1);
end
x=x(2:end);
y=y(2:end);
z=z(2:end);
toc
%% find coordinates
sz=round(psfsigma*6+1);
fprintf('making subregions...\n')
[in_sub t l]=cMakeSubregions(y,x,z,sz,single(in));
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nt = size(in,3);
if nargout<5
clear in
end
fprintf('fitting subregions...\n')
%clear GPUgaussMLE
[x y N_all bg_all s lax lay li lb ls idiv]=GPUgaussMLE(permute(single(in_sub),[2 1
3]),psfsigma,10,1);
[tmp tmp tmp tmp s]=GPUgaussMLE(permute(single(in_sub),[2 1 3]),psfsigma,10,2);
x=x+l;
y=y+t;
figure;hist(N_all,200)
xlabel('Photons/frame')
ylabel('Counts')
figure;hist(idiv,200)
xlabel('idiv')
ylabel('Counts')
figure;hist(s,200)
xlabel('Sigma')
ylabel('Counts')
clear in_sub
%% Connecting the coordinates
LAcutoff=psfsigma/3;
mask=N_all>Ncutoff;
mask=mask&(idiv>iDiv);
mask=mask&(sigmarange(1)<s);
mask=mask&(sigmarange(2)>s);
mask=mask&(sqrt(lax)<LAcutoff);
mask=mask&(sqrt(lay)<LAcutoff);
mask=mask&( (x-l)>0);
mask=mask&( (x-l)<6*psfsigma+1);
mask=mask&( (y-t)>0);
mask=mask&( (y-t)<6*psfsigma+1);
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x=x(mask);
y=y(mask);
z=z(mask);
n=N_all(mask);
s=s(mask);
merit=idiv(mask);
bg=bg_all(mask);
lax=lax(mask);
lay=lay(mask);
%prepare arrays for connectcoords.c
clear x_arr size_arr y_arr n_arr merit_arr z_arr
zold=1;
size_arr(1)=0;
for nn=1:size(x,1)
if z(nn)+1>zold;
zold=z(nn)+1;
size_arr(zold)=1;
else
size_arr(zold)=size_arr(zold)+1;
end
t=z(nn)+1;
num=size_arr(zold);
x_arr(num,t)=x(nn);
y_arr(num,t)=y(nn);
z_arr(num,t)=z(nn);
n_arr(num,t)=n(nn);
merit_arr(num,t)=merit(nn);
end
fprintf('connecting coordinates...\n')
if exist('x_arr')
% save preConnectcoords
tic
[X Y V M I ID]=connectcoords(double(x_arr),double(y_arr),size_arr,D,...
double(n_arr),double(merit_arr),maxjump,maxTjump,goodframes,diffcutoff1,diffcutoff2);
toc
else
warning('no single molucules found');
varargout{1}=0;
varargout{2}=0;
varargout{3}=0;
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varargout{4}=0;
varargout{5}=0;
varargout{6}=0;
varargout{7}=0;
return
end
%% Identifying connected tracks with found values
clear BG LAx LAy Sigma
BG=zeros(size(X));
LAx=zeros(size(X));
LAy=zeros(size(X));
AN=zeros(size(X));
ABG=zeros(size(X));
Sigma=zeros(size(X));
fprintf('identifying coordinates and matching accuracies...\n')
for nn=1:size(X,1)
for tt=1:size(X,2)
if ID(nn,tt)>0
for jj=1:size(x,1)
if (X(nn,tt)==x(jj))&(Y(nn,tt)==y(jj))
BG(nn,tt)=bg(jj);
LAx(nn,tt)=lax(jj); %these are variances
LAy(nn,tt)=lay(jj); %these are variances
AN(nn,tt)=li(jj);
ABG(nn,tt)=lb(jj);
Sigma=zeros(size(X));
end
end
end
end
end
LA=cat(3,sqrt(LAx+LAy),sqrt(LAx),sqrt(LAy),sqrt(AN),sqrt(ABG));
%% Giving outputs
if size(X,2)<nt
X(:,T)=0;
Y(:,T)=0;
V(:,T)=0;
M(:,T)=0;
I(:,T)=0;
LA(:,T,:)=0;
Sigma(:,T)=0;
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end
c=cat(3,X,Y);
if nargout>6
if exist('I')
fprintf('making color overlay...\n')
gs=dip_image(stretch(GaussianSeries(c,[size(in,1)
size(in,2)],psfsigma,1,I)),'uint8');
rd=dip_image(stretch(in),'uint8');
varargout{6}=joinchannels('RGB',gs,rd);
end
end
varargout{1}=c;
varargout{2}=I;
varargout{3}=V;
varargout{4}=M;
varargout{5}=LA; %these are stds
varargout{6}=Sigma;
fprintf('GPUSPT finished\n')
%%
%% Diffusion Analysis
resdir='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM EGF\';
datapath=resdir;
filestring='*.HMMData';
Files=dir([datapath filestring]);
sigma=1.0720e-001;
inc=0;
deltaT=2;
for jj = 1:length(Files)
filename = Files(jj).name;
load([datapath filename],'-mat');
try
if isfield(HMM_Data,'raw_ch1_tracks')
for hh=1:size(HMM_Data.raw_ch1_tracks,1)
track=HMM_Data.raw_ch1_tracks(hh,:,:);
v=HMM_Data.ch1_valids(hh,:);
for ii=1:deltaT:size(track,2)-deltaT
p1=ii;
p2=ii+deltaT;
x=track(:,:,1);
y=track(:,:,2);
if v(1,p1) && v(1,p2)
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inc=inc+1;
r2(inc) = ((x(:,p1)-x(:,p2))^2) + ((y(:,p1)-y(:,p2))^2);
end
close all
end
clear track v x y p1 p2 sz
end
end
catch
end
end
r2sort=sort(r2,2,'ascend');
rmask=r2sort<4; %This filter could be used to remove jumps of greater than 1.5 pixels
... still a question of why we get these at all
r2sort=r2sort(rmask);
r2_1=size(r2sort,2);
rystep=(1:length(r2sort))/length(r2sort);
save([resdir '\Pr2Results'],'r2','r2sort','rystep');
%Two component fit for all data:
rTCopts=fitoptions('Method','Nonlinear','StartPoint',[.5.2.1],'Lower',[0,0,0],'Upper',[1,10,1
0]);
%Schutz, et al., BJ, V73, 1997:
rTCftype=fittype('1-((a.*exp(-x./b))+((1-a).*exp(x./c)))','options',rTCopts,'coeff',{'a','b','c'},'indep','x','depen','y');
[rTCresults, rTCgoodnessL]=fit((r2sort)',rystep',rTCftype);
rTCc_1=coeffvalues(rTCresults);
rTCalpha_1=rTCc_1(1);
rTCdr1_1=rTCc_1(2);
rTCdr2_1=rTCc_1(3);
rTCrmse_1=rTCgoodnessL.rmse;
rTCFitResult=1-((rTCalpha_1.*exp(-r2sort./rTCdr1_1))+((1-rTCalpha_1).*exp(r2sort./rTCdr2_1)));
rTCDout1_1 = (rTCdr1_1-(4*(sigma^2)))/(4*deltaT);
rTCDout2_1 = (rTCdr2_1-(4*(sigma^2)))/(4*deltaT);
rTCD1um_1 = rTCDout1_1*20*0.267^2;
rTCD2um_1 = rTCDout2_1*20*0.267^2;
%All data plotting
rdTC=figure;
semilogx(squeeze(r2sort),squeeze(rystep),'go')
hold on
semilogx(squeeze(r2sort),rTCFitResult,'--b','LineWidth',2)
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hold off
xlabel('(r^2) (pix)')
ylabel('P(r^2)')
legend('Data','Fit')
title('Two Component Fit for All P(r^2) Data')
hold off
saveas(rdTC,[resdir 'rTCPr2'],'fig');
saveas(rdTC,[resdir 'rTCPr2'],'jpg');
pause(2);
close all
%%
%% HMM Simulations
function varargout = GPUSPT(varargin)
d = struct('menu','HMM',...
'display','HMM Simulation',...
'inparams',struct('name',{'sz','N','T','D','IntDis','Pint','Tau','retrack'},...
'description',{'Region Size','Particles per Channel','Frames',...
'Diffustion Const. (pixels^2/frame)','Interaction Distance','Interaction Probability',...
'Interaction Lifetime','Track Image Data'},...
'type',
{'array','array','array','array','array','array','array','array'},...
'dim_check', {0,0,0,0,0,0,0,0},...
'range_check',{[],[],[],[],[],[],[],[]},...
'required', {0,0,0,0,0,0,0,0},...
'default', {32,10,100,1,.25,.5,20,0}...
),...
'outparams',struct('name',{'Tau_found','Tau_Matrix','LogP','Traj_raw',...
'Traj_noise','Traj_found','im1','im2','coloroverlay'},...
'description',{'Found Lifetime','Calculated Tau_on,Tau_off',...
'Log Probability','Simulated Trajectories','Sim Traj. + noise','Tracked Traj.'...
'image 1','image 2','coloroverlay'},...
'type',{'array','array','array','array','arrray','array','image','image','image'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[sz,N,T,D,IntDis,Pint,Tau,retrack] = getparams(d,varargin{:});
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catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
Pblinkon=.2;
Pblinkoff=.1;
LA=.1;
PSFSigma=1;
[tracks,ntracks,series,I]
=
InteractingParticles(sz,2*N,D,T,'Reflecting',IntDis,1/Tau,Pint,Pblinkon,Pblinkoff,LA,0);
Ltracks=tracks(1:N,:,:);
Rtracks=tracks(N+1:end,:,:);
LI=I(1:N,:);
RI=I(N+1:end,:);
Lt = cGaussianSeries(Ltracks,LI,PSFSigma,sz,sz);
Rt = cGaussianSeries(Rtracks,RI,PSFSigma,sz,sz);
nL=noise(1+Lt*(PSFSigma/LA)^2,'poisson');
nR=noise(1+Rt*(PSFSigma/LA)^2,'poisson');
co=joinchannels('RGB',nL,nR);
%%
clear t1 t2 Lvcell Rvcell sigmas1 sigmas2
t1{1}=Ltracks;
t2{1}=Rtracks;
Lvcell{1}=LI;
Rvcell{1}=RI;
sigmas1{1}=LA*ones(N,T);
sigmas2{1}=LA*ones(N,T);
minpath=10;
L=4;
[X1 X2 Y1 Y2 PairID V1 V2 S1 S2 startframe
Preprocess(t1,t2,Lvcell,Rvcell,sigmas1,sigmas2,minpath,L);

endframe

pairlength]

PMatrix
Pmatrix(X1,X2,Y1,Y2,PairID,V1,V2,S1,S2,startframe,endframe,pairlength,IntDis,L);
%% try plots
dT=10.^(0:.05:3.5);
clear MLarray
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=
=

for Tau_oninc=1:length(dT)
for Tau_offinc=1:length(dT)
Tau_BF_test=dT(Tau_oninc);
Tau_BB_test=dT(Tau_offinc);
[Tau_BF_test Tau_BB_test];
[lnP]=Ponly_PODHMM(PMatrix,Tau_BF_test,Tau_BB_test,L,startframe,endframe);
MLarray(Tau_oninc,Tau_offinc)=lnP;
end
end
[tmp id1]=max(MLarray);
[tmp id2]=max(tmp);
found_Tau_BF=dT(id1(id2))
found_Tau_BB=dT(id2)
figure;semilogx(dT,(MLarray(:,id2)))
xlabel('Tau_{BF}')
figure;semilogx(dT,(MLarray(id1(id2),:)))
xlabel('Tau_{BB}')
hold on
%%
X=repmat(dT',[1 length(dT)]);
Y=repmat(dT,[length(dT) 1]);
figure
mesh(X,Y,exp(MLarray-max(max(MLarray))))
%mesh(X,Y,exp(MLarray))
xlabel('\tau_{on}','fontsize',18)
ylabel('\tau_(Diermeier et al.)','fontsize',18)
zlabel('Normalized Likelihood','fontsize',14)
%axis([0 1000 0 1000 max(max(MLarray))-2 max(max(MLarray))])
set(gca,'Yscale','log')
set(gca,'Xscale','log')
function varargout = HMM_GenSimData(varargin)
d = struct('menu','HMM',...
'display','HMM Simulation',...
'inparams',struct('name',{'OutFile','OutDir','Condition','sz','N','T','D','IntDis','PixelSize','Tim
eStep','Pint','Tau'},...
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'description',{'Output
File','Output
Data
Directory','Condition
ID','Region
Size','Particles per Channel','Frames',...
'Diffustion
Const.
(pixels^2/frame)','Interaction
Distance
(nm)','PixelSize
(microns)','TimeStep (s)','Interaction Probability',...
'Interaction Lifetime'},...
'type',
{'outfile','indir','string','array','array','array','array','array','array','array','array','array'},...
'dim_check', {0,0,0,0,0,0,0,0,0,0,0,0},...
'range_check',{'*.HMMData','*.mat',[],[],[],[],[],[],[],[],[],[]},...
'required', {0,0,0,0,0,0,0,0,0,0,0,0},...
'default', {'','','Sim',64,10,100,.01,30,16/60,.05,.5,20}...
),...
'outparams',struct('name',{'HMM_Data'},...
'description',{'HMM Data Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[OutFile,OutDir,Conditions,sz,N,T,D,IntDis,PixelSize,TimeStep,Pint,Tau]
=
getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Generate Data
Pblinkon=.2;
Pblinkoff=.1;
LA=.1;
PSFSigma=1;
N_Photons=200;
bg=5;
n_sigma=PSFSigma/sqrt(N_Photons);
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%convert to pixels and frames
IntDis=IntDis/1000/PixelSize
D=D/PixelSize^2*TimeStep
[tracks,ntracks,series,I]
=
InteractingParticles(sz,2*N,D,T,'Reflecting',IntDis,1/Tau,Pint,Pblinkon,Pblinkoff,LA,0);
Ltracks=tracks(1:N,:,:);
Rtracks=tracks(N+1:end,:,:);
LI=I(1:N,:);
RI=I(N+1:end,:);
Lt = cGaussianSeries(Ltracks,LI,PSFSigma,sz,sz);
Rt = cGaussianSeries(Rtracks,RI,PSFSigma,sz,sz);
nL=noise(bg+Lt*N_Photons,'poisson');
nR=noise(bg+Rt*N_Photons,'poisson');
%% Save Data
sequence=cat(1,nL,nR);
st=max(findstr(OutFile,'\'))+1;
en=max(findstr(OutFile,'.'))-1;
fn=[OutFile(st:en) '.mat'];
save([OutDir '\' fn],'sequence');
%% Link Data
HMM_Data.TreeDir=[OutDir '\'];
HMM_Data.DataFile=fn;
HMM_Data.BGFile='';
HMM_Data.Bead_Align='';
HMM_Data.SaveDir=[OutDir '\'];
HMM_Data.Bead_Gain='';
HMM_Data.PixelSize=PixelSize;
HMM_Data.TimeStep=TimeStep;
HMM_Data.DataConditions=Conditions;
HMM_Data.ch1_tracks=Ltracks+randn(size(Ltracks))*n_sigma;
HMM_Data.ch1_intensities=LI;
HMM_Data.ch1_valids=LI;
HMM_Data.ch1_LA=ones(N,T)*n_sigma;
HMM_Data.ch2_tracks=Rtracks+randn(size(Ltracks))*n_sigma;
HMM_Data.ch2_intensities=RI;
HMM_Data.ch2_valids=RI;
HMM_Data.ch2_LA=ones(N,T)*n_sigma;
%information included for new tracking functions
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HMM_Data.ch_bin=[1 1];
HMM_Data.Dconvert = 1/PixelSize^2*TimeStep;
HMM_Data.FigDir=[HMM_Data.SaveDir 'figures\'];
%% Calculate Gain and Background
HMM_Data.BGImage=squeeze(sequence(:,:,0)*0);
HMM_Data.CCDGain=1;
%% Calculate Shift
sz=size(sequence);
a=newim(sz(1:2));
a=(4+xx(a))/16==round((4+xx(a))/16)&(4+yy(a))/16==round((4+yy(a))/16);
a=gaussf(a);
a=cat(1,a,a);
a=noise(a*1000)
options=set_im_transformOptions;
options = set_im_transformOptions(options,'meritcutoff',.9);
tform = im_transform_gauss(a,options);
options=set_im_transformOptions(options,'tform');
HMM_Data.tform=tform;
close all
%% Write output
save(OutFile, 'HMM_Data');
varargout{1}=HMM_Data;
%%
%% HMM Analysis
%Using DS values for the lowest lnP result for each condition
%If error: ??? Reference to non-existent field 'shifted_ch2_tracks':
HMM_Data.raw_ch2_tracks=zeros(0,1000,2)
HMM_Data.ch2_intensities=zeros(0,1000)
HMM_Data.ch2_valids=zeros(0,1000)
HMM_Data.ch2_LA=zeros(0,1000)
HMM_Data.ch2_sigma=zeros(0,1000)
HMM_Data.shifted_ch2_tracks=zeros(0,1000,2)
tmp=max(strfind(HMM_Data.DataFile,'\'));
if isempty(tmp) tmp=0; end
tmp=tmp+1;
save([HMM_Data.SaveDir HMM_Data.DataFile(tmp:end-4) '.HMMData'] , 'HMM_Data');
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%%Example: analysis of EGF data, A431 cells
%%2-State HMM analysis of candidate pairs
datadir='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\';
IntDis=100; %nm (overlay error)+(probe separation in a dimer)
L=1; %micron. Analysis is restricted to frames where seperation is less than L
minOLF=10; %frames. Minimum number of overlapping valid frames of two tracks for
inclusion in analysis
minTL=50; %frames. Tracks must have valid points seperated by this value or larger or
are excluded
DC=.5; %duty cycle. Tracks must have a (valid frames)/(track length) ratio greater than
DC
appThresh=.2;%micron Tracks must get this close at least once to be included
minOLT=10; %frames. Minimum number of overlapping frames (valid or invalid) of two
tracks for inclusion in analysis
%%EGF
HMM_PreProcessData = HMM_PreProcess([datadir 'HMM EGF\'],'QD EGF',[datadir
'HMM EGF\EGF.HMMPP'],IntDis,L,minOLF,minTL,DC,minOLT,appThresh);
[Tau_BB,Tau_BF,MLarray]
=
HMM_FindLifetimes([datadir
'HMM
EGF\EGF.HMMPP'],[datadir 'HMM EGF\']);
HMM_PreProcessData = HMM_FindDimers([datadir 'HMM EGF\EGF.HMMPP'],0,0)
HMM_PreProcessData = HMM_LifetimeDist([datadir 'HMM EGF\EGF.HMMPP'],[datadir
'HMM EGF\'])
HMM_PlotCandidates([datadir
'HMM
EGF\EGF.HMMPP'],[datadir
'HMM
EGF\CandidatePairsEGF\'])
function varargout = HMM_PreProcess(varargin)
%Written by Shalini Low-Nam and Keith Lidke
conditions ={'QD EGF','QD Nanobody','QD EGF + PD','QD Nanobody + PD',...
'QD Nanobody + dEGF','QD Nanobody + dEGF + PD','QD EGF + dEGF',...
'QD EGF + dEGF + PD','QD EGF + QD VhH','QD EGF + QD VhH +
PD','Sim','QD625',...
'QD IgE','QD IgE DNP(0.01ug/ml)','QD IgE PP2(10uM)','QD IgE DNP(0.1ug/ml)
PP2(10uM)'};
d = struct('menu','HMM',...
'display','HMM Pre-Process Data',...
'inparams',struct('name',{'HMM_DataDir','DataConditions','OutFile',...
'IntDis','L','MinOverlap','MinPath','DutyCycle','MinTime','D_Thresh'},...
'description',{'HMM DataFile Directory','Data Conditions','OutPutFile',...
'Max Dimer Separation (nm)','Analysis Threshold (microns)','Min Overlapping Valid
Frames',...
'Min Traj Length (frames)','Duty Cycle','Min Overlapping Time (Frames)','Close
Approach Threshold (microns)'},...
'type',
{'indir','option','outfile','array','array','array','array','array','array','array'},...
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'dim_check', {0,0,0,0,0,0,0,0,0,0},...
'range_check',{'*.HMMData',conditions,'*.HMMPP',[],[],[],[],[],[],[]},...
'required', {0,0,0,0,0,0,0,0,0,0},...
'default', {'',conditions{1},'',30,3,10,50,0.5,20,0.2}...
),...
'outparams',struct('name',{'HMM_PreProcessData'},...
'description',{'HMM PreProcessed Data Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_DataDir,DataConditions,OutFile,...
IntDis,L,MinOverlap,MinPath,DutyCycle,MinTime,D_Thresh]
getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Make a list of files to process
f=dir([HMM_DataDir '\*.HMMData']);
Files=[];
cnt=1;
switch DataConditions
case 'All'
for ii=1:size(f,1)
Files(Paez et al.)=f(ii).name;
end
otherwise
for ii=1:size(f,1)
load([HMM_DataDir '\' f(ii).name],'-mat');
if strmatch(HMM_Data.DataConditions,DataConditions,'exact')
Files{cnt}=f(ii).name;
cnt=cnt+1;
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=

end
end
end
if isempty(Files)
warning('no files with that condition are found \n');
varargout{1}=[];
return
end
%% Process Files
Nfiles=size(Files,2);
PMatrix=cell(0,0);
StartFrame=cell(0,0);
EndFrame=cell(0,0);
PairID=cell(0,0);
FileID=cell(0,0);
for nn=1:Nfiles
fprintf('Processing File: %s \n',Files{nn})
load([HMM_DataDir '\' Files{nn}],'-mat');
[PMatrix{nn} StartFrame{nn} EndFrame{nn} PairID{nn}]=PP(HMM_Data,...
DutyCycle,MinTime,L/HMM_Data.PixelSize,MinOverlap,MinPath,IntDis/HMM_Data.Pixe
lSize/1000,D_Thresh/HMM_Data.PixelSize);
FileID{nn}=[HMM_DataDir '\' Files{nn}];
Npairs=size(PMatrix{nn},1);
if isempty(PMatrix{nn})
warning('no interactions found in the following data set:')
[HMM_DataDir '\' Files{nn}]
else
fprintf('Interactions found between : \n')
for nf=1:Npairs
fprintf('ch1: %d ch2: %d \n',PairID{nn}(nf,1), PairID{nn}(nf,2))
end
fprintf('\n')
end
end
HMM_PreProcessData.PMatrix=PMatrix;
HMM_PreProcessData.StartFrame=StartFrame;
HMM_PreProcessData.EndFrame=EndFrame;
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HMM_PreProcessData.PairID=PairID;
HMM_PreProcessData.FileID=FileID;
HMM_PreProcessData.D_Thresh=D_Thresh;
HMM_PreProcessData.IntDis=IntDis/HMM_Data.PixelSize/1000; %in pixels
HMM_PreProcessData.L=L/HMM_Data.PixelSize; %in pixels
HMM_PreProcessData.MinOverlap=MinOverlap;
HMM_PreProcessData.MinPath=MinPath;
HMM_PreProcessData.DutyCycle=DutyCycle;
HMM_PreProcessData.MinTime=MinTime;
save([OutFile],'HMM_PreProcessData');
varargout{1}=HMM_PreProcessData;
end
function
[PMatrix
StartFrame
EndFrame
PairID]=PP(HMM_Data,DutyCycle,MinTime,L,MinOverlap,MinPath,IntDis,D_Thresh)
% this calculates the pmatrix for 1 data set
PMatrix=[];
StartFrame=[];
EndFrame=[];
PairID=[];
FileID=[];
if isfield(HMM_Data,'raw_ch1_tracks')
Nframes=size(HMM_Data.raw_ch1_tracks,2);
t1=HMM_Data.raw_ch1_tracks;
%t2=HMM_Data.ch2_tracks; %changed by SLow-Nam; April 26, 2010, to
%accomodate transformed ch2 tracks
t2=HMM_Data.shifted_ch2_tracks;
v1=HMM_Data.ch1_valids;
v2=HMM_Data.ch2_valids;
s1=HMM_Data.ch1_LA;
s2=HMM_Data.ch2_LA;
%temp hack
v1=logical(t1(:,:,1));
v2=logical(t2(:,:,1));
Ntracks_1=size(t1,1);
Ntracks_2=size(t2,1);
num=1;
for nn1=1:Ntracks_1
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sf1=find(v1(nn1,:),1); %find start frame
ef1=max(find(v1(nn1,:))); %find end frame
if isempty(sf1); continue; end
if (ef1-sf1)<MinTime;continue;end %rule out short tracks
if (sum(v1(nn1,sf1:ef1))/(ef1-sf1))<DutyCycle;continue;end %rule out low duty
cycle tracks
for nn2=1:Ntracks_2
sf2=find(v2(nn2,:),1); %find start frame
ef2=max(find(v2(nn2,:))); %find end frame
if isempty(sf2); continue; end
if (ef2-sf2)<MinTime;continue;end %rule out short tracks
if (sum(v2(nn2,sf2:ef2))/(ef2-sf2))<DutyCycle;continue;end %rule out low duty
cyle tracks
validmask=(v1(nn1,:).*v2(nn2,:))==1;
x1=t1(nn1,:,1);
y1=t1(nn1,:,2);
x2=t2(nn2,:,1);
y2=t2(nn2,:,2);
d=sqrt((x2(validmask)-x1(validmask)).^2+(y2(validmask)-y1(validmask)).^2);
if min(d)> D_Thresh; continue; end %rule out tracks that don't get close enough
if sum(d<L)< MinOverlap; continue; end %rule out tracks that don't overlap
enough
%now find start and end frames of the interaction
dcandidate=sqrt((x1-x2).^2+(y1-y2).^2);
mask=(dcandidate<=L).*validmask;
sf=find(mask,1);
ef=max(find(mask));
T = ef- sf;
if T < MinPath; continue; end %rule out tracks that don't overlap for enough
frames
for tt=sf:ef %loop only startframe:endframe
if v1(nn1,tt) && v2(nn2,tt)
d=sqrt((x1(tt)-x2(tt))^2+(y1(tt)-y2(tt))^2);
if d<=L
%PMatrix(num,tt)=Pbr1r2(x1(tt),x2(tt),y1(tt),y2(tt),max([s1(nn1,tt)
.01]),max([s2(nn2,tt)]),IntDis,L);
PMatrix(num,tt)=P_dimer(x1(tt),x2(tt),y1(tt),y2(tt),max([s1(nn1,tt)
.01]),max([s2(nn2,tt)]),IntDis);
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end
end
end
PairID(num,:)=[nn1,nn2];
StartFrame(num)=sf;
EndFrame(num)=ef;
num=num+1;
end
end
if (~isempty(PMatrix))&(size(PMatrix,2)<Nframes) %gaurantee PMatrix is length of
tracks
PMatrix(end,Nframes)=0;
end
else
warning('No ch1 tracks in this data set')
pause(0.5)
return
end
end
function varargout = HMM_FindLifetimes(varargin)
d = struct('menu','HMM',...
'display','HMM Find Lifetimes',...
'inparams',struct('name',{'HMM_PreProcessFile','OutDir'},...
'description',{'HMM PreProcess File','Output Directory'},...
'type',
{'infile','indir'},...
'dim_check', {0,0},...
'range_check',{'*.HMMPP','*.HMMParams'},...
'required', {0,0},...
'default', {'',''}...
),...
'outparams',struct('name',{'Tau_BB','Tau_BF','MLarray'},...
'description',{'Modified HMM Data Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end

203

end
try
[HMM_PreProcessFile, OutDir] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
load(HMM_PreProcessFile,'-mat');
dT=10.^(0:.1:5);
%dT=10.^(0:.05:3.5);
clear MLarray
for Tau_oninc=1:length(dT)
for Tau_offinc=1:length(dT)
Tau_BF_test=dT(Tau_oninc);
Tau_BB_test=dT(Tau_offinc);
[Tau_BF_test Tau_BB_test];
[lnP]=PODHMM(HMM_PreProcessData,Tau_BF_test,Tau_BB_test);
MLarray(Tau_oninc,Tau_offinc)=lnP;
end
end
[tmp id1]=max(MLarray);
[tmp id2]=max(tmp);
found_Tau_BF=dT(id1(id2))
found_Tau_BB=dT(id2)
figure;semilogx(dT,(MLarray(:,id2)))
xlabel('Tau_{BF}')
figure;semilogx(dT,(MLarray(id1(id2),:)))
xlabel('Tau_{BB}')
hold on
X=repmat(dT',[1 length(dT)]);
Y=repmat(dT,[length(dT) 1]);
%old mesh plotting:
% figure
% mesh(X,Y,exp(MLarray-max(max(MLarray))))
% %mesh(X,Y,exp(MLarray))
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% xlabel('\tau_{on}','fontsize',18)
% ylabel('\tau_(Diermeier et al.)','fontsize',18)
% zlabel('Normalized Likelihood','fontsize',14)
% %axis([0 1000 0 1000 max(max(MLarray))-2 max(max(MLarray))])
% set(gca,'Yscale','log')
% set(gca,'Xscale','log')
figure
surfc(X,Y,exp(MLarray-max(max(MLarray))))
set(gca,'zdir','reverse')
%colormap bone
axis([0 1000 0 1000 -0.1 1])
xlabel('\tau_{on}','fontsize',18)
ylabel('\tau_(Diermeier et al.)','fontsize',18)
zlabel('Normalized Likelihood','fontsize',14)
%axis([0 1000 0 1000 max(max(MLarray))-2 max(max(MLarray))])
set(gca,'Yscale','log')
set(gca,'Xscale','log')
HMM_PreProcessData.found_Tau_BB=found_Tau_BB;
HMM_PreProcessData.found_Tau_BF=found_Tau_BF;
HMM_PreProcessData.MLarray=MLarray;
%save(HMM_PreProcessFile,'-mat');
save(HMM_PreProcessFile,'HMM_PreProcessData')
varargout{1}=found_Tau_BB;
varargout{2}=found_Tau_BF;
varargout{3}=MLarray;
function lnP=PODHMM(HMM_PreProcessData,Tau_BF,Tau_BB)
N=size(HMM_PreProcessData.PMatrix,2); %Number of files to analyze
RegionSize=HMM_PreProcessData.L;
lnP=0;
for ii=1:N
%fprintf ('Analyzing file %d of %d \n',ii,N)
pm_all=HMM_PreProcessData.PMatrix(Paez et al.);
for pp=1:size(pm_all,1) %pairs in file
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pm=pm_all(pp,:);
validframes=find(pm)';
Frames=size(validframes,1); %valid time frames.
if ~Frames;continue;end
clear f alpha;
alpha=1;
f=zeros([2 Frames]);
f(:,1)=[1-pm(1) pm(1)];
alpha=zeros([1 Frames]);
P=zeros(2,2);
for ttid=2:Frames
tt=validframes(ttid);
frame=validframes(ttid);
pframe=validframes(ttid-1);
deltat=frame-pframe;
P(1,1)=1-pm(tt);
P(2,2)=pm(tt);
HMM(1,1)=1-(1-exp(-deltat/Tau_BF)); %free to free
HMM(2,1)=(1-exp(-deltat/Tau_BF)); %free to bound
HMM(1,2)=(1-exp(-deltat/Tau_BB)); %bound to free
HMM(2,2)=exp(-deltat/Tau_BB);
%bound to bound
T_DHMM=P*HMM;
tmp=T_DHMM*f(:,ttid-1);
alpha(ttid)=sum(sum(tmp));
f(:,ttid)=tmp/alpha(ttid);
end
lnP=lnP+sum(sum(log(alpha(2:end-2))));
end
end
function varargout = HMM_FindDimers(varargin)
d = struct('menu','HMM',...
'display','HMM Find Dimers',...
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'inparams',struct('name',{'HMM_PreProcessFile','Tau_BB','Tau_BF'},...
'description',{'HMM PreProcess File','Tau off (0 for HMMPP value)','Tau on (0 for
HMMPP value)'},...
'type',
{'infile','array','array'},...
'dim_check', {0,0,0},...
'range_check',{'*.HMMPP',[],[]},...
'required', {0,0,0},...
'default', {'',0,0}...
),...
'outparams',struct('name',{'HMM_PreProcessData'},...
'description',{'HMM_PreProcessData Structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_PreProcessFile,Tau_BB,Tau_BF] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
load(HMM_PreProcessFile,'-mat');
N=size(HMM_PreProcessData.PMatrix,2); %Number of files to analyze
if ~(Tau_BB)
Tau_BB=HMM_PreProcessData.found_Tau_BB;
end
if ~(Tau_BF)
Tau_BF=HMM_PreProcessData.found_Tau_BF;
end
Nstates=2; %(free, bound)
for ii=1:N %loop over files
%fprintf ('Analyzing file %d of %d \n',ii,N)
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pm_all=HMM_PreProcessData.PMatrix(Paez et al.);
States=zeros(size(pm_all,1),size(pm_all,2));
Pout=0;
for pp=1:size(pm_all,1) %pairs in file
pm=pm_all(pp,:);
validframes=find(pm)';
Frames=size(validframes,1); %valid time frames
if ~Frames;continue;end
clear Traj
Traj(:,1)=(0:Nstates-1); %state space trajectory, grows to Nstates*T
P_old=ones(Nstates,1);
for ttid=2:Frames
tt=validframes(ttid);
frame=validframes(ttid);
pframe=validframes(ttid-1);
deltat=frame-pframe;
P(1,1)=1-pm(tt);
P(2,1)=pm(tt);
HMM(1,1)=1-(1-exp(-deltat/Tau_BF)); %free to free
HMM(2,1)=(1-exp(-deltat/Tau_BF)); %free to bound
HMM(1,2)=(1-exp(-deltat/Tau_BB)); %bound to free
HMM(2,2)=exp(-deltat/Tau_BB);
%bound to bound
tmpTraj=Traj;
for ss=0:Nstates-1 %looping over states at time t (current states)
tmp=P_old.*HMM(:,ss+1).*P;
[Ptmp id]=max(tmp);
P_new(ss+1,1)=Ptmp;
tmpTraj(ss+1,1:ttid-1)=Traj(id,:);
tmpTraj(ss+1,ttid)=id-1;
end
Traj=tmpTraj;
P_old=P_new;
end
[Pout(pp) id]=max(P_old);
States(pp,logical(pm))=Traj(id,:);
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end
StateMatrix(Paez et al.)=States;
PViterbi(Paez et al.)=Pout;
end
HMM_PreProcessData.StateMatrix=StateMatrix;
HMM_PreProcessData.PViterbi=PViterbi;
varargout{1}=HMM_PreProcessData;
save(HMM_PreProcessFile,'-mat');
function varargout = HMM_LifetimeDist(varargin)
d = struct('menu','HMM',...
'display','HMM Lifetime Distributions',...
'inparams',struct('name',{'HMM_PreProcessFile','Out_Dir'},...
'description',{'HMM PreProcess File','Output Directory'},...
'type',
{'infile','indir'},...
'dim_check', {0,0},...
'range_check',{'*.HMMPP','*.*'},...
'required', {0,0},...
'default', {'',''}...
),...
'outparams',struct('name',{'HMM_PreProcessData'},...
'description',{'HMM_PreProcessData structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_PreProcessFile,OutDir] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
load(HMM_PreProcessFile,'-mat');
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tmp=max(strfind(HMM_PreProcessFile,'\'));
fnbase=HMM_PreProcessFile(tmp+1:end-6);
SM=HMM_PreProcessData.StateMatrix;
Nfiles=size(SM,2);
cnt=1;
for nf=1:Nfiles
sm=SM(Lund et al.);
pm=HMM_PreProcessData.PMatrix(Lund et al.);
shf=zeros([size(pm,1) size(pm,2)]); %create matrix for state with holes filled
for nn=1:size(pm,1)
s=sm(nn,:);
if (sum(s))==0;continue;end
v=logical(pm(nn,:));
state=0;
for tt=1:max(find(v))
if v(tt)&(s(tt))&(~state);sf=tt;end %this is the start of a dimer
if (v(tt)&(~s(tt))&state)|((tt==max(find(v)))&state) %dimer ends at this condition
StateLength(cnt,1)=tt-sf; %lifetime
StateLength(cnt,2)=nf;%File ID
StateLength(cnt,3:4)=HMM_PreProcessData.PairID(Lund et al.)(1,:);
cnt=cnt+1;
end
if v(tt);state=s(tt);end
shf(nn,tt)=state;
end
end
if sum(sum(shf));%dipshow(shf)
%joinchannels('RGB',shf,sm)
end
FilledStates(Lund et al.)=shf;
end
if cnt==1
StateLength=[];
else
[Thist Thistbins]=hist(StateLength(:,1),20)
%%find fits to histogram
%changed 06.17.10 by Shal to accomodate no interactions found
f_Atau=inline('mse(data,x(1)*exp(-t/x(2)))','x','t','data');
f_A=inline('mse(data,x(1)*exp(-t/tau))','x','t','tau','data');
options=optimset('display','off');
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X0=[Thist(1) Thistbins(end)/2]';
Atau=fminsearch(f_Atau,X0,options,Thistbins,Thist);
X0=[Thist(1)];
t_hmm=HMM_PreProcessData.found_Tau_BB;
A=fminsearch(f_A,X0,options,Thistbins,t_hmm,Thist);
model_fithist=Atau(1)*exp(-Thistbins/Atau(2));
model_hmm=A*exp(-Thistbins/t_hmm);
h=figure
bar(Thistbins,Thist,'k','linewidth', 2)
hold on
plot(Thistbins,model_fithist,'r','linewidth',2)
plot(Thistbins,model_hmm,'g','linewidth',2)
xlabel('Dimer Event Lifetime (frames)','Fontsize', 16)
ylabel('Number of Events','Fontsize',16)
s1=sprintf('Fit to Histogram. tau=%g frames',Atau(2))
s2=sprintf('HMM Model. tau=%g frames',t_hmm)
legend({'Data',s1,s2})
title(fnbase)
saveas(h, [OutDir '\' fnbase '_LifetimeDist.jpg'], 'jpg');
end
%% save back to file
HMM_PreProcessData.FilledStates=FilledStates;
HMM_PreProcessData.StateLength=StateLength;
save(HMM_PreProcessFile,'HMM_PreProcessData');
varargout{1}=HMM_PreProcessData;
function varargout = HMM_PlotCandidates_test(varargin)
%HMM_PlotCandidates(preprocessfile,resdir)
%This function will take the HMM_PreProcess files (of the type *.HMMPP) and make
3D trajectory
%plot and separation distance plot of the candidate pairs.
%Images will be saved (to directory 'resdir') to view later.
%
%written by Diane Lidke and Shalini Low-Nam
%April 15, 2010
%
%Example call of this function:
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%HMM_PlotCandidates('Z:\Shal\EGFDimerExamples\test.HMMPP','Z:\Shal\EGFDimer
Examples\CandidatePairs\');
%%Setup for DIPimage menu
d = struct('menu','HMM',...
'display','HMM Plot Candidates',...
'inparams',struct('name',{'HMM_DataFile','Out_Dir'},...
'description',{'HMM PreProcess File','Output Directory'},...
'type',
{'infile','indir'},...
'dim_check', {0,0},...
'range_check',{'*.HMMPP','*.*'},...
'required', {0,0},...
'default', {'',''}...
),...
'outparams',struct('name',{'tracklengths','ratios'},...
'description',{'Track Lengths','Ratios'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_PreProcessFile,OutDir] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Load PreProcess file and make ResultsDir
HMM_PreProcessFile=varargin{1};
load(HMM_PreProcessFile,'-mat');
resdir=OutDir;
mkdir(resdir);
numfile=size(HMM_PreProcessData.FileID, 2);
%% 3D plot of all tracks in ch1(r) and ch2(g)
%plot candidate pairs 3D trajectory + label
%ch = red, QD655; ch2 = green, QD585
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sz=0;
for hh=1:numfile %loop through each file
tmp=max(strfind(HMM_PreProcessData.FileID{hh},'\'));
fname = HMM_PreProcessData.FileID{hh};
load([fname],'-mat');
basename=fname(tmp+1:end-8);
h(1,3) = figure;
ah = gca;
pair=HMM_PreProcessData.PairID{hh};
numpairs=size(pair,1);
d=zeros(numpairs,1000);
state=HMM_PreProcessData.StateMatrix{hh};
dimer=HMM_PreProcessData.FilledStates{hh};
for ii=1:numpairs %size(ch,1)
ch1spot=pair(ii,1);
ch2spot=pair(ii,2); %%THERE NEEDS TO BE A CHECK FOR SHIFTED
TRACKS!!
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
s1=logical(xch1(:,:)); %find the valid points of trajectory 1
tmps1=find(s1,1); %start of trajectory 1
tmpe1=max(find(s1)); %end of trajectory 1
l1=tmpe1-tmps1+1; %length of trajectory 1
xch2=HMM_Data.shifted_ch2_tracks(ch2spot,:,1);
ych2=HMM_Data.shifted_ch2_tracks(ch2spot,:,2);
%
xch2=HMM_Data.ch2_tracks(ch2spot,:,1);
%
ych2=HMM_Data.ch2_tracks(ch2spot,:,2);
s2=logical(xch2(:,:)); %find the valid points of trajectory 2
tmps2=find(s2,1); %start of trajectory 2
tmpe2=max(find(s2)); %end of trajectory 2
l2=tmpe2-tmps2+1; %length of trajectory 2
intensities1(ii,:)=HMM_Data.ch1_intensities(ch1spot,:); %For bleedthrough check
intensities2(ii,:)=HMM_Data.ch2_intensities(ch2spot,:);
valid=dimer(ii,:); %valids of when dimer
hsvline(squeeze(xch1),squeeze(ych1),HMM_Data.TimeStep,h(1,3),2,1,[],[],[],[],[1 0
0],[],[],1);
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hold on
hsvline(squeeze(xch2),squeeze(ych2),HMM_Data.TimeStep,h(1,3),2,1,[],[],[],[],[0 1
0],[],[],1);
hold on
xlabel('X Coordinate')
ylabel('Y Coordinate')
zlabel('Time (s)')
if sum(state(ii,:))>0
dimerextent=sum(dimer(ii,:));
sz=sz+1;
tracklengths(sz,:)=[hh pair(ii,1) pair(ii,2) l1 l2 dimerextent];
hsvline(squeeze(xch1).*valid,squeeze(ych1).*valid,HMM_Data.TimeStep,h(1,3),2,1,1.5,[
],[],[],[1 0 0]*.3,[],'o',1);
hold on
hsvline(squeeze(xch2).*valid,squeeze(ych2).*valid,HMM_Data.TimeStep,h(1,3),2,1,1.5,[
],[],[],[0 1 0]*.3,[],'d',1); %.*logical(state(ii,:))
hold on
set(findall(allchild(gca),'type','line'),'markersize',0.3)
else
hold on
end
text(xch1(find(logical(xch1),1)),...
ych1(find(logical(ych1),1)),...
find(logical(xch1),1)*HMM_Data.TimeStep,num2str(ch1spot));
text(xch2(find(logical(xch2),1)),...
ych2(find(logical(ych2),1)),...
find(logical(xch2),1)*HMM_Data.TimeStep,num2str(ch2spot));
axis tight
end
hold off
title(basename)
axis tight
saveas(h(1,3),[resdir basename '_3D' ],'fig');
for nn=1:numpairs %Focal Drift Plots with State
ch1spot=pair(nn,1);
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ch2spot=pair(nn,2);
figure
trace=dimer(nn,:);
x1=[0.05:.05:50];
y1=trace;
hl1 = line(x1,y1,'Color',[0 1 0]*0.6,'linewidth',5);
ax1 = gca;
set(ax1,'XColor',[0 1 0]*0.3,'YColor',[0 1 0]*0.3);
axis([0 50 0 1.05]);
xlabel('Time (s)')
ylabel('State')
sigma1=HMM_Data.ch1_sigma(ch1spot,:);
sigma2=HMM_Data.ch2_sigma(ch2spot,:);
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
ylabel('Sigma (\mu m)')
x2=[0.05:.05:50];
y2=sigma1;
z2=sigma2;
svalids1=logical(sigma1);
svalids2=logical(sigma2);
hl2 = line(x2(svalids1),y2(svalids1).*0.267,'Color','r','Parent',ax2,'linewidth',0.7);
hl3 = line(x2(svalids2),z2(svalids2).*0.267,'Color','g','Parent',ax2,'linewidth',0.7);
hold off
title('Sigmas of found dimers');
saveas(gcf, [resdir basename '_Sigma_ch1_' num2str(ch1spot) '_ch2_'
num2str(ch2spot)], 'jpg');
close all
clear trace
end
for mm=1:numpairs %Focal Drift Plots with Distance
ch1spot=pair(mm,1);
ch2spot=pair(mm,2);
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
xch2=HMM_Data.shifted_ch2_tracks(ch2spot,:,1);
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ych2=HMM_Data.shifted_ch2_tracks(ch2spot,:,2);
%
xch2=HMM_Data.ch2_tracks(ch2spot,:,1);
%
ych2=HMM_Data.ch2_tracks(ch2spot,:,2);
figure
d(mm,:)=sqrt((xch1-xch2).^2+(ych1-ych2).^2).*logical(xch1).*logical(xch2);
d=(d(mm,:).*0.267);
x1=[0.05:.05:50];
y1=d;
dvalids=logical(d);
hl1 = line(x1(dvalids),y1(dvalids),'Color','b','linewidth',1);
ax1 = gca;
set(ax1,'XColor',[0 0 1],'YColor',[0 0 1]);
axis([0 50 0 1.5]);
xlabel('Time (s)')
ylabel('Distance (\mu m)')
hold on
sigma1=HMM_Data.ch1_sigma(ch1spot,:);
sigma2=HMM_Data.ch2_sigma(ch2spot,:);
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
%axis([0 50 0 1.5]);
ylabel('Sigma (\mu m)')
x2=[0.05:.05:50];
y2=sigma1;
z2=sigma2;
svalids1=logical(sigma1);
svalids2=logical(sigma2);
hl2 = line(x2(svalids1),y2(svalids1).*0.267,'Color','r','Parent',ax2,'linewidth',0.7);
hl3 = line(x2(svalids2),z2(svalids2).*0.267,'Color','g','Parent',ax2,'linewidth',0.7);
hold off
title('Sigmas and Distance');
saveas(gcf, [resdir basename '_Sigma_and_Distance_ch1_' num2str(ch1spot)
'_ch2_' num2str(ch2spot)], 'fig');
close all
end
for nn=1:numpairs %Distance Plots
ch1spot=pair(nn,1);
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ch2spot=pair(nn,2); %%THERE NEEDS TO BE A CHECK FOR SHIFTED
TRACKS!!
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
%
xch2=HMM_Data.ch2_tracks(ch2spot,:,1);
%
ych2=HMM_Data.ch2_tracks(ch2spot,:,2);
xch2=HMM_Data.shifted_ch2_tracks(ch2spot,:,1);
ych2=HMM_Data.shifted_ch2_tracks(ch2spot,:,2);
figure
trace=dimer(nn,:);
x1=[0.05:.05:50];
y1=trace;
hl1 = line(x1,y1,'Color',[0 1 0]*0.6,'linewidth',5);
ax1 = gca;
set(ax1,'XColor',[0 1 0]*0.3,'YColor',[0 1 0]*0.3);
axis([0 50 0 1.05]);
xlabel('Time (s)')
ylabel('State')
d(nn,:)=sqrt((xch1-xch2).^2+(ych1-ych2).^2).*logical(xch1).*logical(xch2);
d=(d(nn,:).*0.267);
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
ylabel('Distance (\mu m)')
x2=[0.05:.05:50];
y2=d;
dvalids=logical(d);
hl2 = line(x2(dvalids),y2(dvalids),'Color','b','Parent',ax2,'linewidth',1);
hold on
ID=0.1; %a horizontal line for the specified interaction distance
line([0.05;50],[ID;ID],'Color','m','linewidth',0.3,'LineStyle','--')
hold off
title('Distance between QDs of found dimers');
saveas(gcf,
[resdir
num2str(ch2spot)], 'jpg');
close all

basename

'_D_ch1_'
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num2str(ch1spot)

'_ch2_'

clear trace
end
% for ff=1:numpairs %Intensity plots to check for bleedthrough
% (simultaneous blinking)
%
ch1spot=pair(ff,1);
%
ch2spot=pair(ff,2);
%
figure
%
plot(intensities1(ff,:),'color',[1 0 0],'linewidth',1)
%
hold on
%
plot(intensities2(ff,:),'color',[0 1 0],'linewidth',1)
%
xlabel('Frame number')
%
ylabel('Intensity')
%
saveas(gcf, [resdir basename 'Intensities_ch1_' num2str(ch1spot) '_ch2_'
num2str(ch2spot)], 'jpg');
%
close all
% end
for ll=1:numpairs %Localization accuracy plots
ch1spot=pair(ll,1);
ch2spot=pair(ll,2);
LA1=HMM_Data.ch1_LA(ch1spot,:);
LA2=HMM_Data.ch2_LA(ch2spot,:);
figure
plot(LA1(logical(LA1))*0.267,'color',[1 0 0],'linewidth',1)
hold on
plot(LA2(logical(LA2))*0.267,'color',[0 1 0],'linewidth',1)
xlabel('Frame number')
ylabel('Localization Accuracy (\mu m)')
title('Localization Accuracy of Candidate Trajectories');
saveas(gcf,
[resdir
basename
'_LA_ch1_'
num2str(ch1spot)
num2str(ch2spot)], 'jpg');
close all
end
for pp=1:numpairs %P Matrix with Filled States
ch1spot=pair(pp,1);
ch2spot=pair(pp,2);
P=HMM_PreProcessData.PMatrix{hh};
figure
trace=dimer(pp,:);
x1=[0.05:.05:50];
y1=trace;
hl1 = line(x1,y1,'Color',[0 1 0]*0.6,'linewidth',5);
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ax1 = gca;
set(ax1,'XColor',[0 1 0]*0.3,'YColor',[0 1 0]*0.3)
axis([0 50 0 1.05]);
xlabel('Time (s)')
ylabel('State')
x2=[0.05:.05:50];
y2=P(pp,:);
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
hl2
=
line(x2(logical(y2)),y2(logical(y2)),'Color',[0
1]*0.8,'Parent',ax2,'linewidth',0.9);
ylabel('Probability')
title('Probability of found interactions');
saveas(gcf, [resdir basename '_PMatrix_ch1_' num2str(ch1spot)
num2str(ch2spot)], 'jpg');
close all
clear trace
end
clear tmp d fname basename
end
%%determine ratios of dimer duration to track length
if exist('tracklengths')
ratio=zeros(size(tracklengths,1),4);
for rr=1:size(tracklengths,1)
pair1(rr)=tracklengths(rr,2);
pair2(rr)=tracklengths(rr,3);
ratio1(rr)=(tracklengths(rr,6)/tracklengths(rr,4))*100;
ratio2(rr)=(tracklengths(rr,6)/tracklengths(rr,5))*100;
ratio(rr,:)=[pair1(rr) pair2(rr) ratio1(rr) ratio2(rr)];
clear pair1 pair2 ratio1 ratio2
end
end
try
varargout{1}=tracklengths;
varargout{2}=ratio;
save([resdir 'CandidateTrackLengths.mat'],'tracklengths','ratio');
catch
end
%%3-State HMM analysis of candidate pairs
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% datadir='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\';
% IntDis=50; %nm (overlay error)+(probe separation in a dimer)
% L=1; %micron. Analysis is restricted to frames where separation is less than L
% DomainSize=250; %nm based on observation of excursion-and-return distance
% minOLF=10; %frames. Minimum number of overlapping valid frames of two tracks for
inclusion in analysis
% minTL=50; %frames. Tracks must have valid points separated by this value or larger
or are excluded
% DC=.5; %duty cycle. Tracks must have a (valid frames)/(track length) ratio greater
than DC
% appThresh=.2;%micron Tracks must get this close at least once to be included
% minOLT=10; %frames. Minimum number of overlapping frames (valid or invalid) of
two tracks for inclusion in analysis
%%EGF
for DS=150
for ID=50
datadir='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\';
L=1; %micron. Analysis is restricted to frames where separation is less than L
minOLF=10; %frames. Minimum number of overlapping valid frames of two tracks
for inclusion in analysis
minTL=50; %frames. Tracks must have valid points separated by this value or
larger or are excluded
DC=.5; %duty cycle. Tracks must have a (valid frames)/(track length) ratio greater
than DC
appThresh=.2;%micron Tracks must get this close at least once to be included
minOLT=10; %frames. Minimum number of overlapping frames (valid or invalid) of
two tracks for inclusion in analysis
HMM_PreProcessData = HMM_PreProcessStates([datadir 'HMM EGF\'],'QD
EGF',[datadir 'HMM EGF\EGF_3state_DD' num2str(DS) 'nm_ID' num2str(ID)
'nm.HMMPP'],ID,DS,L,minOLF,minTL,DC,minOLT,appThresh);
[HMM_PreProcessData K_found K_found_err] = HMM_FindRates([datadir 'HMM
EGF\EGF_3state_DD' num2str(DS) 'nm_ID' num2str(ID) 'nm.HMMPP']);
clear HMM_PreProcessData
end
end
HMM_PreProcessData = HMM_FindStates([datadir 'HMM EGF\EGF_3state_DD'
num2str(DS) 'nm_ID' num2str(ID) 'nm.HMMPP']);
HMM_PreProcessData = HMM_StatesDist([datadir 'HMM EGF\EGF_3state_DD'
num2str(DS) 'nm_ID' num2str(ID) 'nm.HMMPP'],[datadir 'HMM EGF\EGF_3state_DD'
num2str(DS) 'nm_ID' num2str(ID) 'nm.HMMPP']);
HMM_PlotCandidates_3state([datadir 'HMM EGF\EGF_3state_DD' num2str(DS)
'nm_ID'
num2str(ID)
'nm.HMMPP'],[datadir
'HMM
EGF\CandidatePlotsFinalTest_3state_DD' num2str(DS) 'nm_ID' num2str(ID) 'nm\'],1)
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datapath='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM UNM HeLa
EGF\';
ppfilestring='EGF_3state_DD150nm_ID50nm.HMMPP';
resdir=datapath;
HMM_StatesHist(datapath,ppfilestring,resdir)
clear
uiopen('Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM UNM HeLa
EGF\EGF_3state_DD150nm_ID50nm.HMMPP',1)
EGF=HMM_PreProcessData.StateLength;
EGF=sort(EGF); %if there are events of 50 s, extra line needed
EGF=EGF./20;
edges=0:1:50;
N_EGF=histc(EGF,edges)
figure; bar(N_EGF,'b');
function varargout = HMM_PreProcessStates(varargin)
conditions ={'QD EGF','QD Nanobody','QD EGF + PD','QD Nanobody + PD',...
'QD Nanobody + dEGF','QD Nanobody + dEGF + PD','All','QD EGF + QD VhH',...
'QD Neu','QD rH','QD IgE','QD IgE DNP(0.01ug/ml)','QD IgE PP2(10uM)',...
'QD IgE DNP(0.1ug/ml) PP2(10uM)','QD IgE + DNP(1ug/ml)','QD IgE DNP(1ug/ml)',...
'QD IgE + DNP(0.01ug/ml)','QD IgE DNP(0.01ug/ml)','QD IgE + DNP(0.1ug/ml)',...
'QD IgE DNP(0.1ug/ml)','QD IgE + DNP(0.01ug/ml) PP2(10uM)','QD IgE +
DNP(0.1ug/ml) PP2(10uM)',...
'QD IgE DNP(0.01ug/ml) PP2(10uM)','QD rH + QD EGF','QD rH + QD EGF + PD','QD
Neu + Lap30min'};
d = struct('menu','HMM',...
'display','HMM Pre-Process Data',...
'inparams',struct('name',{'HMM_DataDir','DataConditions','OutFile',...
'IntDis','DomainSize','L','MinOverlap','MinPath','DutyCycle','MinTime','D_Thresh'},...
'description',{'HMM DataFile Directory','Data Conditions','OutPutFile',...
'Max Dimer Separation (nm)','Domain Size (nm)','Analysis Threshold (microns)','Min
Overlapping Valid Frames',...
'Min Traj Length (frames)','Duty Cycle','Min Overlapping Time (Frames)','Close
Approach Threshold (microns)'},...
'type',
{'indir','option','outfile','array','array','array','array','array','array','array','array'},...
'dim_check', {0,0,0,0,0,0,0,0,0,0,0},...
'range_check',{'*.HMMData',conditions,'*.HMMPP',[],[],[],[],[],[],[],[]},...
'required', {0,0,0,0,0,0,0,0,0,0,0},...
'default', {'',conditions{1},'',30,100,3,10,50,0.5,20,0.2}...
),...
'outparams',struct('name',{'HMM_PreProcessData'},...
'description',{'HMM PreProcessed Data Structure'},...
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'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_DataDir,DataConditions,OutFile,...
IntDis,DomainSize,L,MinOverlap,MinPath,DutyCycle,MinTime,D_Thresh]
getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Make a list of files to process
f=dir([HMM_DataDir '\*.HMMData']);
Files=[];
cnt=1;
switch DataConditions
case 'All'
for ii=1:size(f,1)
Files(Paez et al.)=f(ii).name;
end
otherwise
for ii=1:size(f,1)
load([HMM_DataDir '\' f(ii).name],'-mat');
if strmatch(HMM_Data.DataConditions,DataConditions,'exact')
Files{cnt}=f(ii).name;
cnt=cnt+1;
end
end
end
if isempty(Files)
warning('no files with that condition are found \n');
varargout{1}=[];
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return
end
%% Process Files
Nfiles=size(Files,2);
StartFrame=cell(0,0);
EndFrame=cell(0,0);
PairID=cell(0,0);
FileID=cell(0,0);
for nn=1:Nfiles
fprintf('Processing File: %s \n',Files{nn})
load([HMM_DataDir '\' Files{nn}],'-mat');
if isfield(HMM_Data,'raw_ch1_tracks')
[P_states{nn}
V_states{nn}
StartFrame{nn}
EndFrame{nn}
PairID{nn}]=PP(HMM_Data,...
DutyCycle,MinTime,L/HMM_Data.PixelSize,MinOverlap,MinPath,...
IntDis/HMM_Data.PixelSize/1000,DomainSize/HMM_Data.PixelSize/1000,D_Thresh/H
MM_Data.PixelSize);
FileID{nn}=[HMM_DataDir '\' Files{nn}];
Npairs=size(P_states{nn},3);
if isempty(P_states{nn})
warning('no interactions found in the following data set:')
[HMM_DataDir '\' Files{nn}]
else
fprintf('Interactions found between : \n')
for nf=1:Npairs
fprintf('ch1: %d ch2: %d \n',PairID{nn}(nf,1), PairID{nn}(nf,2))
end
fprintf('\n')
end
else
warning('no trajectories in data set')
continue
end
end
HMM_PreProcessData.StartFrame=StartFrame;
HMM_PreProcessData.EndFrame=EndFrame;
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HMM_PreProcessData.PairID=PairID;
HMM_PreProcessData.FileID=FileID;
HMM_PreProcessData.D_Thresh=D_Thresh;
HMM_PreProcessData.IntDis=IntDis/HMM_Data.PixelSize/1000; %in pixels
HMM_PreProcessData.L=L/HMM_Data.PixelSize; %in pixels
HMM_PreProcessData.MinOverlap=MinOverlap;
HMM_PreProcessData.MinPath=MinPath;
HMM_PreProcessData.DutyCycle=DutyCycle;
HMM_PreProcessData.MinTime=MinTime;
HMM_PreProcessData.Nstates=3;
HMM_PreProcessData.P_states=P_states;
HMM_PreProcessData.V_states=V_states;
HMM_PreProcessData.DomainSize=DomainSize/HMM_Data.PixelSize/1000;
pixels

%in

save([OutFile],'HMM_PreProcessData');
varargout{1}=HMM_PreProcessData;
end
function
[P
Vout
StartFrame
EndFrame
PairID]=PP(HMM_Data,DutyCycle,MinTime,L,MinOverlap,MinPath,IntDis,DomainSize,D
_Thresh)
%Written by Shalini Low-Nam and Keith Lidke
%this calculates the pmatrix for 1 data set
P=[];
Vout=[];
StartFrame=[];
EndFrame=[];
PairID=[];
FileID=[];
Nframes=size(HMM_Data.raw_ch1_tracks,2);
%all sizes in pixels, frames
t1=HMM_Data.raw_ch1_tracks;
%t2=HMM_Data.ch2_tracks; %for data transformed during tracking
t2=HMM_Data.shifted_ch2_tracks; %this should be the shifted tracks, common
coordinate registration
v1=HMM_Data.ch1_valids;
v2=HMM_Data.ch2_valids;
s1=HMM_Data.ch1_LA;
s2=HMM_Data.ch2_LA;
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Diff=HMM_Data.Dconvert;
OverlayError=HMM_Data.tform.error.fre; %in pixels
%temp hack
v1=logical(v1(:,:,1));
v2=logical(v2(:,:,1));
Ntracks_1=size(t1,1);
Ntracks_2=size(t2,1);
num=1;
P_bound=inline('1./S2.*exp(-d.^2./(2*S2)).*d','d','S2');
P_free=inline('2/L^2*d','d','L');
P_freeD=inline('r/(2*pi*S2)*.01*sum(
d^2/(2*S2)+r*d/S2*sin((0:.01:2*pi))))','r','d','S2');

exp(-r^2/(2*S2)-

for nn1=1:Ntracks_1
sf1=find(v1(nn1,:),1); %find start frame
ef1=max(find(v1(nn1,:))); %find end frame
if isempty(sf1); continue; end
if (ef1-sf1)<MinTime;continue;end %rule out short tracks
if (sum(v1(nn1,sf1:ef1))/(ef1-sf1))<DutyCycle;continue;end %rule out low duty cycle
tracks
for nn2=1:Ntracks_2
sf2=find(v2(nn2,:),1); %find start frame
ef2=max(find(v2(nn2,:))); %find end frame
if isempty(sf2); continue; end
if (ef2-sf2)<MinTime;continue;end %rule out short tracks
if (sum(v2(nn2,sf2:ef2))/(ef2-sf2))<DutyCycle;continue;end %rule out low duty cyle
tracks
validmask=(v1(nn1,:).*v2(nn2,:))==1;
x1=t1(nn1,:,1);
y1=t1(nn1,:,2);
x2=t2(nn2,:,1);
y2=t2(nn2,:,2);
d=sqrt((x2(validmask)-x1(validmask)).^2+(y2(validmask)-y1(validmask)).^2);
if min(d)> D_Thresh; continue; end %rule out tracks that don't get close enough
if sum(d<L)< MinOverlap; continue; end %rule out tracks that don't overlap enough
%now find start and end frames of the interaction
dcandidate=sqrt((x1-x2).^2+(y1-y2).^2);
mask=(dcandidate<=L).*validmask;
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sf=find(mask,1);
ef=max(find(mask));
T = ef- sf;
if T < MinPath; continue; end %rule out tracks that don't overlap for enough frames
D_array=zeros(Nframes,1);
Valids=zeros(Nframes,1);
for tt=sf:ef %loop only startframe:endframe
if v1(nn1,tt) && v2(nn2,tt)
d=sqrt((x1(tt)-x2(tt))^2+(y1(tt)-y2(tt))^2);
if d<=L
D_array(tt)=d;
Valids(tt)=1;
end
end
end
%Calculate Probalities
%localization errors are sqrt(sx^2+sy^2)
IDs=find(Valids);
S2_1=1/2*s1(nn1,IDs).^2+1/2*s2(nn2,IDs).^2+OverlayError.^2+IntDis.^2;
S2_2=1/2*s1(nn1,IDs).^2+1/2*s2(nn2,IDs).^2+OverlayError.^2+DomainSize.^2;
%index is for current, with a past valid
ID_now=IDs(2:end);
ID_past=IDs(1:end-1);
delt=ID_now-ID_past;
d_past=D_array(IDs(1:end-1));
d_now=D_array(IDs(2:end));
S2_3=1/2*s1(nn1,ID_past).^2+1/2*s2(nn2,ID_past).^2+...
1/2*s1(nn1,ID_now).^2+1/2*s2(nn2,ID_now).^2+...
OverlayError.^2+2*Diff*delt';
P1=P_bound(D_array(IDs),S2_1');
P2=P_bound(D_array(IDs),S2_2');
clear P3; P3(1)=P_free(D_array(IDs(1)),L);
for ii=2:length(d_now)+1;P3(ii)=P_freeD(d_now(ii-1),d_past(ii-1),S2_3(ii-1));end
P1out=zeros(Nframes,1);
P2out=zeros(Nframes,1);
P3out=zeros(Nframes,1);
P1out(IDs)=P1;
P2out(IDs)=P2;
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P3out(IDs)=P3;
%[D_array(1:10) P1out(1:10) P2out(1:10) P3out(1:10)]
Vout(:,num)=Valids;
P(:,:,num)=cat(2,P1out,P2out,P3out);
PairID(num,:)=[nn1,nn2];
StartFrame(num)=sf;
EndFrame(num)=ef;
num=num+1;
end
end
end
function varargout = HMM_FindRates(varargin)
d = struct('menu','HMM',...
'display','HMM Find Lifetimes',...
'inparams',struct('name',{'HMM_PreProcessFile'},...
'description',{'HMM PreProcess File'},...
'type',
{'infile'},...
'dim_check', {0},...
'range_check',{'*.HMMPP'},...
'required', {0},...
'default', {''}...
),...
'outparams',struct('name',{'HMM_PreProcessData','K_found','K_found_err'},...
'description',{'Modified HMM Data Structure','Found k matrix','precision of k matrix'},...
'type',{'strct','array','array'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_PreProcessFile] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
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error(firsterr)
end
end
load(HMM_PreProcessFile,'-mat');
%get number of states
N=HMM_PreProcessData.Nstates;
%% Use fminsearch to maximize likelihood
options=optimset('TolX',10e-8,'MaxFunEvals',10e8,'MaxIter',10e8,'Display','iter');
func=@PODHMM; %this points to the function that will be minimized
X0=repmat(.001,[N*(N-1) 1]); %these are the starting guesses; value of X0=0.001
decided 08.19.2010
LB=repmat(0,[N*(N-1) 1]);
UB=repmat(1,[N*(N-1) 1]);
[out]=fminsearch(func,X0,options,HMM_PreProcessData,N); %original
%[out]=lsqnonlin(func,X0,LB,UB,options,HMM_PreProcessData,N); %PJC
out=abs(out);
mask=~eye(N);
K=zeros(N,N);
K(mask)=out;
% find errors
%1: calculate Hessian:
sz=N*(N-1);
H=zeros(sz,sz);
deltaf=.05; %use a 5 percent change around found k value
mindeltaf=10e-8;
for ii=1:sz
for jj=1:sz
deltaii=max(deltaf*out(ii),mindeltaf);
deltajj=max(deltaf*out(jj),mindeltaf);
%measure slope wrt ii at two positions of jj
K_in1=out;
K_in2=out;
K_in1(ii)=K_in1(ii)-deltaii/2;
K_in2(ii)=K_in2(ii)+deltaii/2;
K_in1(jj)=K_in1(jj)-deltajj/2;
K_in2(jj)=K_in2(jj)-deltajj/2;
s1=1/deltaii*(PODHMM(K_in2,HMM_PreProcessData,N)PODHMM(K_in1,HMM_PreProcessData,N));
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%s1 = sum(s1); %PJC
K_in1=out;
K_in2=out;
K_in1(ii)=K_in1(ii)-deltaii/2;
K_in2(ii)=K_in2(ii)+deltaii/2;
K_in1(jj)=K_in1(jj)+deltajj/2;
K_in2(jj)=K_in2(jj)+deltajj/2;
s2=1/deltaii*(PODHMM(K_in2,HMM_PreProcessData,N)PODHMM(K_in1,HMM_PreProcessData,N));
%s2 = sum(s2); %PJC
H(ii,jj)=1/deltajj*(s2-s1);
end
end
K_err=sqrt(diag(inv(H)));
HMM_PreProcessData.K_matrix_found=K
HMM_PreProcessData.K_matrix_found_err=K_err
HMM_PreProcessData.K_matrix_found_Hessian=H;
HMM_PreProcessData.lnP=PODHMM(out,HMM_PreProcessData,N); %this calculates
the lnP at the found k values
save(HMM_PreProcessFile,'-mat');
varargout{1}=HMM_PreProcessData;
varargout{2}=K;
varargout{3}=K_err;
function lnP=PODHMM(K_vector,HMM_PreProcessData,N)
%K_vector must be a vector for fminsearch. Size is N*(N-1). Convert back to matrix
%N: number of states
mask=~eye(N);
K=zeros(N,N);
K(mask)=K_vector;
%if(min(min(K)))<0; warning('negative rate constant');end;
K=abs(K);
%disp(K_vector) %original
Nfiles=size(HMM_PreProcessData.P_states,2); %Number of files to analyze
RegionSize=HMM_PreProcessData.L;
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lnP=0; %original
for ii=1:Nfiles
%fprintf ('Analyzing file %d of %d \n',ii,N) %original
P_states=HMM_PreProcessData.P_states(Paez et al.); %probability of each state in
each timestep
V_states=HMM_PreProcessData.V_states(Paez et al.); %indicates valid time frames
for analysis
if isempty(P_states);continue;end
for pp=1:size(P_states,3) %pairs in file
VFrames=sum(V_states(:,pp)); %valid time frames
if ~VFrames;continue;end
%prepare input for HMM_lnP
Frames=size(P_states,1);
T=(1:Frames)';
mask=logical(V_states(:,pp));
T=T(mask); %times for valid analyis
P=P_states(mask,:,pp);
[lnP_pair]=HMM_lnP(P,T,K);
lnP=lnP+lnP_pair;
end
end
lnP=-lnP;
function varargout = HMM_FindStates(varargin)
d = struct('menu','HMM',...
'display','HMM Find States',...
'inparams',struct('name',{'HMM_PreProcessFile','K'},...
'description',{'HMM PreProcess File','k vector (0 for HMMPP value)'},...
'type',
{'infile','array'},...
'dim_check', {0,0},...
'range_check',{'*.HMMPP',[]},...
'required', {0,0},...
'default', {'',0}...
),...
'outparams',struct('name',{'HMM_PreProcessData'},...
'description',{'HMM_PreProcessData Structure'},...
'type',{'strct'}...
)...
);
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if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_PreProcessFile,K] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
load(HMM_PreProcessFile,'-mat');
Nfiles=size(HMM_PreProcessData.P_states,2); %Number of files to analyze
if ~(K(1))
K_matrix=HMM_PreProcessData.K_matrix_found;
end
StateMatrix{Nfiles}=[];
PViterbi{Nfiles}=[];
for ii=1:Nfiles %loop over files
%fprintf ('Analyzing file %d of %d \n',ii,N)
P_states=HMM_PreProcessData.P_states(Paez et al.); %probability of each state in
each timestep
V_states=HMM_PreProcessData.V_states(Paez et al.); %indicates valid time frames
for analysis
K_matrix=HMM_PreProcessData.K_matrix_found; %matrix of rate constants
(k_from,to)
N=size(K,1);
if isempty(P_states);
continue;
end
Npairs=size(P_states,3);%pairs in file
Frames=size(V_states,1);
States=zeros(Frames,Npairs);
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Pout=zeros(Npairs,1);
for pp=1:Npairs
VFrames=sum(V_states(:,pp)); %valid time frames
if ~VFrames;continue;end
%prepare input for HMM_Viterbi
Frames=size(P_states,1);
T=(1:Frames)';
T=T(logical(V_states(:,pp))); %times for valid analyis
mask=repmat(V_states(:,pp),[1 N])>0;
tmp=P_states(:,:,pp);
P=reshape(tmp(mask),[sum(V_states(:,pp)) N]);
[States(logical(V_states(:,pp)),pp) Pout(pp)]=HMM_Viterbi(P,T,K_matrix);
end
StateMatrix(Paez et al.)=States;
PViterbi(Paez et al.)=Pout;
end
HMM_PreProcessData.StateMatrix=StateMatrix;
HMM_PreProcessData.PViterbi=PViterbi;
varargout{1}=HMM_PreProcessData;
save(HMM_PreProcessFile,'-mat');
end
function [States Pout]=HMM_Viterbi(P,T,K)
%HMM_Viterbi: Finds the most likely states of a Markov series
%
%INPUT:
% P: A (Frames x N) probability matrix
% T: Each element is a (Frames x 1) time array
% K: NxN Matrix. Rate constants for state transitions
%OUTPUT:
% States: Mx1 Cell array. Each element is a Tx1 State array.
%state are 1 based indexed
N=size(K,1);
Tsteps=size(T,1);
%intialize
Traj(:,1)=(1:N); %state space trajectory, grows to Nstates*T
P_old(1,:)=P(1,:);
%first index-from, second index-to
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for tt=2:Tsteps %loop over frames
deltat=T(tt)-T(tt-1);
HMM=K*deltat;
HMM(eye(size(HMM,1))==1)=0;
HMM(eye(size(HMM,1))==1)=1-sum(HMM,2);
tmpTraj=Traj;
%find best way to get to each current state
for ss=1:N %looping over states at time t (current states)
tmp=P_old.*HMM(:,ss)'.*P(tt,:);
[Ptmp id]=max(tmp);
P_new(ss)=Ptmp;
tmpTraj(ss,1:tt-1)=Traj(id,:);
tmpTraj(ss,tt)=id;
end
Traj=tmpTraj;
P_old=P_new/sum(P_new);
[Pout id]=max(P_old);
States=Traj(id,:);
end
function varargout = HMM_StatesDist(varargin)
%This function fills state information for the 3-state HMM (similar to
%HMM_LifetimeDist for 2-state model)
%Written by Shalini Low-Nam
d = struct('menu','HMM',...
'display','HMM Lifetime Distributions',...
'inparams',struct('name',{'HMM_PreProcessFile','Out_Dir'},...
'description',{'HMM PreProcess File','Output Directory'},...
'type',
{'infile','indir'},...
'dim_check', {0,0},...
'range_check',{'*.HMMPP','*.*'},...
'required', {0,0},...
'default', {'',''}...
),...
'outparams',struct('name',{'HMM_PreProcessData'},...
'description',{'HMM_PreProcessData structure'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
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return
end
end
try
[HMM_PreProcessFile,OutDir] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%%
load(HMM_PreProcessFile,'-mat');
Nfiles=size(HMM_PreProcessData.P_states,2);
HMM_PreProcessData.StateMatrix{Nfiles}=[]; %In case the size of the StateMatrix does
not match that of P_states;
%commented out for simulations
SM=HMM_PreProcessData.StateMatrix;
PM=HMM_PreProcessData.P_states;
tmp=max(strfind(HMM_PreProcessFile,'\'));
fnbase=HMM_PreProcessFile(tmp+1:end-6);
cnt=1;
for nf=1:Nfiles
sm=SM(Lund et al.);
if sum(size(sm))==0
FilledStates(Lund et al.)=[];
continue
else
pm=PM(Lund et al.);
shf=zeros([size(pm,1) size(pm,3)]); %create matrix for state with holes filled
for nn=1:size(pm,3) %loop over number of candidate pairs
s=sm(:,nn);
if (sum(s))==0 %if there are no states; these are filled with state 3
shf=3.*ones([size(pm,1) size(pm,3)]); %commented out new
continue;
end
v=logical(pm(:,1,nn));
state=s(1,:);
for tt=1:max(find(v))
if v(tt)&s(tt)&(~state) %start of a state
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sf=tt;
state=s(tt); %which state has begun at sf
end
if v(tt)&(~s(tt))&state|((tt==max(find(v)))&state) %for
currently incomplete
ef=tt;
%StateLength=ef-sf; %commented out for simulations
end
if v(tt);
state=s(tt);
end
shf(tt,nn)=state;
end
shf(shf==0)=3; %replace any remaining zeros with 3
end
FilledStates(Lund et al.)=shf;
end
end

plotting

lifetimes;

%% save back to file
HMM_PreProcessData.FilledStates=FilledStates;
% HMM_PreProcessData.StateLength=StateLength;
save(HMM_PreProcessFile,'HMM_PreProcessData');
varargout{1}=HMM_PreProcessData;
function varargout = HMM_PlotCandidates_3state(varargin)
%HMM_PlotCandidates_3state(preprocessfile,resdir)
%This function will take the HMM_PreProcess files (of the type *.HMMPP) and make
3D trajectory
%plot and separation distance plot of the candidate pairs.
%Images will be saved (to directory 'resdir') to view later.
%
% input:
% HMM_DataFile: HMM PreProcess File of the format .HMMPP
% Out_Dir: path for saving plots
% plot_flag: if 0 don't make plot else make plot. Default 1.
%
% output:
% Images will be saved (to directory 'Out_Dir') to view later.
%
%updated by Shalini Low-Nam
%July 14, 2010
%
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%Example call of this function:
%HMM_PlotCandidates('Z:\Shal\EGFDimerExamples\test.HMMPP','Z:\Shal\EGFDimer
Examples\CandidatePairs\');
%%Setup for DIPimage menu
d = struct('menu','HMM',...
'display','HMM Plot Candidates',...
'inparams',struct('name',{'HMM_DataFile','Out_Dir','plot_flag'},...
'description',{'HMM PreProcess File','Output Directory','plot flag'},...
'type',
{'infile','indir','boolean'},...
'dim_check', {0,0,0},...
'range_check',{'*.HMMPP','*.*',[]},...
'required', {0,0,0},...
'default', {'','',1}...
),...
'outparams',struct('name',{'tracklengths','ratios'},...
'description',{'Track Lengths','Ratios'},...
'type',{'strct'}...
)...
);
if nargin == 1
s = varargin{1};
if ischar(s) & strcmp(s,'DIP_GetParamList')
varargout{1} = d;
return
end
end
try
[HMM_PreProcessFile,OutDir,plot_flag] = getparams(d,varargin{:});
catch
if ~isempty(paramerror)
error(paramerror)
else
error(firsterr)
end
end
%% Load PreProcess file and make ResultsDir
HMM_PreProcessFile=varargin{1};
load(HMM_PreProcessFile,'-mat');
resdir=OutDir;
mkdir(resdir);
numfile=size(HMM_PreProcessData.FileID, 2);
%% 3D plot of all tracks in ch1(r) and ch2(g)
%plot candidate pairs 3D trajectory + label
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%ch1 = red, QD655; ch2 = green, QD585
for hh=1:numfile %loop through each file
try
tmp=max(strfind(HMM_PreProcessData.FileID{hh},'\'));
fname = HMM_PreProcessData.FileID{hh};
load([fname],'-mat');
basename=fname(tmp+1:end-8);
if plot_flag
h(1,3) = figure;
ah = gca;
pair=HMM_PreProcessData.PairID{hh};
numpairs=size(pair,1);
d=zeros(numpairs,1000);
state=HMM_PreProcessData.FilledStates{hh}; %should be FILLEDSTATES
dimer=state'==1; %where dimer state found
domain=state'==2; %where domain state found
free=state'==3; %where free state found
for ii=1:numpairs %size(ch,1)
ch1spot=pair(ii,1);
ch2spot=pair(ii,2); %%THERE NEEDS TO BE A CHECK FOR SHIFTED
TRACKS!!
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
s1=logical(xch1(:,:)); %find the valid points of trajectory 1
tmps1=find(s1,1); %start of trajectory 1
tmpe1=max(find(s1)); %end of trajectory 1
l1=tmpe1-tmps1+1; %length of trajectory 1
xch2=HMM_Data.shifted_ch2_tracks(ch2spot,:,1);
ych2=HMM_Data.shifted_ch2_tracks(ch2spot,:,2);
s2=logical(xch2(:,:)); %find the valid points of trajectory 2
tmps2=find(s2,1); %start of trajectory 2
tmpe2=max(find(s2)); %end of trajectory 2
l2=tmpe2-tmps2+1; %length of trajectory 2
%
check
%

intensities1(ii,:)=HMM_Data.ch1_intensities(ch1spot,:); %For bleedthrough
intensities2(ii,:)=HMM_Data.ch2_intensities(ch2spot,:);
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valid1=dimer(ii,:); %valids of when dimer
valid2=domain(ii,:);
hsvline(squeeze(xch1),squeeze(ych1),HMM_Data.TimeStep,h(1,3),2,1,[],[],[],[],[1
0],[],[],1);
hold on

0

hsvline(squeeze(xch2),squeeze(ych2),HMM_Data.TimeStep,h(1,3),2,1,[],[],[],[],[0
0],[],[],1);
hold on
xlabel('X Coordinate')
ylabel('Y Coordinate')
zlabel('Time (s)')

1

if sum(dimer(ii,:))>0 %blue; dimer
dimerextent=sum(dimer(ii,:));
hsvline(squeeze(xch1).*valid1,squeeze(ych1).*valid1,HMM_Data.TimeStep,h(1,3),2,1,1.
5,[],[],[],[0 0 1],[],'o',1);
hold on
hsvline(squeeze(xch2).*valid1,squeeze(ych2).*valid1,HMM_Data.TimeStep,h(1,3),2,1,1.
5,[],[],[],[0 0 1],[],'d',1); %.*logical(state(ii,:))
hold on
set(findall(allchild(gca),'type','line'),'markersize',2)
else
hold on
if sum(domain(ii,:))>0 %purple; domain
domainextent=sum(domain(ii,:));
hsvline(squeeze(xch1).*valid2,squeeze(ych1).*valid2,HMM_Data.TimeStep,h(1,3),2,1,1.
5,[],[],[],[1 0 1]*0.7,[],'o',1);
hold on
hsvline(squeeze(xch2).*valid2,squeeze(ych2).*valid2,HMM_Data.TimeStep,h(1,3),2,1,1.
5,[],[],[],[1 0 1]*0.7,[],'d',1); %.*logical(state(ii,:))
hold on
set(findall(allchild(gca),'type','line'),'markersize',2)
else
hold on
end
end
text(xch1(find(logical(xch1),1)),...
ych1(find(logical(ych1),1)),...
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find(logical(xch1),1)*HMM_Data.TimeStep,num2str(ch1spot));
text(xch2(find(logical(xch2),1)),...
ych2(find(logical(ych2),1)),...
find(logical(xch2),1)*HMM_Data.TimeStep,num2str(ch2spot));
title(basename)
axis tight
saveas(h(1,3),[resdir basename '_3D' ],'fig');
end
for nn=1:numpairs %Distance Plots
ch1spot=pair(nn,1);
ch2spot=pair(nn,2);
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
xch2=HMM_Data.shifted_ch2_tracks(ch2spot,:,1);
ych2=HMM_Data.shifted_ch2_tracks(ch2spot,:,2);
state=HMM_PreProcessData.FilledStates{hh};
figure
d(nn,:)=sqrt((xch1-xch2).^2+(ych1-ych2).^2).*logical(xch1).*logical(xch2);
d=(d(nn,:).*0.267);
ax1 = gca;
set(ax1,'XColor',[0 0 0],'YColor',[0 0 0]);
axis([0 50 0 3.05]);
xlabel('Time (s)')
ylabel('Distance (\mu m)')
x1=[0.05:.05:50];
y1=d;
dvalids=logical(d);
hl1 = line(x1(dvalids),y1(dvalids),'Color','k','Parent',ax1,'linewidth',0.5);
axis([0 50 0 max(d)+0.05]);
hold on
path=state(:,nn)';
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
ylabel('State')
for pp=1:size(state,1)-1
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seg1=path(:,pp);
seg2=path(:,pp+1);
x2=[0.05:.05:50];
if seg1==seg2
if seg1&&seg2==2
c=[1 0 1]*0.7;l=3; %domain %magenta
end
if seg1&&seg2==1
c=[0 0 1];l=3; %dimer %blue
end
if seg1&&seg2==3
c=[1 0 0];l=3; %free %red
end
else
c=[0 1 0]*0.8; l=0.75; %dk green
end
hl2 = line([x2(pp) x2(pp+1)],[seg1 seg2],'Color',c,'linewidth',l);
hold on
end
axis([0 50 0.95 3.05]);
hold off
title('Distance between found interactions');
saveas(gcf, [resdir
num2str(ch2spot)], 'jpg');
clear d state
close all
clear path
end
end
catch
end
end

basename

'_D_ch1_'

num2str(ch1spot)

%%
% try
% varargout{1}=tracklengths;
% varargout{2}=ratio;
% save([resdir 'CandidateTrackLengths.mat'],'tracklengths','ratio');
% catch
% end
function h = HMM_StatesHist(datapath,ppfilestring,resdir)
% Generate histogram of dimers, using HMM_PreProcessData.FilledStates
% Similar to HMM_LifetimeDist for 2-state HMM
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'_ch2_'

%
% h = HMM_StatesHist(datapath,filestring,ppfilestring,resdir,deltaT)
%
% INPUTS
% OUTPUT
%
% Written by Shalini Low-Nam
% August 2010
%% Example:
% datapath='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM EGF\';
% ppfilestring='EGF_3state_DD150nm_ID50nm.HMMPP';
% resdir=datapath;
% HMM_StatesHist(datapath,ppfilestring,resdir)
%% Determine Lengths of Dimers
T=1000;
ppFile=dir([datapath ppfilestring]);
HMM_PreProcessFile=([datapath ppfilestring]);
load([datapath ppFile.name],'-mat'); %load HMM_PreProcessData file
tmp=max(strfind(HMM_PreProcessFile,'\'));
fnbase=HMM_PreProcessFile(tmp+1:end-6);
FS=HMM_PreProcessData.FilledStates;
Nfiles=size(FS,2);
cnt=1;
multi=1;
for nf=1:Nfiles %Loop over number of files
fprintf('Analyzing File: %d of %d\n',nf,Nfiles)
if size(FS(Lund et al.),1) == 0
fprintf('No interactions; proceeding to next data set ...\n')
continue
end
s=FS(Lund et al.);
mask=s==1;
ds=s.*mask;
for ii=1:size(FS(Lund et al.),2) %Loop over number of pairs
dimers=ds(:,ii);
[a]=find(dimers); %Find all dimers within dataset
if size(a,1) ~= 0
if size(a,1) ~= (a(end,1)-a(1,1))+1
for mm=1:size(find(diff(a)>1))+1 %Loop over number of multiple dimers
z=(find(diff(a)>1));
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if mm == 1
sf=a(1,1);
ef=a(min(find(diff(a)>1)));
Multi(multi,1)=ef-sf+1;
multi=multi+1;
else
sfm=a(z(mm-1,1)+1,1);
if mm+1 <= size(find(diff(a)>1),1)+1
efm=a(z(mm,1),1); %could exceed mm
else
efm=a(end,1);
end
Multi(multi,1)=efm-sfm+1;
multi=multi+1;
clear sf ef sfm efm
end
end
else
SingleDimer(cnt,1)=size(a,1)+1; %Length of single dimer events
cnt=cnt+1;
end
end
end
clear s mask ds
end
%% Graph results
if multi == 1
Multi=[];
end
if cnt == 1
SingleDimer=[];
else
StateLength=[Multi ; SingleDimer];
[Thist Thistbins]=hist(StateLength(:,1),20); %Histogram in frames
h=figure;
bar(Thistbins,Thist,'k','linewidth', 2);
%axis([0 50 0 160]); %To plot all conditions on same axes
xlabel('Dimer Event Lifetime (frames)','Fontsize', 16);
ylabel('Number of Events','Fontsize',16);
title('Distribution of Dimer Lifetimes - 3 State HMM','Fontsize',16);
saveas(h,[resdir 'DimerDistribution_frames'],'fig');
saveas(gcf, [resdir 'DimerDistribution_frames'], 'jpg');
[Thists Thistbinss]=hist(StateLength(:,1)./20,20); %Histogram in seconds
hs=figure;
bar(Thistbinss,Thists,'k','linewidth', 2);
%axis([0 50 0 160]); %To plot all conditions on same axes
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xlabel('Dimer Event Lifetime (seconds)','Fontsize', 16);
ylabel('Number of Events','Fontsize',16);
title('Distribution of Dimer Lifetimes - 3 State HMM','Fontsize',16);
saveas(hs,[resdir 'DimerDistribution_seconds'],'fig');
saveas(gcf, [resdir 'DimerDistribution_seconds'], 'jpg');
% close all
end
%% Save StateLength back to HMMPP file
HMM_PreProcessData.StateLength=StateLength;
save(HMM_PreProcessFile,'HMM_PreProcessData');
varargout{1}=HMM_PreProcessData;
%%Diffusion by state
datapath='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM UNM HeLa
EGF\';
filestring='EGF*.HMMData';
ppfilestring='EGF*.HMMPP';
resdir=[datapath 'Pr2Results_deltaT2\'];
mkdir(resdir);
sigma=1.0720e-001;
Pr2_3State(datapath,filestring,ppfilestring,resdir,2,sigma)
function h = Pr2_3State(datapath,filestring,ppfilestring,resdir,deltaT,sigma)%fittypeoption for one, two, or immobile component fitting
% Generate P(r2) as in de Keijzer et al., JCS 2008
%
% h = Pr2_3State(datapath,filestring,ppfilestring,resdir,deltaT,sigma)
%
% Inputs are location of trajectories, delta T, 1 or 2 component fit, sigma
% DeltaT is in frames (not time step)
% Read in tracks & valids
%
% INPUTS
% datapath - string; path to files of type .HMMData
% filestring - string of the type 'EGF*.HMMData'
% ppfilestring - string of the type 'EGF*.HMMPP'
% resdir - results directory where fit results and plots are saved
% deltaT - step size for jumps to be calculated
% OUTPUT
% h - handle for cpa figure
%
% Written by Shalini Low-Nam
% August 2010
%% Input examples:

243

% datapath='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM EGF\';
% filestring='EGF*.HMMData';
% ppfilestring='EGF*.HMMPP';
% resdir=[datapath 'Pr2Results_deltaT2\'];
% mkdir(resdir);
% sigma=1.0720e-001;
% Pr2_3State(datapath,filestring,ppfilestring,resdir,deltaT,sigma)
%% Calculate jump sizes and fitting
%calculate jump size for specific bin of deltaT
fprintf('Determining Square Displacements ...\n')
inc=0; idinc=0; finc=0; ddinc=0; dinc=0; %counters for free, domain, and dimer states
clear r2sort ystep
Files=dir([datapath filestring]);
ppFile=dir([datapath ppfilestring]);
load([datapath ppFile.name],'-mat'); %load HMM_PreProcessData file
Nfiles=size(HMM_PreProcessData.P_states,2); %Number of files to analyze
HMM_PreProcessData.FilledStates{Nfiles}=[]; %In case the size of the FilledStates
does not match that of P_states
for jj = 1:length(Files)
fprintf('Analyzing File: %d of %d\n',jj,length(Files))
filename = Files(jj).name;
load([datapath filename],'-mat'); %load HMM_Data file
state=HMM_PreProcessData.FilledStates{jj};
pair=HMM_PreProcessData.PairID{jj};
if size(pair)==0
continue
end
fpair=unique(pair(:,1)); %!!This will remove QD655 trajectory numbers that are
repeated; it will not matter for this analysis, but should not be used for any 2-channel
analyses
ss=1; %this must be reset to one for each new HMM_Data file
try
if isfield(HMM_Data,'raw_ch1_tracks')
for hh=1:size(HMM_Data.raw_ch1_tracks,1)
track=HMM_Data.raw_ch1_tracks(hh,:,:);
v=HMM_Data.ch1_valids(hh,:);
if fpair(ss,1)==hh; %if the track is a candidate track
v1=v.*(state(:,ss)');
ss=ss+1;
for ii=1:deltaT:size(track,2)-deltaT
p1=ii;
p2=ii+deltaT;
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x=track(:,:,1);
y=track(:,:,2);
if v1(1,p1)==v1(1,p2)
if v1(1,p1)== 1 %r2 values for dimers
dinc=dinc+1;
dr2(dinc) = ((x(:,p1)-x(:,p2))^2) + ((y(:,p1)-y(:,p2))^2);
end
if v1(1,p1)== 2 %r2 values for domain-confined receptors
ddinc=ddinc+1;
ddr2(ddinc) = ((x(:,p1)-x(:,p2))^2) + ((y(:,p1)-y(:,p2))^2);
end
if v1(1,p1)== 3 %r2 values for free receptors
idinc=idinc+1;
fr2(idinc) = ((x(:,p1)-x(:,p2))^2) + ((y(:,p1)-y(:,p2))^2);
end
else
if v(1,p1) && v(1,p2) %r2 values for monomers in candidate tracks
finc=finc+1;
mr2(finc) = ((x(:,p1)-x(:,p2))^2) + ((y(:,p1)-y(:,p2))^2);
end
end
close all
end
clear track x y p1 p2 v1
else %for all other tracks, treat as monomers
for kk=1:deltaT:size(track,2)-deltaT
p1=kk;
p2=kk+deltaT;
x=track(:,:,1);
y=track(:,:,2);
if v(1,p1) && v(1,p2)
inc=inc+1;
r2(inc) = ((x(:,p1)-x(:,p2))^2) + ((y(:,p1)-y(:,p2))^2);
else
end
close all
end
clear track v x y p1 p2
end
end
else
fprintf('No tracks; continuing with next ...\n')
continue
end
catch
end
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end
if idinc == 0
fr2=[];
end
if finc == 0
mr2=[];
end
if inc == 0
r2=[];
end
m_r2=[fr2 mr2 r2]; %concatenate all monomer r2 values
if dinc == 0
d_r2=[];
save([resdir '\Pr2FittingResults_Dimer_Domain_Monomer'],'m_r2','dd_r2');
else
d_r2=dr2;
save([resdir '\Pr2FittingResults_Dimer_Domain_Monomer'],'m_r2','d_r2');
end
if ddinc == 0
dd_r2=[];
save([resdir '\Pr2FittingResults_Dimer_Domain_Monomer'],'m_r2','d_r2');
else
dd_r2=ddr2;
save([resdir '\Pr2FittingResults_Dimer_Domain_Monomer'],'m_r2','dd_r2','d_r2');
end
load([resdir '\Pr2FittingResults_Dimer_Domain_Monomer.mat'])
%Remove jumps greater than 2 pixels (r^2=4)
mr2sort=sort(m_r2,2,'ascend');
mmask=mr2sort<4; %This filter could be used to remove jumps of greater than 1.5
pixels ... still a question of why we get these at all
mr2sort=mr2sort(mmask);
mr2=size(mr2sort,2);
ddr2sort=sort(dd_r2,2,'ascend');
ddmask=ddr2sort<4; %This filter could be used to remove jumps of greater than 1.5
pixels ... still a question of why we get these at all
ddr2sort=ddr2sort(ddmask);
ddr2=size(ddr2sort,2);
dr2sort=sort(d_r2,2,'ascend');
dmask=dr2sort<4; %This filter could be used to remove jumps of greater than 1.5 pixels
... still a question of why we get these at all
dr2sort=dr2sort(dmask);
dr2=size(dr2sort,2);
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mystep=(1:length(mr2sort))/length(mr2sort);
ddystep=(1:length(ddr2sort))/length(ddr2sort);
dystep=(1:length(dr2sort))/length(dr2sort);
%%Combined r2
clear r2
r2=[m_r2,d_r2,dd_r2];
rr2sort=sort(r2,2,'ascend');
rmask=rr2sort<4; %This filter could be used to remove jumps of greater than 1.5 pixels
... still a question of why we get these at all
rr2sort=rr2sort(rmask);
rr2=size(rr2sort,2);
rystep=(1:length(rr2sort))/length(rr2sort);
%% Two component fits
%Two component fit for monomer data:
mTCopts=fitoptions('Method','Nonlinear','StartPoint',[.5
.1],'Lower',[0,0,0],'Upper',[1,10,10]);
%Schutz, et al., BJ, V73, 1997:
mTCftype=fittype('1-((a.*exp(-x./b))+((1-a).*exp(x./c)))','options',mTCopts,'coeff',{'a','b','c'},'indep','x','depen','y');
[mTCresults, mTCgoodnessL]=fit((mr2sort)',mystep',mTCftype);

.2

mTCc=coeffvalues(mTCresults);
mTCalpha=mTCc(1);
mTCdr1=mTCc(2);
mTCdr2=mTCc(3);
mTCrmse=mTCgoodnessL.rmse;
mTCFitResult=1-((mTCalpha.*exp(-mr2sort./mTCdr1))+((1-mTCalpha).*exp(mr2sort./mTCdr2)));
%get confidence interval (95% is default)
mTC_CI=confint(mTCresults);
mTC_alpha_CI=mTC_CI(:,1);
mTC_dr1_CI=mTC_CI(:,2);
mTC_dr2_CI=mTC_CI(:,3);
%Two component fit for domain data:
ddTCopts=fitoptions('Method','Nonlinear','StartPoint',[.5
.1],'Lower',[0,0,0],'Upper',[1,10,10]);
%Schutz, et al., BJ, V73, 1997:
ddTCftype=fittype('1-((a.*exp(-x./b))+((1-a).*exp(x./c)))','options',ddTCopts,'coeff',{'a','b','c'},'indep','x','depen','y');
[ddTCresults, ddTCgoodnessL]=fit((ddr2sort)',ddystep',ddTCftype);
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.2

ddTCc=coeffvalues(ddTCresults);
ddTCalpha=ddTCc(1);
ddTCdr1=ddTCc(2);
ddTCdr2=ddTCc(3);
ddTCrmse=ddTCgoodnessL.rmse;
ddTCFitResult=1-((ddTCalpha.*exp(-ddr2sort./ddTCdr1))+((1-ddTCalpha).*exp(ddr2sort./ddTCdr2)));
%get confidence interval (95% is default)
ddTC_CI=confint(ddTCresults);
ddTC_alpha_CI=ddTC_CI(:,1);
ddTC_dr1_CI=ddTC_CI(:,2);
ddTC_dr2_CI=ddTC_CI(:,3);
%Two component fit for dimer data:
dTCopts=fitoptions('Method','Nonlinear','StartPoint',[.5
.1],'Lower',[0,0,0],'Upper',[1,10,10]);
%Schutz, et al., BJ, V73, 1997:
dTCftype=fittype('1-((a.*exp(-x./b))+((1-a).*exp(x./c)))','options',dTCopts,'coeff',{'a','b','c'},'indep','x','depen','y');
[dTCresults, dTCgoodnessL]=fit((dr2sort)',dystep',dTCftype);

.2

dTCc=coeffvalues(dTCresults);
dTCalpha=dTCc(1);
dTCdr1=dTCc(2);
dTCdr2=dTCc(3);
dTCrmse=dTCgoodnessL.rmse;
dTCFitResult=1-((dTCalpha.*exp(-dr2sort./dTCdr1))+((1-dTCalpha).*exp(dr2sort./dTCdr2)));
%get confidence interval (95% is default)
dTC_CI=confint(dTCresults);
dTC_alpha_CI=dTC_CI(:,1);
dTC_dr1_CI=dTC_CI(:,2);
dTC_dr2_CI=dTC_CI(:,3);
%Two component fit for all data:
rTCopts=fitoptions('Method','Nonlinear','StartPoint',[.5
.1],'Lower',[0,0,0],'Upper',[1,10,10]);
%Schutz, et al., BJ, V73, 1997:
rTCftype=fittype('1-((a.*exp(-x./b))+((1-a).*exp(x./c)))','options',rTCopts,'coeff',{'a','b','c'},'indep','x','depen','y');
[rTCresults, rTCgoodnessL]=fit((rr2sort)',rystep',rTCftype);
rTCc=coeffvalues(rTCresults);
rTCalpha=rTCc(1);
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.2

rTCdr1=rTCc(2);
rTCdr2=rTCc(3);
rTCrmse=rTCgoodnessL.rmse;
rTCFitResult=1-((rTCalpha.*exp(-rr2sort./rTCdr1))+((1-rTCalpha).*exp(rr2sort./rTCdr2)));
%get confidence interval (95% is default)
rTC_CI=confint(rTCresults);
rTC_alpha_CI=rTC_CI(:,1);
rTC_dr1_CI=rTC_CI(:,2);
rTC_dr2_CI=rTC_CI(:,3);
%% Convert results to um^2/s and save in a table
%Solve for D using: D=(MSD-(4*(sigma^2)))/(4*deltaT)
mTCDout1 = (mTCdr1-(4*(sigma^2)))/(4*deltaT);
mTCDout2 = (mTCdr2-(4*(sigma^2)))/(4*deltaT);
mTCD1um=mTCDout1*20*0.267^2;
mTCD2um=mTCDout2*20*0.267^2;
mTC_dr1_CI_LB=((mTC_dr1_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
and upper bounds for 95% confidence interval in units of um^2/s
mTC_dr1_CI_UB=((mTC_dr1_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
mTC_dr2_CI_LB=((mTC_dr2_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
mTC_dr2_CI_UB=((mTC_dr2_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
% Dmr2=((median(mr2sort)-(4*(sigma^2)))/(4*deltaT))*(20*(.267^2))
ddTCDout1 = (ddTCdr1-(4*(sigma^2)))/(4*deltaT);
ddTCDout2 = (ddTCdr2-(4*(sigma^2)))/(4*deltaT);
ddTCD1um=ddTCDout1*20*0.267^2;
ddTCD2um=ddTCDout2*20*0.267^2;
ddTC_dr1_CI_LB=((ddTC_dr1_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
and upper bounds for 95% confidence interval in units of um^2/s
ddTC_dr1_CI_UB=((ddTC_dr1_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
ddTC_dr2_CI_LB=((ddTC_dr2_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
ddTC_dr2_CI_UB=((ddTC_dr2_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
% Dddr2=((median(ddr2sort)-(4*(sigma^2)))/(4*deltaT))*(20*(.267^2))

%lower

%lower

dTCDout1 = (dTCdr1-(4*(sigma^2)))/(4*deltaT);
dTCDout2 = (dTCdr2-(4*(sigma^2)))/(4*deltaT);
dTCD1um=dTCDout1*20*0.267^2;
dTCD2um=dTCDout2*20*0.267^2;
dTC_dr1_CI_LB=((dTC_dr1_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2; %lower and
upper bounds for 95% confidence interval in units of um^2/s
dTC_dr1_CI_UB=((dTC_dr1_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
dTC_dr2_CI_LB=((dTC_dr2_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
dTC_dr2_CI_UB=((dTC_dr2_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
% Ddr2=((median(dr2sort)-(4*(sigma^2)))/(4*deltaT))*(20*(.267^2))
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rTCDout1 = (rTCdr1-(4*(sigma^2)))/(4*deltaT);
rTCDout2 = (rTCdr2-(4*(sigma^2)))/(4*deltaT);
rTCD1um=rTCDout1*20*0.267^2;
rTCD2um=rTCDout2*20*0.267^2;
rTC_dr1_CI_LB=((rTC_dr1_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2; %lower and
upper bounds for 95% confidence interval in units of um^2/s
rTC_dr1_CI_UB=((rTC_dr1_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
rTC_dr2_CI_LB=((rTC_dr2_CI(1,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
rTC_dr2_CI_UB=((rTC_dr2_CI(2,1)-(4*(sigma^2)))/(4*deltaT))*20*0.267^2;
% Rdr2=((median(rr2sort)-(4*(sigma^2)))/(4*deltaT))*(20*(.267^2))
clear excelPr2
excelPr2(1,1) = {'Pr2 Summary:'};
excelPr2(2,1)
=
{'Monomer'};excelPr2(3,1:11)
=
{'N','Alpha_LB','Alpha','Alpha_UB','D1CI_LB','D1','D1CI_UB','D2CI_LB','D2','D2CI_UB','
RMSE'};
excelPr2(2,13)
=
{'Domain'};excelPr2(3,13:23)
=
{'N','Alpha_LB','Alpha','Alpha_UB','D1CI_LB','D1','D1CI_UB','D2CI_LB','D2','D2CI_UB','
RMSE'};
excelPr2(2,25)
=
{'Dimer'};excelPr2(3,25:35)
=
{'N','Alpha_LB','Alpha','Alpha_UB','D1CI_LB','D1','D1CI_UB','D2CI_LB','D2','D2CI_UB','
RMSE'};
excelPr2(2,37)
=
{'All
Data'};excelPr2(3,37:47)
=
{'N','Alpha_LB','Alpha','Alpha_UB','D1CI_LB','D1','D1CI_UB','D2CI_LB','D2','D2CI_UB','
RMSE'};
excelPr2(4,1:11)
=
{mr2,mTC_alpha_CI(1,1),mTCalpha,mTC_alpha_CI(2,1),mTC_dr1_CI_LB,mTCD1um,
mTC_dr1_CI_UB,mTC_dr2_CI_LB,mTCD2um,mTC_dr2_CI_UB,mTCrmse};
excelPr2(4,13:23)
=
{ddr2,ddTC_alpha_CI(1,1),ddTCalpha,ddTC_alpha_CI(2,1),ddTC_dr1_CI_LB,ddTCD1u
m,ddTC_dr1_CI_UB,ddTC_dr2_CI_LB,ddTCD2um,ddTC_dr2_CI_UB,ddTCrmse};
excelPr2(4,25:35)
=
{dr2,dTC_alpha_CI(1,1),dTCalpha,dTC_alpha_CI(2,1),dTC_dr1_CI_LB,dTCD1um,dTC
_dr1_CI_UB,dTC_dr2_CI_LB,dTCD2um,dTC_dr2_CI_UB,dTCrmse};
excelPr2(4,37:47)
=
{rr2,rTC_alpha_CI(1,1),rTCalpha,rTC_alpha_CI(2,1),rTC_dr1_CI_LB,rTCD1um,rTC_dr1
_CI_UB,rTC_dr2_CI_LB,rTCD2um,rTC_dr2_CI_UB,rTCrmse};
xlswrite([resdir 'Pr2_FitData.xls'], excelPr2);
fprintf('Two Component Fitting Complete!\n')
%% TC plotting
%Monomer plotting
hmTC=figure;
semilogx(squeeze(mr2sort),squeeze(mystep),'ko')
hold on
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semilogx(squeeze(mr2sort),mTCFitResult,'--r','LineWidth',2)
hold off
xlabel('(r^2) (pix)')
ylabel('P(r^2)')
legend('Data','Fit')
title('Two Component Fit for Monomer P(r^2) Data')
hold off
saveas(hmTC,[resdir 'mTCPr2' ],'fig');
saveas(hmTC,[resdir 'mTCPr2' ],'jpg');
%Domain plotting
hddTC=figure;
semilogx(squeeze(ddr2sort),squeeze(ddystep),'co')
hold on
semilogx(squeeze(ddr2sort),ddTCFitResult,'--m','LineWidth',2)
hold off
xlabel('(r^2) (pix)')
ylabel('P(r^2)')
legend('Data','Fit')
title('Two Component Fit for Domain P(r^2) Data')
hold off
saveas(hddTC,[resdir 'ddTCPr2' ],'fig');
saveas(hddTC,[resdir 'ddTCPr2' ],'jpg');
%Dimer plotting
hdTC=figure;
semilogx(squeeze(dr2sort),squeeze(dystep),'go')
hold on
semilogx(squeeze(dr2sort),dTCFitResult,'--b','LineWidth',2)
hold off
xlabel('(r^2) (pix)')
ylabel('P(r^2)')
legend('Data','Fit')
title('Two Component Fit for Dimer P(r^2) Data')
hold off
saveas(hdTC,[resdir 'dTCPr2' ],'fig');
saveas(hdTC,[resdir 'dTCPr2' ],'jpg');
%Composite
hTC=figure;
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semilogx(squeeze(mr2sort),squeeze(mystep),'ko')
hold on
semilogx(squeeze(mr2sort),mTCFitResult,'--r','LineWidth',2)
hold on
semilogx(squeeze(ddr2sort),squeeze(ddystep),'co')
hold on
semilogx(squeeze(ddr2sort),ddTCFitResult,'--m','LineWidth',2)
hold on
semilogx(squeeze(dr2sort),squeeze(dystep),'go')
hold on
semilogx(squeeze(dr2sort),dTCFitResult,'--b','LineWidth',2)
hold off
xlabel('(r^2) (pix)')
ylabel('P(r^2)')
legend('Monomer Data','Monomer Fit','Domain Data','Domain Fit','Dimer Data','Dimer
Fit')
title('Two Component Fit for P(r^2) Data')
hold off
axis([1*10^-7 1*10^1 0 1]);
saveas(hTC,[resdir 'TCPr2' ],'fig');
saveas(hTC,[resdir 'TCPr2' ],'jpg');
%All data plotting
rdTC=figure;
semilogx(squeeze(rr2sort),squeeze(rystep),'go')
hold on
semilogx(squeeze(rr2sort),rTCFitResult,'--b','LineWidth',2)
hold off
xlabel('(r^2) (pix)')
ylabel('P(r^2)')
legend('Data','Fit')
title('Two Component Fit for All P(r^2) Data')
hold off
saveas(rdTC,[resdir 'rTCPr2' ],'fig');
saveas(rdTC,[resdir 'rTCPr2' ],'jpg');
pause(2);
close all
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%%
%% Figures for manuscripts
%%Tracks on raw data (example from VhH+PD since receptors experience
%%greater excursion)
%Pair ID = 108; Spots ch1=16, ch2=13
%Raw Data
load('Z:\Shal\SPT
Data\GroupedData_A431_Final\VhH_PD\100108\Chamber2\VhH_3fold-2010-1-8-1537.mat')
%Left Side (655)
%Right Side (585)
clear L
clear Ru
clear series
series=squeeze(sequence);
im=series;
[ch1,ch2] = splitImage(im,5,[1 1],0);
L=ch1(:,:,999);
mask=max(L);
L=joinchannels('RGB',mask.*L,L,mask.*L);
dipshow(L,[370000,900000]); %use dipmapping to show only magenta for single
molecules
hm=gca;
scaleLine(hm,2,0.267,[115 140],[1 1 1],3) %2 um scale bar on all figure one DAQ
images
Ru=ch2(:,:,999);
mask=max(Ru);
Ru=joinchannels('RGB',Ru,mask.*Ru,Ru);
dipshow(Ru,[285000,430000]); %use dipmapping to show only green for single
molecules
hg=gca;
scaleLine(hg,2,0.267,[115 140],[1 1 1],3)
save(['Z:\Shal\Manuscripts\erbB1HomodimerLifetimes_Science\Figure1RawChannels'],'
L','Ru');
%%SPT Jump Correlation
%To do SPTJC on a single movie
resultsdir='C:\Users\slow-nam\Desktop\ExEGFtracks\';
Lfiles=dir([resultsdir 'trackinfo_L_*']);
Rstracksfiles=dir([resultsdir 'Rstracks_trackinfo_*']);
Rfiles=dir([resultsdir 'trackinfo_Ru_*']);
SPTJCdir='C:\Users\slow-nam\Desktop\ExEGFtracks\SPTJC\';
mkdir(SPTJCdir);
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shiftvector=[0 0]';
cutoff=0.5;
binsize=.05;
pixelsize=0.067;
for nn=1:size(Lfiles,1)%data series
L=load([resultsdir Lfiles(nn).name]);
R=load([resultsdir Rfiles(nn).name]);
Rs=load([resultsdir Rstracksfiles(nn).name]);
if length(size(L.tracks))==2
continue
end
R.valids=repmat(R.valids,[1 1 2]);
TracksI{nn}=Rs.Rstracks.*R.valids;
TracksII{nn}=L.tracks;
end
%%call SPTJumpCorrelation
% shiftvector=[0 0]';
% cutoff=10;
% binsize=.1;
% pixelsize=.1;
for nn=1:size(Lfiles,1)%data series
[Data_all{nn}]=SPTJumpCorrelation(TracksI{nn},TracksII{nn},cutoff,binsize,pixelsize,shif
tvector);
end
%[Data_all{nn}
c]=SPTJumpCorrelation(L_tracks{3}(3,:,:),R_tracks{3}(9,:,:),cutoff,binsize,pixelsize,shiftv
ector)
bin_num=round(cutoff/binsize);
cutoff=bin_num*binsize;
X=linspace(0,cutoff,bin_num);
for n=1:bin_num-1
cnt(n)=0;
Parameter=[0 0];
Parameter2=[0 0];
Parameter3=[0 0];
Y(n)=0;
E(n)=0;
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for nn=1:size(Lfiles,1)%Nsets
Data=Data_all{nn};
for m=1:size(Data,1)
if X(n)<=Data(m,3)&&Data(m,3)<X(n+1)
cnt(n)=cnt(n)+1;
Parameter(cnt(n))=Data(m,12);
Parameter2(cnt(n))=sqrt(Data(m,6)^2+Data(m,7)^2);
Parameter3(cnt(n))=Data(m,10);
cnt(n)=cnt(n)+1;
Parameter(cnt(n))=Data(m,13);
Parameter2(cnt(n))=sqrt(Data(m,8)^2+Data(m,9)^2);
Parameter3(cnt(n))=Data(m,11);
end
end
end
%Y is getting larger than X
if cnt(n)>0
%take average of each interval
Y(n)=mean(Parameter);
Y2(n)=mean(Parameter2);
Y3(n)=mean(Parameter3);
%calculate std. error of the mean NOTE:2 type of std. which one is
%better.
E(n)=std(Parameter)/sqrt(cnt(n));
E2(n)=std(Parameter2)/sqrt(cnt(n));
E3(n)=std(Parameter3)/sqrt(cnt(n));
end
end
%shift x over by half a bin size. this will plot values within a bin at a
%centered point
X=X+binsize/2;
X=X(1:end-1);
X=X(cnt>0);
Y=Y(cnt>0);
Y2=Y2(cnt>0);
Y3=Y3(cnt>0);
E=E(cnt>0);
E2=E2(cnt>0);
E3=E3(cnt>0);
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sz=1;
figure
if(sz>0)
hold on
errorbar(X,Y,E)
name = ['Graph of Uncorrelated Jump Distance'];
title(name)
xlabel('Seperation Distance (\mum)')
ylabel('Average Correlation (\mum)')
errorbar(X,Y2,E2,'r')
%errorbar(X,Y3,E3,'g')
legend('uncorrelated jump distance','jump magnitude')
%legend('uncorrelated jump distance','jump magnitude','jump to center of mass')
hold off
end
%To perform SPTJC for a condition (all movies)
topdir='Z:\Shal\SPT Data\GroupedData_erbB3\erbB3\'
cutoff=2;
binsize=0.05;
%EGF
SPTdirs={[topdir 'HMM EGF\']};
figDir=[topdir 'HMM EGF\SPTJumpCorrelation'];
if ~exist(figDir,'dir')
mkdir(figDir)
end
conditions{1}='QD EGF';
[jumpResults condIdx cnt h]=SPTJumpCorrelation(SPTdirs,cutoff,binsize,conditions);
conditions=conditions{1};
saveas(gca,[figDir '\SPTJC_' conditions],'fig');
saveas(gca,[figDir '\SPTJC_' conditions],'jpg');
close all
clear jumpResults condIdx cnt h SPTdirs figDir conditions
function
[jumpResults
condIdx
cnt
h
unCorrelatedJD
JumpMagnitude]=SPTJumpCorrelation(SPTdirs,cutoff,binsize,conditions,jumpResults,c
ondIdx)
% SPTJUMPCORRELATION compute jump correlation for files in specifed directories
%
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%
[jumpResults
condIdx
cnt
h
unCorrelatedJD
JumpMagnitude]=SPTJumpCorrelation(SPTdirs,cutoff,binsize,conditions,jumpResults,c
ondIdx)
%
%
%
% INPUTS:
% SPTdirs: cell array of directories containing '*.SPTData' or '*.HMMData'
%
data files for which to compute the jump correlation
% cutoff: Max separation distance for analysis in microns
% binsize: jump binsize in microns
% conditions: DataConditions in SPTData or HMMData files for which compute
%
the jump correlation. Conditions are used for plot titles.
%
Leave empty to perform single jump correlation analysis
%
for all files.
% jumpResults: optional input. 'jumpResults' output from previous call to
%
SPTJumpCorrelation. If nargin > 4 then only plot results
% condIdx: 'condIdx' output from previous call to SPTJumpCorrelation.
%
Required if input jumpResults.
% unCorrelatedJD: cell array of all calculated uncorrelated jump distance
%
Each cell is for the corresponding condition
% JumpMagnitude:
% OUTPUTS:
% jumpResults: cell array of matrices with 13 columns and rows equal to the number
of
%
times particles came within the cutoff distance. Each cell
%
corresponds to a different data file/movie.
% [i j S COM(1) COM(2) J1(1) J1(2) J2(1) J2(2) J1_COM J2_COM D1(1) D2(1) t]
%
Above is the layout of a row of the Data Matrix.
%
i is the particle from TracksI that was involved in the interaction
%
j is the particle from TracksII that was involved in the interaction
%
S is the seperation distance between the two particles.
%
The others are mentioned below in the DESCRIPTION section with ...(1)
%
meaning the x-axis and ...(2) meaning the y-axis.
% condIdx: vector with same size as jumpResults cell array. Each
%
element contains the index of the input 'conditions' that
%
correspond to the jumpResults in the cell array.
% cnt: cell array with size of conditions. each cell contains a vector
%
with the number of events in each bin
% h: vector of figure handles
%
% NOTE: Only works for 2 channel data
%
% Written by Jonas Anderson
% Revised by Shalini Low-Nam and Keith Lidke, 2009
% Updated by Pat Cutler July 2010
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%
% DESCRIPTION
%
% This function will take two color data as input and search for correlations
% between the two data sets.
%
% First the function looks at a track from TracksI and compares it with all
% tracks in TracksII. If two tracks are found below the user specified cutoff,
% calculations are performed to measure correlations between the tracks.
%
% These calculations involve finding the seperation distance, the center of
% mass (COM), the jump vector(J1,J2), the jump toward the COM (J1_COM,
% J2_COM), and the uncorrelated jump distance (D1,D2).
%
% The jump vector has magnitude that is the length a particle
% jumps between consecutive time frames and points in the direction of the jump.
% J1 is the jump vector of a track in TracksI while J2 is for TracksII.
%
% Jump toward the COM is similar to the Jump vector except the lenght and
% direction are calculated in relation to the COM.
%
% The uncorrelated jump distance is a measure of correlation between J1 and
% J2. If the two tracks make similar (correlated) jumps, the uncorrelated
% jump distance will be small.
%
% After the quantities of interest are calculated and saved to the Data matrix
% intervals are defined based on seperation distance.
% Each interval is defined by user input (binsize) and the range is 0 to user input
(cutoff).
% Each interaction between particles that happened when the seperation
% distance was in the specified interval is added together. Then the
% average of all the interactions that occured in this interval is taken.
% This same process is repeated for each interval. Finally, error bars are
% calculated using Standard Error of the Mean (sigma/sqrt(N)).
%
% A similar process of is used for the Jump vectors.
%
% These are all plotted and output.
%
%
%SPT Jump Correlation
%July 22, 2010
%Making SPTJC compatible with new HMM and SPT data structures
%Shalini Low-Nam and Pat Cutler
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%% perform jump correlation analysis on each data set
disp('SPTJumpCorrelation Started')
if nargin < 4
conditions = [];
end
if nargin < 5
condIdx = [];
for ii = 1:length(SPTdirs)
disp(['Checking directory ' SPTdirs(Paez et al.)])
Files_SPT = dir([SPTdirs(Paez et al.) '\*.SPTData']); % find SPTData files in single
directory
Files_HMM = dir([SPTdirs(Paez et al.) '\*.HMMData']); % find SPTData files in
single directory
Files = [Files_SPT Files_HMM];
for jj = 1:length(Files)
temp = load([SPTdirs(Paez et al.) '\' Files(jj).name],'-mat'); % load data file
if isfield(temp,'SPT_Data') % identify SPTData files
Data = temp.SPT_Data;
else if isfield(temp,'HMM_Data') % identify HMMData files
HMMcheck = 1;
Data = temp.HMM_Data;
end
end
if ~isempty(conditions)
if ~isempty(find(strcmp(Data.DataConditions,conditions),1))
condIdx(ii,jj) = find(strcmp(Data.DataConditions,conditions)); % determine
conditions for SPTData file
else
condIdx(ii,jj) = 0;
end
else
condIdx(ii,jj) = 1; % if no conditions specified group everything together
end
if condIdx(ii,jj)
disp(['computing jumpCorrelation for ' Files(jj).name])
if isfield(Data,'shifted_ch2_tracks')
jumpResults{ii,jj}
=
jumpCorrelation(Data.raw_ch1_tracks,Data.shifted_ch2_tracks,cutoff,binsize,Data.Pixel
Size);
else
try
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jumpResults{ii,jj}
=
jumpCorrelation(Data.raw_ch1_tracks,Data.ch2_tracks,cutoff,binsize,Data.PixelSize,Da
ta(1).tform);
catch
end
end
else
jumpResults{ii,jj} = [];
end
end
end
else if nargin ~= 6
error('SPTJumpCorrelation: if ''jumpResults'' input ''condIdx'' input also required')
end
end
jumpResults = jumpResults(:);
condIdx = condIdx(:);
uniqueCondIdx = unique(condIdx);
if isempty(conditions)
disp('Making jumpCorrelation plot')
[cnt{1},unCorrelatedJD{1},JumpMagnitude{1},JumpCOM{1},h(1)]
=
plotJumpDistance(cutoff,binsize,jumpResults,conditions);
else
for ii = uniqueCondIdx'
if ii
disp(['Making jumpCorrelation plots for ' conditions(ii)])
[cnt(Paez et al.),unCorrelatedJD(Paez et al.),JumpMagnitude(Paez et
al.),JumpCOM(Paez et al.),h(ii)] = plotJumpDistance(cutoff,binsize,jumpResults(condIdx
== ii),conditions(Paez et al.));
end
end
end
disp('SPTJumpCorrelation Finished')
%
% Plot results for jump distance for each condition
%
function
[cnt,unCorrelatedJD,JumpMagnitude,JumpCOM,h]
plotJumpDistance(cutoff,binsize,jumpResults,conditions)
bin_num=round(cutoff/binsize);
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=

cutoff=bin_num*binsize;
X=linspace(0,cutoff,bin_num);
for n=1:bin_num-1
cnt(n)=0;
unCorrelatedJD{n}=[0 0];
JumpMagnitude{n}=[0 0];
JumpCOM{n}=[0 0];
Y(n)=0;
E(n)=0;
for nn=1:length(jumpResults) %Nsets
if ~isempty(jumpResults{nn})
for m = 1:size(jumpResults{nn},1)
if X(n)<=jumpResults{nn}(m,3)&&jumpResults{nn}(m,3)<X(n+1)
cnt(n)=cnt(n)+1;
unCorrelatedJD{n}(cnt(n))=jumpResults{nn}(m,12); % uncorrelated jump
Distance
JumpMagnitude{n}(cnt(n))=sqrt(jumpResults{nn}(m,6)^2+jumpResults{nn}(m,7)^2);
JumpCOM{n}(cnt(n))=jumpResults{nn}(m,10);
cnt(n)=cnt(n)+1;
unCorrelatedJD{n}(cnt(n))=jumpResults{nn}(m,13);
JumpMagnitude{n}(cnt(n))=sqrt(jumpResults{nn}(m,8)^2+jumpResults{nn}(m,9)^2);
JumpCOM{n}(cnt(n))=jumpResults{nn}(m,11);
end
end
end
end
%Y is getting larger than X
if cnt(n)>0
%take average of each interval
Y(n)=mean(unCorrelatedJD{n});
Y2(n)=mean(JumpMagnitude{n});
Y3(n)=mean(JumpCOM{n});
%calculate std. error of the mean NOTE:2 type of std. which one is
%better.
E(n)=std(unCorrelatedJD{n})/sqrt(cnt(n));
E2(n)=std(JumpMagnitude{n})/sqrt(cnt(n));
E3(n)=std(JumpCOM{n})/sqrt(cnt(n));
end
end
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%shift x over by half a bin size. this will plot values within a bin at a
%centered point
X=X+binsize/2;
X=X(1:end-1);
X=X(cnt>0);
Y=Y(cnt>0);
Y2=Y2(cnt>0);
Y3=Y3(cnt>0);
E=E(cnt>0);
E2=E2(cnt>0);
E3=E3(cnt>0);
sz=1;
% h = figure; %commented out by SL-N and SS 12.20.10
if(sz>0)
% errorbar_tick(H,W,T) adjust the width of error bars with handle H.
%
The input W is given in the units of the current x-axis.
%
The input T is the 'LineWidth' of the errorbar
figure;
hold on
h=errorbar(X,Y,E)
name = ['Graph of Uncorrelated Jump Distance (' conditions ')'];
errorbar_tick(h,100) %Added 12.20.10 by SL-N and SS; change the second
parameter (smaller = wider)
title(name)
xlabel('Separation Distance (\mum)')
ylabel('Average Correlation (\mum)')
h=errorbar(X,Y2,E2,'r')
errorbar_tick(h,100)
%errorbar(X,Y3,E3,'g')
legend('uncorrelated jump distance','jump magnitude')
%legend('uncorrelated jump distance','jump magnitude','jump to center of mass')
hold off
end
%
% compute jump correlation for individual data set
%
function jumpResults = jumpCorrelation(TracksI,TracksII,cutoff,binsize,pixelsize,tform)
if nargin > 5 % shift tracks2 if tform is given
tempX = TracksII(:,:,1);
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tempY = TracksII(:,:,2);
[tempX1,tempY1] = point_transform(tempX(:),tempY(:),tform);
tempX1(~tempX) = 0;
tempY1(~tempY) = 0;
TracksII(:,:,1) = reshape(tempX,[size(TracksII,1) size(TracksII,2)]);
TracksII(:,:,2) = reshape(tempY,[size(TracksII,1) size(TracksII,2)]);
end
% scale tracks by pixelsize
TracksI=TracksI*pixelsize;
TracksII=TracksII*pixelsize;
bin_num=round(cutoff/binsize);
cutoff=bin_num*binsize;
timesteps=size(TracksI,2);
sz=0;
for i=1:size(TracksI,1)
for j=1:size(TracksII,1)
for t=1:timesteps-1
% check if two tracks are close, if so check for correlation
% make zero condition applys to t and t+1 tracks
if TracksI(i,t,1)&&TracksII(j,t,1)
if TracksI(i,t+1,1)&&TracksII(j,t+1,1)
if
(sqrt((TracksI(i,t,1)-TracksII(j,t,1)).^2+(TracksI(i,t,2)TracksII(j,t,2)).^2)<=cutoff)
sz=sz+1;
%seperation distance
S=sqrt((TracksI(i,t,1)-TracksII(j,t,1)).^2+(TracksI(i,t,2)-TracksII(j,t,2)).^2);
%calculate center of mass (x and y)
COM = (1/2)*squeeze(TracksII(j,t,:)+TracksI(i,t,:));
%define jump vectors
J1=squeeze((TracksI(i,t+1,:)-TracksI(i,t,:)));
J2=squeeze((TracksII(j,t+1,:)-TracksII(j,t,:)));
%define jump vectors to COM
j1tocom=COM-squeeze(TracksI(i,t,:));
j2tocom=COM-squeeze(TracksII(j,t,:));
J1_COM=dot(J1,j1tocom/norm(j1tocom));
J2_COM=dot(J2,j2tocom/norm(j2tocom));
%define uncorrelated jump distance
D1=norm(J1-J1*dot(J1,J2/norm(J1)/norm(J2)));
D2=norm(J2-J2*dot(J2,J1/norm(J1)/norm(J2)));
%save data
jumpResults(sz,:)=[i j S COM(1) COM(2) J1(1) J1(2) J2(1) J2(2)
J1_COM J2_COM D1(1) D2(1) t];
end
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end
end
end
end
end
if ~exist('jumpResults','var')
jumpResults = [];
end
%%State trace examples
%%1 to 2 to 1 oscillations:
%%Results directory, filestring, and raw data
resdir
=
'Z:\Shal\Manuscripts\erbB1HomodimerLifetimes_Science\SupportingFigures\StateExam
ples\';
basename = 'EGF_12-16-11-46_ch1_8_ch2_19';
%EGF figure for 12-16-11-46
%Ch1:8; Ch2:19
%Raw data:
load('Z:\Shal\SPT Data\091216\EGF_A431_NPR-2009-12-16-11-46.mat')
%Raw channels:
load('Z:\Shal\SPT
Data\091216\Chamber1\Ru_EGF_A431_NPR-2009-12-16-1146.mat')
load('Z:\Shal\SPT Data\091216\Chamber1\L_EGF_A431_NPR-2009-12-16-11-46.mat')
%HMM_Data file:
uiopen('Z:\Shal\SPT
Data\GroupedData_A431_Final\HMM
Final\HMM
EGF\EGF_A431_NPR-2009-12-16-11-46.HMMData',1)
%Color overlay
load('Z:\Shal\SPT Data\091216\Chamber1\ColorOverlays\co_L_EGF_A431_NPR-200912-16-11-46.mat')
%Color overlay of both trajectories on one image (movie)
HMMDataFile = 'Z:\Shal\SPT Data\GroupedData_A431_Final\HMM
EGF\EGF_A431_NPR-2009-12-16-11-46.HMMData';
tracks = [8;19];
pix = 8;
scaleline = 0.5;
getframes = 1;
tailpoints = 1;
zm = 4;
fps = 20;
plotTracks = [1 1];
overlayChannels = [1 1];
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magenta = 1;
dataRep = 4;
CreateAVI = 'GaussFilterScaleMagenta';
Coloroverlay
=
SPT_CreateOverlay(HMMDataFile,tracks,pix,scaleline,getframes,tailpoints,zm,dataRep,
CreateAVI,fps,plotTracks,overlayChannels,magenta)
dataRep = 3;
CreateAVI = 'GaussFilterMagenta';
Coloroverlay
=
SPT_CreateOverlay_Threshold(HMMDataFile,tracks,pix,scaleline,getframes,tailpoints,z
m,dataRep,CreateAVI,fps,plotTracks,overlayChannels,magenta)
%Frames for stills
load('Z:\Shal\SPT Data\091216\Chamber1\ColorOverlays\co_L_EGF_A431_NPR-200912-16-11-46.mat')
g=co{2}; %extract 585 data
r=co{1}; %extract 655 data
g=g(5:21,91:107,130:end);
r=r(5:21,91:107,130:end);
gcrop=g(:,:,:); %crop frames
rcrop=r(:,:,:); %crop frames
gout=gaussf(gcrop,[0.7 0.7 0],'best') %crop frames
rout=gaussf(rcrop,[0.7 0.7 0],'best') %crop frames
cropco=joinchannels('RGB',stretch(rout),stretch(gout),stretch(rout))
%stills: Frames 0,70,293,316,371,427,615,695,833
x=833;
gframe=cropco{2}; %extract 585 data
rframe=cropco{1}; %extract 655 data
gcropframe=gframe(:,:,x) %crop frames
rcropframe=rframe(:,:,x) %crop frames
cropcoframe=joinchannels('RGB',rcropframe,gcropframe,rcropframe)
a=squeeze(cropcoframe);
[out,barlength] = scalebar(a,0.267,'bottomright','hor',0.5,0)
%3-D plot for fluctuating interactions
load('Z:\Shal\SPT
Data\GroupedData_A431_Final\HMM
EGF\EGF_A431_NPR-2009-12-16-11-46.HMMData','-mat')
xch1=HMM_Data.raw_ch1_tracks(8,:,1);
ych1=HMM_Data.raw_ch1_tracks(8,:,2);
s1=logical(xch1(:,:)); %find the valid points of trajectory 1
tmps1=find(s1,1); %start of trajectory 1
tmpe1=max(find(s1)); %end of trajectory 1
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l1=tmpe1-tmps1+1; %length of trajectory 1
xch2=HMM_Data.shifted_ch2_tracks(19,:,1);
ych2=HMM_Data.shifted_ch2_tracks(19,:,2);
s2=logical(xch2(:,:)); %find the valid points of trajectory 2
tmps2=find(s2,1); %start of trajectory 2
tmpe2=max(find(s2)); %end of trajectory 2
l2=tmpe2-tmps2+1; %length of trajectory 2
h(1,3) = figure;
ah = gca;
hsvline(squeeze(xch1),squeeze(ych1),HMM_Data.TimeStep,h(1,3),2,1,3,[],[],[],[1
1],[],[],1);
hold on
hsvline(squeeze(xch2),squeeze(ych2),HMM_Data.TimeStep,h(1,3),2,1,3,[],[],[],[0
0],[],[],1);
hold on
xlabel('X Coordinate')
ylabel('Y Coordinate')
zlabel('Time (s)')

0
1

saveas(gcf, [resdir basename '_3D'], 'jpg');
saveas(gcf, [resdir basename '_3D'], 'fig');
%2-State Distance and State Plot
uiopen('Z:\Shal\SPT
Data\GroupedData_A431_Final\HMM
EGF\2StateResults_ID100\EGF.HMMPP',1)
dimer=HMM_PreProcessData.FilledStates{109};
nn=3;
figure
d(nn,:)=sqrt((xch1-xch2).^2+(ych1-ych2).^2).*logical(xch1).*logical(xch2);
d=(d(nn,:).*0.267);
ax1 = gca;
set(ax1,'XColor',[0 0 0],'YColor',[0 0 0]);
axis([0 50 0 3.05]);
% xlabel('Time (s)')
% ylabel('Distance (\mu m)')
x1=[0.05:.05:50];
y1=d;
dvalids=logical(d);
hl1 = line(x1(dvalids),y1(dvalids),'Color','k','Parent',ax1,'linewidth',0.5);
axis([0 50 0 max(d)+0.05]);
hold on
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ID=0.1; %a horizontal line for the specified interaction distance
line([0.05;50],[ID;ID],'Color','m','linewidth',2,'LineStyle','--')
hold on
n=3; %pair number
trace=dimer(n,:);
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
x2=[0.05:.05:50];
y2=trace;
hl2 = line(x2,y2,'Color',[0 1 0]*0.6,'linewidth',3);
ax2 = gca;
set(ax2,'XColor','k','YColor','k');
axis([0 50 0 1.05]);
% xlabel('Time (s)')
% ylabel('State')
hold off
title('Distance between QDs of found dimers');
saveas(gcf, [resdir basename '_D_2state'], 'jpg');
saveas(gcf, [resdir basename '_D_2state'], 'fig');
%3-State Distance and State Plot
load('Z:\Shal\SPT
Data\GroupedData_A431_Final\HMM
EGF\EGF_3state_DD150nm_ID50nm.HMMPP','-mat')
state=HMM_PreProcessData.FilledStates{109};
nn=3; %which PairID element
figure
d(nn,:)=sqrt((xch1-xch2).^2+(ych1-ych2).^2).*logical(xch1).*logical(xch2);
d=(d(nn,:).*0.267);
ax1 = gca;
set(ax1,'XColor',[0 0 0],'YColor',[0 0 0]);
axis([0 50 0 3.05]);
xlabel('Time (s)')
ylabel('Distance (\mu m)')
x1=[0.05:.05:50];
y1=d;
dvalids=logical(d);
hl1 = line(x1(dvalids),y1(dvalids),'Color','k','Parent',ax1,'linewidth',0.5);
axis([0 50 0 max(d)+0.05]);
hold on
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path=state(:,nn)';
ax2 = axes('Position',get(ax1,'Position'),...
'XAxisLocation','top',...
'YAxisLocation','right',...
'Color','none',...
'XColor','k','YColor','k');
ylabel('State')
for pp=1:size(state,1)-1
seg1=path(:,pp);
seg2=path(:,pp+1);
x2=[0.05:.05:50];
if seg1==seg2
if seg1&&seg2==2
c=[1 0 1]*0.7;l=3; %domain %magenta
end
if seg1&&seg2==1
c=[0 0 1];l=3; %dimer %blue
end
if seg1&&seg2==3
c=[1 0 0];l=3; %free %red
end
else
c=[0 1 0]*0.8; l=0.75; %dk green
end
hl2 = line([x2(pp) x2(pp+1)],[seg1 seg2],'Color',c,'linewidth',l);
hold on
end
hold on
path=state(:,nn)';
ID=-0.02; %timeline
for pp=1:size(state,1)-1
seg1=path(:,pp);
seg2=path(:,pp+1);
x2=[0.05:.05:50];
if seg1==seg2
if seg1&&seg2==2
c=[1 0 1]*0.7;l=10; %domain %magenta
end
if seg1&&seg2==1
c=[0 0 1];l=10; %dimer %blue
end
if seg1&&seg2==3
c=[1 0 0];l=10; %free %red
end
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end
hl2 = line([x2(pp) x2(pp+1)],[ID ID],'Color',c,'linewidth',l);
hold on
end
axis([0 50 -0.055 2.75]);
title('Distance between found interactions');
saveas(gcf, [resdir basename '_D_state'], 'jpg');
saveas(gcf, [resdir basename '_D_state'], 'fig');
%Distance Only
%D between particles, with correction for pixel size
figure
d=sqrt((xch1-xch2).^2+(ych1-ych2).^2).*logical(xch1).*logical(xch2);
d=(d.*0.267);
ax1 = gca;
set(ax1,'XColor',[0 0 0],'YColor',[0 0 0]);
axis([0 50 0 3.05]);
xlabel('Time (s)')
ylabel('Distance (\mu m)')
x1=[0.05:.05:50];
y1=d;
dvalids=logical(d);
hl1 = line(x1(dvalids),y1(dvalids),'Color','k','Parent',ax1,'linewidth',2);
axis([0 50 0 max(d)+0.05]);
hold on
ID=0.06; %a horizontal line for the specified interaction distance
line([0.05;50],[ID;ID],'Color','m','linewidth',2,'LineStyle','--')
hold off
function h = HMM_DvsLifetime(datapath,filestring,ppfilestring,resdir,deltaT)
% Generate P(r2) as in de Keijzer et al., JCS 2008
%
% h = HMM_DvsLifetime(datapath,filestring,ppfilestring,resdir,deltaT)
%
% Inputs are location of trajectories, delta T, 1 or 2 component fit, sigma
% DeltaT is in frames (not time step)
% Read in tracks & valids
%
% INPUTS
% datapath - String; path to files of type .HMMData
% filestring - String of the type '*.HMMData'
% ppfilestring - String of the type '*.HMMPP'
% resdir - Results directory where fit results and plots are saved

269

% deltaT - Step size for jumps to be calculated
% OUTPUT
% h - Handle for figure
%
% Written by Shalini Low-Nam
% August 2010
%% Input example:
% datapath='Z:\Shal\SPT Data\GroupedData_A431_Final\HMM Final\HMM EGF\';
% filestring='EGF*.HMMData';
% ppfilestring='*.HMMPP';
% resdir=[datapath 'DvsLifetime\'];
% mkdir(resdir);
%% Determine Lengths of Dimers
T=1000;
ppFile=dir([datapath ppfilestring]);
HMM_PreProcessFile=([datapath ppfilestring]);
load([datapath ppFile.name],'-mat'); %load HMM_PreProcessData file
tmp=max(strfind(HMM_PreProcessFile,'\'));
fnbase=HMM_PreProcessFile(tmp+1:end-6);
FS=HMM_PreProcessData.FilledStates; %states of interactions
Nfiles=size(FS,2);
Files=dir([datapath filestring]);
cnt=1;
multi=1;
deltaT=2; %calculate jump size for specific bin of deltaT
inc=0;sdinc=0;sz=1;sdsz=1;
clear sdr2 r2sort ystep Firstr2 Multir2
Firstr2=[];
Multir2=[];
%%
for nf=1:Nfiles %Loop over number of files
fprintf('Analyzing File: %d of %d\n',nf,Nfiles)
filename = Files(nf).name;
load([datapath filename],'-mat'); %load HMM_Data file
pair=HMM_PreProcessData.PairID(Lund et al.);
if size(FS(Lund et al.),1) == 0
fprintf('No interactions; proceeding to next data set ...\n')
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continue
end
for pp=1:size(FS(Lund et al.),2) %Loop over number of pairs
ch1spot=pair(pp,1);
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
v1=HMM_Data.ch1_valids(ch1spot,:);
s=FS(Lund et al.);
mask=s==1;
ds=s.*mask;
dimers=ds(:,pp);
[a]=find(dimers); %Find all dimers within dataset
if size(a,1) ~= 0
if size(a,1) ~= (a(end,1)-a(1,1))+1
for mm=1:size(find(diff(a)>1))+1 %Loop over number of multiple dimers
z=(find(diff(a)>1));
if mm == 1
sf=a(1,1);
ef=a(min(find(diff(a)>1)));
Multi(multi,1)=ef-sf+1;
multi=multi+1;
for ii=sf:deltaT:ef-deltaT
p1=ii;
p2=ii+deltaT;
if v1(1,p1)&&v1(1,p2)
inc=inc+1;
Multir2(inc,1) = (xch1(:, p1)-xch1(:, p2))^2 + (ych1(:, p1)-ych1(:,
p2))^2;
end
end
%
meanr2(sz,:)=[median(Multir2) (ef-sf+1)];
meanr2(sz,:)=[mean(Multir2) (ef-sf+1)];
sz=sz+1;
else
sfm=a(z(mm-1,1)+1,1);
if mm+1 <= size(find(diff(a)>1),1)+1
efm=a(z(mm,1),1); %could exceed mm
else
efm=a(end,1);
end
Multi(multi,1)=efm-sfm+1;
multi=multi+1;
for ii=sfm:deltaT:efm-deltaT
p1=ii;
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p2=ii+deltaT;
if v1(1,p1)&&v1(1,p2)
inc=inc+1;
Multir2(inc,1) = (xch1(:, p1)-xch1(:, p2))^2 + (ych1(:, p1)-ych1(:,
p2))^2;
end
end
%
meanr2(sz,:)=[median(Multir2) (efm-sfm+1)];
meanr2(sz,:)=[mean(Multir2) (efm-sfm+1)];
sz=sz+1;
Multir2 = []; %PJC 9-21-10
inc = 0; %PJC 9-21-10
clear sf ef sfm efm
end
end
end
end
end
clear ch1spot xch1 ych1 v1 s mask ds dimers a
for rr=1:size(FS(Lund et al.),2) %Loop over number of pairs %This is happening
multiple times! should only be done once!
ch1spot=pair(rr,1);
xch1=HMM_Data.raw_ch1_tracks(ch1spot,:,1);
ych1=HMM_Data.raw_ch1_tracks(ch1spot,:,2);
v1=HMM_Data.ch1_valids(ch1spot,:);
s=FS(Lund et al.);
mask=s==1;
ds=s.*mask;
dimers=ds(:,rr);
[a]=find(dimers); %Find all dimers within dataset
if size(a,1) ~= 0
if size(a,1) == (a(end,1)-a(1,1))+1
SingleDimer(cnt,1)=size(a,1)+1; %Length of single dimer events
cnt=cnt+1;
for jj=a(1,1):deltaT:a(end,1)-deltaT
p1=jj;
p2=jj+deltaT;
if v1(1,p1)&&v1(1,p2)
sdinc=sdinc+1;
sdr2(sdinc,1) = (xch1(:, p1)-xch1(:, p2))^2 + (ych1(:, p1)-ych1(:, p2))^2;
end
end
%
sdmeanr2(sdsz,:)=[median(sdr2) (a(end,1)-a(1,1)+1)];
sdmeanr2(sdsz,:)=[mean(sdr2) (a(end,1)-a(1,1)+1)];
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sdr2=[];
sdinc = 0; %PJC 9-21-10
sdsz=sdsz+1;
else
continue
end
end
clear a
end
clear s mask ds
end
if sz==1 %PJC 9-21-10
Firstr2=[];
Multir2=[];
meanr2=[];
fmeanr2=sdmeanr2;
fmeanr2=[meanr2;sdmeanr2];
save([resdir '\DvsLifetime'],'meanr2','sdmeanr2','fmeanr2');
else
fmeanr2=[meanr2;sdmeanr2];
save([resdir '\DvsLifetime'],'meanr2','sdmeanr2','fmeanr2');
end
%% Plot
a=figure
axis([0 50 0 0.3]);
plot(fmeanr2(:,2)./20,fmeanr2(:,1),'bo')
xlabel('Length of Dimer (seconds)')
ylabel('Average r^2 (pix^2)')
title('Mean r^2 for All Dimers')
saveas(a,[resdir '\DvsLifetime_AllDimers' ],'fig');
saveas(a,[resdir '\DvsLifetime_AllDimers' ],'tif');
b=figure
axis([0 50 0 0.3]);
plot(meanr2(:,2)./20,meanr2(:,1),'ko')
hold on
plot(sdmeanr2(:,2)./20,sdmeanr2(:,1),'mo')
xlabel('Length of Dimer (seconds)')
ylabel('Average r^2 (pix^2)')
legend('Multiple Dimer Events','Single Dimer Event')
title('Mean r^2 for Dimers')
saveas(b,[resdir '\DvsLifetime_DimersByType' ],'fig');
saveas(b,[resdir '\DvsLifetime_DimersByType' ],'tif');
close all
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APPENDIX E – SUPLEMENTARY INFORMATION FOR CH. 4

Supplemental Figure 4.1. Results from a TranSignal phosphotyrosine profiling (SH2)
array. SKBR3 cell lysates were prepared from cells after 2 min HRG stimulation (12
nM). SH2 array membranes were incubated with cell lysates, sequentially probed with
1o antibodies for erbB3 or erbB2 and HRP-conjugated 2o antibodies, and
chemiluminescence was detected using the ECL method. Quantitative data were
acquired using a Genegenome densitometer and plotted for each kinase. ErbB3specific binding was only detected for p85, a known binding partner of erbB3. An array
probed with erbB3 is shown (inset).
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Supplemental Figure 4.2. In addition to enhancing kinase activity, the E933Q gain-offunction mutation enhances sensitivity of erbB3 to low doses of ligand. All data was
collected from CHO cells stably expressing either erbB3WT-mCit or erbB3E933Q-mCit as
indicated.

(A,B) Fluorescence microscopy images showing transfected CHO cells

expressed erbB3-mCit at the cell membrane. (C) Western blots of total lysates from
CHO transfectants after cells were treated with varying concentrations of HRG. Blots
were probed with antibodies for phospho-or total erbB3. ErbB3 tyrosine phosphorylation
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(PY1289) was maximal at low doses of HRG in cells expressing erbB3E933Q-mCit. (D)
Akt, the major downstream target of erbB3, showed similarly enhanced phosphorylation
in E933Q transfectants at low HRG doses. (E) Co-precipation of the p85 subunit of PI 3Kinase is also maximal at low doses of HRG in cells expressing the gain-of-function
mutant.

Band intensities for blots in C, D and E were quantified and the ratio of

phospho-protein to total protein (C,D) or relative band intensity (E) was plotted with
respect to HRG concentration in the graphs on the right.

Supplemental Figure 4.3. Effect of 2C4 treatment on CHO cells transfected with
ErbB3WT-mCit or ErbB3E933Q-mCit. Western blot of total lysates from CHO cells
expressing ErbB3WT-mCit or ErbB3E933Q-mCit treated with 12 nM HRG, 2C4 or both as
labeled above. Treatment with 2C4 reduces both ErbB3WT –mCit and ErbB3E933Q-mCit
phosphorylation, but ErbB3E933Q -mCit has a higher level of residual ErbB3 and Akt
phosphorylation after treatment.

276

Supplemental Figure 4.4. Biotinylated HRG (bHRG) and QDot-HRG activate ErbB3 as
well as unmodified HRG. SKBR3 cells were serum-starved for 4 hours and then
stimulated for 2 min. with 12 nM HRG, biotinylated NRG or NRG conjugated to QDs.
All 3 conditions show increased phospho-ErbB3. Total ErbB3 was used as a loading
control
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.

Supplemental Figure 4.5. Estimated distance from the center of QD pairs in
heterodimer and homodimers. Structural information for ErbB1 dimer distances (and
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ligand, ErbB2 and its FAB antibody, and reported Qdot diameters (Antelman, 2009) was
used to estimate the distance between pairs of quantum dots, an important parameter
for image analysis. Note that QD655 is not spherical and the longest diameter for the
QD655 was used thus the calculations give an upper estimate of the Qdot distances in
a dimer. A ErbB3 homodimer distance between Qdots. The model is based on the
EGFR homodimer crystal structure (along with calculations suggesting that ErbB3
homodimer distances would be comparable (Warren et al, 2006). B ErbB2/ErbB3
heterodimer. Distances are based on the crystal structure of the Trastuzumab FAB
bound to domain IV of the ErbB2 extracellular region (Cho et al, 2003). W e assumed
rotation of Domain IV to allow dimerization.
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Supplemental Figure 4.6. Distanct plots of candidate pairs from single particle
tracking. A) ErbB3 homodimer candidates based on separation distances between two
color HRG/HRG QDot tracking have long periods where pairs are at or near the
estimated dimer distance. B) ErbB2/ErbB3 heterodimer candidates (HRG/Trastuzumab
Qdots) generally approach the estimated dimer distance and then separate quickly.
Rare instances show receptors staying together for longer time periods.

C) ErbB2

dimer candidates (two-color Trastuzumab Qdots) generally show short interactions with
an occasional pair cstaying together for longer time periods.

The purple line indicates

the estimated distance between two Qdots in a given dimer based on distances shown
in Supplemental Figure 4.
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